8-K - NKLR - Equibles

UNITED

STATES

SECURITIES

AND EXCHANGE COMMISSION

Washington,

D.C. 20549

FORM

8-K

CURRENT

REPORT

PURSUANT

TO SECTION 13 OR 15(d)

OF

THE SECURITIES EXCHANGE ACT OF 1934

Dateof Report (Date of earliest event reported): October 9, 2025

TerraInnovatum Global N.V.

(Exactname of registrant as specified in its charter)

Netherlands	001-42901	N/A
(State or other jurisdiction<br><br> <br>of incorporation)	(Commission File Number)	(I.R.S. Employer<br><br> <br>Identification No.)
Via della Chiesa XXXII,<br><br> <br>759Lucca, Italy	55100
---	---
(Address of principal executive offices)	(Zip Code)

+39

0583 55797

(Registrant’stelephone number, including area code)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐	Written<br> communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐	Soliciting<br> material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
---	---
☐	Pre-commencement<br> communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
---	---
☐	Pre-commencement<br> communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
---	---

Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Trading Symbol(s)	Name of each exchange<br><br> <br>on which registered
Ordinary Shares, par value EUR 0.01 per share	NKLR	The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (Sec.230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (Sec.240.12b-2 of this chapter).

Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

INTRODUCTORY

NOTE

Unless the context otherwise requires, “we,” “us,” “our,” “PubCo,” “Terra” and the “Company” refer to Terra Innovatum Global N.V., a public limited liability company organized under Dutch law and its consolidated subsidiaries following the Closing (as defined below). Unless the context otherwise requires, references to “GSR III” refer to GSR III Acquisition Corp., a Cayman Islands exempted company, prior to the Closing and a wholly-owned subsidiary of Terra following Closing. All references herein to the “Board” refer to the board of directors of the Company.

Terms used in this Current Report on Form 8-K (this “Report”) but not defined herein, or for which definitions are not otherwise incorporated by reference herein, shall have the meaning given to such terms in the Proxy Statement/Prospectus (as defined below) in the section entitled “Frequently Used Terms” beginning on page 3 thereof, and such definitions are incorporated herein by reference.

Item1.01. Entry into a Material Definitive Agreement.

BusinessCombination

As disclosed under the sections entitled “The Business Combination Proposal” beginning on page 247 of the proxy statement/prospectus (the “Proxy Statement/Prospectus”) filed with the Securities and Exchange Commission (the “SEC”) by GSR III on September 16, 2025, Terra Innovatum s.r.l., an Italian limited liability company (“Terra OpCo”) entered into a business combination agreement (as amended, the “Business Combination Agreement”), dated April 21, 2025, with GSR III. Pursuant to several transactions contemplated under the Business Combination Agreement, Terra OpCo caused to be formed Terra Innovatum Global s.r.l., an Italian limited liability company (Italian Società a responsabilità limitata) with the same quotaholders in the same ownership percentages as Terra Opco, (“New TopCo”); New TopCo converted into a limited liability company organized under Dutch law, referred to herein as “Terra”; GSR III was merged with and into GSR III Cayman Merger Sub ( a wholly-owned subsidiary of Terra), with GSR III surviving the merger as a wholly owned subsidiary of Terra (the “Merger” and, together with the other transactions contemplated by the Business Combination Agreement, the “Business Combination”).

As previously reported on the Current Report on Form 8-K filed with the SEC on October 14, 2025, GSR III held an extraordinary general meeting of shareholders on October 7, 2025 (the “Special Meeting”), at which GSR III shareholders considered and adopted, among other matters, a proposal to approve the Business Combination, including (a) adopting the Business Combination Agreement and (b) approving the other transactions contemplated by the Business Combination Agreement and related agreements described in the Proxy Statement/Prospectus.

Pursuant to the terms and subject to the conditions set forth in the Business Combination Agreement, following the Special Meeting, on October 9, 2025 (the “Closing Date”), the Business Combination was consummated (the “Closing”).

Item 2.01 of this Report discusses the consummation of the Business Combination and the entry into agreements relating thereto and is incorporated herein by reference.

RegistrationRights Agreement

On October 9, 2025, in connection with the consummation of the Business Combination and as contemplated by the Business Combination Agreement, GSR III Sponsor LLC, prior independent directors of GSR III, members of management of Terra and certain other investors entered into a registration rights agreement (the “Registration Rights Agreement”). The material terms of the Registration Rights Agreement are described in the section of the Proxy Statement/Prospectus beginning on page 128 titled “Ancillary Agreements – RegistrationRights Agreement.” Such description is qualified in its entirety by the text of the Registration Rights Agreement, which is included as Exhibit 10.1 to this Report and is incorporated herein by reference.

PIPEAgreements

As previously announced, on September 23, 2025, GSR III entered into Subscription Agreements (the “PIPE Subscription Agreement”) with certain accredited investors (the “Subscribers”), pursuant to which GSR III agreed to issue and sell, in a private placement (the “PIPE Financing”), 3,184,000 of its ordinary shares (the “PIPE Shares”), warrants to purchase up to 1,592,000 ordinary shares of GSR III at $12.00 per share (the “Half Warrants”) and warrants to purchase up to 796,000 ordinary shares of GSR III at $16.00 per share (the “Quarter Warrants”, and together with the Half Warrants, the “PIPE Warrants”), for an aggregate total of approximately $31.8 million.

Subsequent to September 23, 2025, GSR III entered into PIPE Subscription Agreements for an additional 499,500 PIPE Shares, Half Warrants to purchase up to 249,750 ordinary shares, and Quarter Warrants to purchase up to 124,875 ordinary shares, for an aggregate total of approximately $4.99 million.

The PIPE Warrants, issued in connection with closing of the PIPE Financing, are exercisable immediately upon issuance and have a term of five years from the date of issuance. The PIPE Shares and PIPE Warrants, as well as the ordinary shares issuable upon exercise of the PIPE Warrants, are subject to registration rights as described therein. Such description of the PIPE Subscription Agreement and the PIPE Warrants are qualified in their entirety by the text of the PIPE Subscription Agreement and PIPE Warrants, which are included as Exhibits 10.4, 4.1 and 4.2, respectively, and are incorporated herein by reference.

On October 9, 2025, Terra entered into an assumption and assignment agreement with GSR III (the “Assignment Agreement”), pursuant to which Terra assumed all rights and obligations of GSR III under the PIPE Subscription Agreement and PIPE Warrants. Such description is qualified in its entirety by the text of the Assignment Agreement, which is included as Exhibit 10.5 to this Report and is incorporated herein by reference.

The PIPE Shares and the PIPE Warrants issued and sold in the PIPE Investment have not been registered under the Securities Act of 1933 (the “Securities Act”) and have been issued in reliance on the availability of an exemption from such registration.

BridgeLoans

As disclosed in the Proxy Statement/Prospectus, between May 2025 and August 2025, Terra Innovatum entered into convertible bridge loans for gross cash proceeds of $5.0 million (the “Bridge Loans”). The Bridge Loans bear interest at the rate of 15.00% per annum, payable in kind (“PIK”) calculated on the outstanding principal balance. On the Closing, the principal and accrued interest on the Bridge Loans converted into 752,326 ordinary shares of the Company (“Ordinary Shares” or “PubCo Ordinary Shares”), in the aggregate, at a conversion price of $7.00 per share. Additionally, in connection with the Bridge Loans, as amended in August 2025, Terra Innovatum committed to issue to the Bridge Loan Lenders following the business combination (i) warrants to purchase at an exercise price of $11.50 per share the number of Ordinary Shares equal to 100% of the number of Ordinary Shares into which the applicable Bridge Loan will convert into at Closing and (ii) warrants to purchase at an exercise price of $15.00 per share the number of Ordinary Shares equal to 100% of the number of Ordinary Shares into which the applicable Bridge Loan will convert into at Closing (the “Bridge Warrants”). The Bridge Warrants have an exercise period of 36 months from the Closing.

In August 2025 and September 2025, for certain lenders (“the lenders”), Terra Innovatum amended the terms of their outstanding Bridge Loan agreements including the terms of the associated warrant commitments. For the existing warrant commitments having an exercise price of $11.50 per share, the amendments increased the number of shares underlying such warrants to equal 100% of the shares issuable upon conversion of the Bridge Loans, and shortened the exercise period of warrants held by certain lenders from 48 months to 36 months. Additionally, Terra Innovatum added a commitment to issue to the lenders new warrants having a number of underlying common shares equal to 100% of the shares issuable upon conversion of the Bridge Loans and an exercise price of $15.00 per share.

In September 2025 Terra Innovatum entered into additional Bridge Loans for additional aggregate proceeds of $690,000 having comparable terms as the original Bridge Loans, as amended, including with respect to warrant coverage and terms of the Bridge Warrants for the additional Bridge Loans. On the Closing, the principal and accrued interest on the additional Bridge Loans converted into 99,157 Ordinary Shares, in the aggregate, at a conversion price of $7.00 per share.

The description of the Bridge Warrants is qualified in its entirety by the text of the Bridge Warrants, a form of which is included as Exhibit 4.3, and is incorporated herein by reference.

Item2.01 Completion of Acquisition or Disposition of Assets.

The disclosure set forth in the “Introductory Note” above is incorporated into this Item 2.01 by reference. In addition, the material terms of the Business Combination are described in greater detail in the Proxy Statement/Prospectus in the section titled “Proposal No. 1—The Business Combination Proposal” beginning on page 247 thereof, which is incorporated herein by reference.

On October 7, 2025, GSR III held the Special Meeting, at which the GSR III shareholders considered and adopted, among other matters, a proposal to approve the Business Combination. The Business Combination was consummated on October 9, 2025.

FORM

10 INFORMATION

Item 2.01(f) of Form 8-K provides that if the predecessor registrant was a “shell company” (as such term is defined in Rule 12b-2 under the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), as GSR III was immediately before the Business Combination, then the registrant must disclose the information that would be required if the registrant were filing a general form for registration of securities on Form 10. Accordingly, the Company is providing the information below that would be included in a Form 10 if it were to file a Form 10. Please note that the information provided below relates to the combined company after the consummation of the Business Combination, unless otherwise specifically indicated or the context otherwise requires.

CautionaryNote Regarding Forward-Looking Statements

This Report includes statements that express Company’s opinions, expectations, beliefs, plans, objectives, assumptions or projections regarding future events or future results and therefore are, or may be deemed to be, “forward-looking statements.” These forward-looking statements can generally be identified by the use of forward-looking terminology, including the terms “believes,” “estimates,” “anticipates,” “expects,” “seeks,” “projects,” “intends,” “plans,” “may” or “should” or, in each case, their negative or other variations or comparable terminology. These forward-looking statements include all matters that are not historical facts. They appear in a number of places throughout this Report (including in information that is incorporated by reference into this Report) and include statements regarding Terra’s intentions, beliefs or current expectations concerning, among other things, the results of operations, financial condition, liquidity, prospects, growth, and strategies of Terra and the markets in which Terra operates. Such forward-looking statements are based on available current market material and management’s expectations, beliefs and forecasts concerning future events impacting Terra. Factors that may impact such forward-looking statements include:

●	the<br>ability to implement business plans, forecasts, and other expectations after the completion of the Business Combination, and identify<br>and realize additional opportunities;
●	the<br>risk of downturns and the possibility of rapid change in the highly competitive industry in which Terra operates;
---	---

●	the<br>risk that Terra and its current and future collaborators are unable to successfully develop and commercialize Terra’s products<br>or services, or experience significant delays in doing so;
●	the<br>risk that Terra may never achieve or sustain profitability;
---	---
●	the<br>risk that Terra will need to raise additional capital to execute its business plan, which may not be available on acceptable terms or<br>at all;
---	---
●	the<br>risk that Terra experiences difficulties in managing its growth and expanding operations;
---	---
●	the<br>risk that third-party suppliers and manufacturers are not able to fully and timely meet their obligations;
---	---
●	the<br>risk of product liability or regulatory lawsuits or proceedings relating to Terra’s products and services;
---	---
●	the<br>risk that Terra is unable to secure or protect its intellectual property;
---	---
●	the<br>risk that Terra will not be able to maintain the listing of its securities on Nasdaq;
---	---
●	the<br>price of Terra’s securities may be volatile due to a variety of factors, including changes in the competitive industries in which<br>Terra plans to operate, variations in performance across competitors, changes in laws and regulations affecting Terra’s business<br>and changes in the combined capital structure; and
---	---
●	other<br>factors detailed under the section titled “Risk Factors” beginning on page 23 of the Proxy Statement/Prospectus and incorporated<br>herein by reference.
---	---

The foregoing list of factors is not exhaustive. You should carefully consider the foregoing factors and the other risks and uncertainties described in the “Risk Factors” section of the other documents filed by Terra from time to time with the SEC. The forward-looking statements contained in this Report and in any document incorporated by reference are based on current expectations and beliefs concerning future developments and their potential effects on Terra. There can be no assurance that future developments affecting Terra will be those that Terra has anticipated. Terra undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as may be required under applicable securities laws.

Business

Terra’s business is described in the Proxy Statement/Prospectus in the section titled “Business of Terra Innovatum” beginning on page 154, which is incorporated herein by reference. ****

RiskFactors

The risks associated with Terra’s business are described in the Proxy Statement/Prospectus in the section titled “Risk Factors” beginning on page 23 and are incorporated herein by reference. A summary of the risks associated with Terra’s business is also included beginning on page 18 of the Proxy Statement/Prospectus under the heading “Summary Risk Factors” and are incorporated herein by reference.

FinancialInformation

The audited financial statements of GSR III as of December 31, 2024 and 2023 and for the year ended December 31, 2024 and for the period from May 10, 2023 (inception) through December 31, 2023 are included in the Proxy Statement/Prospectus beginning on page F-19, which are incorporated herein by reference.

The audited financial statements of Terra Opco as of December 31, 2024 and 2023 and for the years ended December 31, 2024 and 2023 are included in the Proxy Statement/Prospectus beginning on page F-37, which are incorporated herein by reference.

The audited financial statements of New TopCo as of April 29, 2025 and for the period beginning April 29, 2025 (inception) and ended April 29, 2025, are included in the Proxy Statement/Prospectus beginning on page F-68, which are incorporated herein by reference.

The unaudited financial statements of GSR III as of June 30, 2025 and for the periods ended June 30, 2025 and 2024 are included in the Proxy Statement/Prospectus beginning on page F-2, which are incorporated herein by reference.

The unaudited consolidated financial statements of New TopCo as of June 30, 2025 and for the periods ended June 30, 2025 and 2024 are included in the Proxy Statement/Prospectus beginning on page F-51, which are incorporated herein by reference.

The unaudited pro forma condensed combined financial information of New TopCo and GSR III as of and for the six months ended June 30, 2025 and for the year ended December 31, 2024 is set forth in Exhibit 99.1 hereto and is incorporated herein by reference.

Management’sDiscussion and Analysis of Financial Condition and Results of Operations

Management’s discussion and analysis of the financial condition and results of operation of NewTopco for the years ended December 31, 2024 and 2023 and the six months ended June 30, 2025 and 2024 are included in the Proxy Statement/Prospectus beginning on page 165, which are incorporated herein by reference.

Management’s discussion and analysis of the financial condition and results of operation of GSR III for the years ended December 31, 2024 and 2023 and the six months ended June 30, 2025 and 2024 are included in the Proxy Statement/Prospectus beginning on page 205, which are incorporated herein by reference

Properties

The Company’s headquarters is located in Lucca, Italy. Its workplace is described in the Proxy Statement/Prospectus in the section titled “Information About Terra Innovatum –Human Capital” on page 164 and that information is incorporated herein by reference.

SecurityOwnership of Certain Beneficial Owners and Management

The following table sets forth information known to us regarding the beneficial ownership of our Ordinary Shares immediately following consummation of the Transactions by:

●	each<br> person who is the beneficial owner of more than 5% of the outstanding shares of our Ordinary<br> Shares;
●	each<br> of our named executive officers and directors; and
---	---
●	all<br> of our executive officers and directors as a group.
---	---

Beneficial ownership is determined according to the rules of the SEC, which generally provide that a person has beneficial ownership of a security if he, she or it possesses sole or shared voting or investment power over that security, including options and warrants that are currently exercisable or exercisable within 60 days. Except as described in the footnotes below and subject to applicable community property laws and similar laws, we believe that each person listed above has sole voting and investment power with respect to such shares.

The beneficial ownership of our Common Stock is based on (i) 70,300,948 ordinary shares issued and outstanding immediately following consummation of the Transactions, (ii) 1,000,000 PubCo Ordinary Shares potentially issuable to PAC upon the exercise of a warrant issued upon the Closing of the Business Combination, (iii) 1,702,966 PubCo Ordinary Shares potentially issuable upon the exercise of warrants issued upon the Closing of the Business Combination to certain Bridge Loan lenders, and (iv) 2,762,625 PubCo Ordinary Shares potentially issuable to the PIPE Financing subscribers upon the exercise of the PIPE Warrants issued upon the Closing of the Business Combination. All such warrants are exercisable within 60 days of the Closing.

BeneficialOwnership Table

	Actual Redemptions^(1)^
Name and Address of Beneficial Owner^(13)^	Number of PubCo Ordinary Shares		% of PubCo<br><br>Ordinary Shares
Directors and Executive Officers of PubCo
Alessandro Petruzzi^(2)(12)^		25,840,000		34.1	%
Cesare Frepoli^(3)^		12,920,000		17.1	%
Marco Cherubini^(4)(12)^		25,840,000		34.1	%
Massimo Morichi^(5)^		4,275,000		5.6	%
Guillaume Moyen^(6)^		237,500		*
Giordano Morichi^(7)^		3,800,000		5.0	%
Rex S. Jackson		-		0.0	%
Martha J. Crawford		-		0.0	%
Katherine Williams		-		0.0	%
Michael Howard		-		0.0	%
Peter Hastings		-		0.0	%
All PubCo directors and executive officers as a group (eleven individuals)		47,072,500		61.8	%
5% Holders of PubCo Ordinary Shares
GSR III Sponsor LLC^(8)^		5,934,346		7.8	%
NINENG S.R.L.^(12)^		25,840,000		34.1	%
Gus Garcia^(8)(9)^		5,956,012		7.9	%
Lewis Silberman^(8)(10)^		5,951,608		7.9	%
Anantha Ramamurti^(8)(11)^		5,951,560		7.9	%
Cesare Frepoli^(3)^		12,920,000		17.1	%
Massimo Morichi^(5)^		4,275,000		5.6	%
Giordano Morichi^(7)^		3,800,000		5.0	%
*	Less<br> than one percent.
---	---
(1)	The<br>Post-Business Combination percentage of beneficial ownership is calculated based on an aggregate of 75,766,539 PubCo Ordinary Shares<br>which includes (i) 70,300,948 PubCo Ordinary Shares issued and outstanding on the Closing Date. This amount includes 8,524,394 GSR III<br>Class A ordinary shares that were subject to possible redemption which GSR III public shareholders elected not to redeem in connection<br>with the Business Combination, (ii) 1,000,000 PubCo Ordinary Shares potentially issuable to Moonshot’s partners upon the exercise of a warrant issued<br>upon the Closing of the Business Combination, (iii) 1,702,966 PubCo Ordinary Shares potentially issuable upon the exercise of warrants<br>issued upon the Closing of the Business Combination to certain Bridge Loan lenders, and (iv) 2,762,625 PubCo Ordinary Shares potentially<br>issuable to the PIPE Financing subscribers upon the exercise of the PIPE Warrants issued upon the Closing of the Business Combination.<br>All such warrants are exercisable within 60 days of the Closing.
---	---

(2)	Includes<br>25,840,000 PubCo Ordinary Shares held by NINENG S.R.L., a holding company, which is beneficially owned 50% by Alessandro Petruzzi and<br>50% by Marco Cherubini.
(3)	Includes<br>12,920,000 PubCo Ordinary Shares held by Cesare Frepoli upon the Closing.
---	---
(4)	Includes<br>25,840,000 PubCo Ordinary Shares held by NINENG S.R.L., a holding company upon Closing, which is beneficially owned 50% by Alessandro<br>Petruzzi and 50% by Marco Cherubini.
---	---
(5)	Includes<br>4,275,000 PubCo Ordinary Shares held by Massimo Morichi upon the Closing.
---	---
(6)	Includes<br>237,500 PubCo Ordinary Shares held by Guillaume Moyen upon the Closing.
---	---
(7)	Includes<br>3,800,000 PubCo Ordinary Shares held by Giordano Morichi upon the Closing.
---	---
(8)	GSR III Sponsor LLC is<br> the record holder of the PubCo Ordinary Shares reported herein consisting of the following GSR III Ordinary Shares which were<br> exchanged on a one-for-one basis for PubCo Ordinary Shares on the Closing Date: (i) 5,495,000 GSR III Class B Ordinary Shares,<br> including 549,500 Vesting Sponsor Shares, subject to the vesting conditions pursuant to the Business Combination Agreement as the<br> Sponsor will retain voting power with respect to the Vesting Sponsor Shares, (ii) 384,428 GSR III Class A Ordinary Shares, and (iii)<br> 54,918 Private Placement Rights. Gus Garcia, Lewis Silberman, and Anantha Ramamurti are the managers of the Sponsor, who by virtue<br> of their control may be deemed to share beneficial ownership of the shares held by the Sponsor. Each of Mr. Garcia, Silberman,<br> and Ramamurti disclaims beneficial ownership of the shares held by the Sponsor except of any pecuniary interest therein. The<br> foregoing does not include the immediate distribution of all PubCo Ordinary Shares held by Sponsor to certain third parties and<br> affiliates concurrently with the Closing. The address for GSR III Sponsor LLC is 5900 Balcones Drive, Suite 100, Austin, Texas<br> 78731.
---	---
(9)	Includes<br>(i) 5,934,346 PubCo Ordinary Shares held by the Sponsor upon the Closing, of which Gus Garcia may be deemed to share beneficial<br>ownership of the shares held by the Sponsor, (ii) 7,222 PubCo Ordinary Shares underlying the conversion of the Bridge Loans upon<br>the Closing, and (iii) 14,444 PubCo Ordinary shares underlying the warrants in connection with the Bridge Loans which become exercisable<br>for PubCo Ordinary shares upon the Closing. The foregoing does not include the immediate distribution of all PubCo<br>Ordinary Shares held by Sponsor to certain third parties and affiliates concurrently with the Closing.
---	---
(10)	Includes<br>(i) 5,934,346 PubCo Ordinary Shares held by the Sponsor upon the Closing, of which Lewis Silberman may be deemed to share beneficial<br>ownership of the shares held by the Sponsor, (ii) 5,754 PubCo Ordinary Shares underlying the conversion of the Bridge Loans upon<br>the Closing, and (iii) 11,508 PubCo Ordinary shares underlying the warrants in connection with the Bridge Loans which become exercisable<br>for PubCo Ordinary shares upon the Closing. The foregoing does not include the immediate distribution of all<br>PubCo Ordinary Shares held by Sponsor to certain third parties and affiliates concurrently with the Closing.
---	---
(11)	Includes<br>(i) 5,934,346 PubCo Ordinary Shares held by the Sponsor upon the Closing, of which Anantha Ramamurti may be deemed to share beneficial<br>ownership of the shares held by the Sponsor, (ii) 5,738 PubCo Ordinary Shares underlying the conversion of the Bridge Loans upon<br>the Closing, and (iii) 11,476 PubCo Ordinary shares underlying the warrants in connection with the Bridge Loans which become exercisable<br>for PubCo Ordinary shares upon the Closing. The foregoing does not include the immediate distribution of all PubCo<br>Ordinary Shares held by Sponsor to certain third parties and affiliates concurrently with the Closing.
---	---
(12)	NINENG<br>S.R.L., is the record holder of the PubCo Ordinary Shares reported herein. Alessandro Petruzzi and Marco Cherubini are the sole members<br>and managers of NINENG S.R.L., and share voting and dispositive power over the Ordinary Shares. The address for NINENG S.R.L., is Lucca<br>(LU), via di Poggio 34 CAP 55100.
---	---
(13)	Unless<br>otherwise noted, the business address of each of the following entities or individuals is Via della Chiesa XXXII, 759 Lucca, Italy.
---	---

Managementof the Company

DirectorIndependence

Terra’s independent directors are described in the Proxy Statement/Prospectus in the section titled “Board Of Directors And Senior ManagementOf Pubco After The Business Combination-Independence of the Board of Directors” beginning on page 187 and that information is incorporated herein by reference.

The Board committees to which each director of Terra has been appointed is described in a Prospectus Supplement to the Proxy Statement/Prospectus, filed with the SEC on October 2, 2025, in the section titled “Additional Supplementary Information – Committees of theBoard of Directors” on page 32 and that information is incorporated herein by reference.

Committeesof the Board

The Combined Company’s Board has three standing committees: Audit Committee, Compensation Committee and a Nominating/Corporate Governance Committee, each of which has the composition and responsibilities described below. Members serve on these committees until their resignation or until otherwise determined by our Board. Each committee operates under a charter that was approved by the Board. The Board may from time to time establish other committees.

AuditCommittee

Our Audit Committee has been established in accordance with Section 3(a)(58)(A) of the Exchange Act and consists of Rex Jackson, Michael Howard, and Martha Crawford, each of whom is a non-executive director of PubCo’s board of directors and an independent director as well as “financially literate” as defined under the Nasdaq listing standards. Rex Jackson serves as chairperson of the Audit Committee, who also qualifies as an “audit committee financial expert,” as defined under rules and regulations of the SEC.

The purpose of the Audit Committee is to prepare the audit committee report required by the SEC to be included in PubCo’s proxy statement and to assist the PubCo board of directors to (A) oversee: (i) accounting and financial reporting processes and the audits of the financial statements of PubCo; (ii) the integrity of PubCo’s financial statements; (iii) PubCo’s processes relating to risk management and the conduct and systems of internal control over financial reporting and disclosure controls and procedures; (iv) the qualifications, engagement, compensation, independence and performance of PubCo’s independent auditor, and the auditor’s conduct of the annual audit of the PubCo’s financial statements and any other services provided to PubCo; and (v) the performance of PubCo’s internal audit function, if any; and (B) produce the annual report of the Audit Committee required by the rules of the SEC.

The Audit Committee operates pursuant to a written charter for the Audit Committee which is available on PubCo’s website, a copy of which is also attached hereto as Exhibit 99.3 and incorporated herein by reference.

CompensationCommittee

Our Compensation Committee consists of Michael Howard and Peter Hastings, each of whom is a non-executive director of PubCo’s board of directors and an independent director under Nasdaq’s listing standards. Michael Howard serves as the chairperson of the Compensation Committee.

The purpose of the Compensation Committee is to assist the PubCo board of directors to (A) carry out the PubCo board of directors’ overall responsibility relating to organizational strength and executive compensation; (B) assist the PubCo board of directors in overseeing PubCo’s employee compensation policies and practices, including (i) determining and approving the compensation of PubCo’s Chief Executive Officer (“CEO”) and PubCo’s other executive officers, and (ii) reviewing and approving incentive compensation and equity compensation policies and programs, and exercising discretion in the administration of such programs; and (C) produce the annual report of the Compensation Committee required by the rules of the SEC.

The Compensation Committee operates pursuant to a written charter for the Compensation Committee which is available on PubCo’s website, a copy of which is also attached hereto as Exhibit 99.4 and incorporated herein by reference.

Nominatingand Corporate Governance Committee

Our Nominating and Corporate Governance Committee consists of Peter Hastings, Michael Howard, and Katherine Williams, each of whom is a non-executive director of PubCo’s board of directors and an independent director under Nasdaq’s listing standards. Peter Hastings serves as the chairperson of the Nominating and Corporate Governance Committee. The Nominating and Corporate Governance Committee is responsible for overseeing the selection of persons to be nominated to serve on PubCo’s board of directors.

The purpose of the Nominating and Corporate Governance Committee is to assist the PubCo board of directors to (i) identify and screen individuals qualified to serve as directors and recommend to the PubCo board of directors candidates for nomination for election at the annual meeting of shareholders or to fill PubCo board of directors vacancies; (ii) develop, recommend to the PubCo board of directors and review PubCo’s Corporate Governance Guidelines; (iii) coordinate and oversee self-evaluations of the PubCo board of directors, its committees, individual directors and management in the governance of PubCo; (iv) review and approve, if appropriate, any related person transactions and other potential significant conflicts of interest; and (v) review on a regular basis the overall corporate governance of PubCo and recommend improvements for approval by the PubCo board of directors where appropriate.

The Nominating and Corporate Governance Committee operates pursuant to a written charter for the Nominating and Corporate Governance Committee which is available on PubCo’s website, a copy of which is also attached hereto as Exhibit 99.5 and incorporated herein by reference.

DirectorCompensation

The compensation of Terra’s directors is described in the Proxy Statement/Prospectus in the section titled “Executive Compensationof PubCo Directors and Officers” beginning on page 180 and that information is incorporated herein by reference.

ExecutiveCompensation

The compensation of Terra’s executive officers is described in the Proxy Statement/Prospectus in the section titled “ExecutiveCompensation of PubCo Directors and Officers” beginning on page 180 and that information is incorporated herein by reference.

The compensation outlined in the Proxy Statement/Prospectus will be paid to the executive officers in Euros, in lieu of U.S. Dollars. Each of the executive officers identified in the Proxy Statement/Prospectus are finalizing their Directorship Agreements with Terra. Once executed, Terra will file a Current Report on Form 8-K disclosing the terms and filing each Directorship Agreement.

CertainRelationships and Related Transactions

Certain relationships and related party transactions of Terra are described in the Proxy Statement/Prospectus in the section titled “CertainRelationships and Related Party Transactions” beginning on page 243 and that information is incorporated herein by reference.

LegalProceedings

Reference is made to the disclosure regarding legal proceedings in the section of the Proxy Statement/Prospectus titled “Information AboutTerra Innovatum– Legal Proceedings” beginning on page 164, which is incorporated herein by reference.

MarketPrice of and Dividends on the Registrant’s Common Equity and Related Stockholder Matters

Terra’s ordinary shares commenced trading on the Nasdaq under the symbols “NKLR” on October 10, 2025. Terra has not paid any cash dividends on its shares of common stock to date. It is the present intention of the Board to retain all earnings, if any, for use in Terra’s business operations and, accordingly, Terra’s board does not anticipate declaring any dividends in the foreseeable future. The payment of cash dividends in the future will be dependent upon Terra’s revenues and earnings, if any, capital requirements and general financial condition, as well as contractual restrictions. The payment of any cash dividends is within the discretion of the Board. Further, the ability of Terra to declare dividends may be limited by the terms of financing or other agreements entered into by it or its subsidiaries from time to time.

Information respecting GSR III’s Class A ordinary shares, rights and units and related stockholder matters are described in the Proxy Statement/Prospectus in the section titled “Price Range of Securities and Dividends” on page 59 and such information is incorporated herein by reference.

Descriptionof Registrant’s Securities

The description of Terra’s securities is contained in the Proxy Statement/Prospectus in the section titled “Description ofthe PubCo Securities” beginning on page 209 and is incorporated herein by reference.

Indemnificationof Directors and Officers

The description of the indemnification provided to the directors and officers of Terra is contained in the Proxy Statement/Prospectus in the section titled “Indemnification of PubCo directors and officers” beginning on page 215 and is incorporated herein by reference.

Item3.02. Unregistered Sales of Equity Securities.

At the Closing, Terra consummated the PIPE Investment. The disclosure under Item 2.01 of this Report relating to the PIPE Investment is incorporated into this Item 3.02 by reference.

Terra issued the foregoing securities under Section 4(a)(2) of the Securities Act of 1933, as amended (the “Securities Act”), as a transaction not requiring registration under Section 5 of the Securities Act. The parties receiving the securities represented their intentions to acquire the securities for investment only and not with a view to or for sale in connection with any distribution, and appropriate restrictive legends were affixed to the certificates representing the securities (or reflected in restricted book entry with Terra’s transfer agent). The parties also had adequate access, through business or other relationships, to information about Terra.

Item3.03. Material Modification to Rights of Security Holders.

In connection with the Closing, New TopCo, Terra Innovatum Global S.R.L., converted into a Dutch public limited liability company (naamloze vennootschap). In connection with the Conversion, the Amended and Restated Memorandum and Articles of Association of PubCo (the “PubCo Articles of Association “) came in effect, pursuant to which the name of New TopCo changed into “Terra Innovatum Global N.V.” The terms of the PubCo Articles of Association are described in greater detail in the section titled “Description of PubCo Securities” beginning on page 209 and “Comparison of Shareholder Rights” beginning on page 221 of the Proxy Statement/Prospectus, which are incorporated herein by reference.

A copy of the PubCo Articles of Association is attached as Exhibit 3.1, to this Report and is incorporated herein by reference.

Item5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements ofCertain Officers.

Upon the Closing, each of the officers and directors of GSR III tendered their resignations.

The information set forth in the sections titled “Directors and Executive Officers”, “Executive Compensationof PubCo Directors and Officers” and “Certain Relationships and Related Transactions” in Item 2.01 of this Report is incorporated herein by reference.

TerraEquity Incentive Plan

At the Special Meeting, the GSR III shareholders approved the Terra Innovatum Equity Incentive Plan (the “Incentive Plan”). The Incentive Plan was previously approved, subject to stockholder approval, by GSR III’s board of directors . The Incentive Plan became effective immediately upon the Closing. A total of 7,030,094 Ordinary Shares were reserved under the Incentive Plan.

A summary of the terms of the Incentive Plan is set forth in the Proxy Statement/Prospectus in the section titled “Proposal No.3 – The Incentive Plan Proposal” beginning on page 251of the Proxy Statement/Prospectus, which is incorporated herein by reference. Such summary and the foregoing description are qualified in their entirety by reference to the text of the Incentive Plan, a copy of which is attached hereto as Exhibit 10.6 and incorporated herein by reference.

Item5.05. Amendments to the Registrant’s Code of Ethics, or Waiver of a Provision of the Code of Ethics.

In connection with the Business Combination, on October 9, 2025, Terra’s board of directors approved and adopted a new Code of Business Conduct and Ethics applicable to all employees, officers and directors of Terra. The above description of the Code of Business Conduct and Ethics does not purport to be complete and is qualified in its entirety by reference to the full text of the Code of Business Conduct and Ethics, a copy of which is filed as Exhibit 14 hereto and incorporated herein by reference. A copy of the Code of Business Conduct and Ethics can also be found at https://investors.terrainnovatum.com/corporate-governance/documents-charters under the link “Code of Conduct and Ethics.”

Item7.01 Regulation FD Disclosure.

On October 9, 2025, Terra and GSR III issued a press release announcing that the Business Combination had closed on October 9, 2025. A copy of the press release is filed herewith as Exhibit 99.2.

The information in this Item 7.01, including Exhibit 99.2, is furnished and shall not be deemed “filed” for purposes of Section 18 of the Exchange Act, or otherwise subject to liabilities under that section, and shall not be deemed to be incorporated by reference into the filings of the Company under the Securities Act or the Exchange Act, regardless of any general incorporation language in such filings. This Report will not be deemed an admission as to the materiality of any information of the information contained in this Item 7.01, including Exhibit 99.2.

Item9.01. Financial Statements and Exhibits.

(a) Financial statements of businesses acquired.

(b) Pro forma financial information.

The unaudited pro forma condensed combined financial information of New TopCo, Terra OpCo and GSR III as of and for the six months ended June 30, 2025 and for the year ended December 31, 2024 is set forth in Exhibit 99.1 hereto and is incorporated herein by reference.

(d) Exhibits.

Exhibit No.	Description
2.1†	Business Combination Agreement, dated as of April 21, 2025, by and among GSR III Acquisition Corp. and Terra Innovatum, s.r.l. (incorporated by reference to Exhibit 2.1 to the Current Report on Form 8-K filed on April 25, 2025).
2.2	Plan of Merger, dated as of October 9, 2025, by and among GSR III Acquisition Corp., GSR III Cayman Merger Sub and Terra Innovatum Global, N.V. (incorporated by reference to Annex B to the Registration Statement on Form S-4 (File No. 333-287271) filed on September 11, 2025
3.1*	English Translation of Certified Articles of Association of Terra Innovatum Global, N.V.
3.2*	Board Regulations of Terra Innovatum Global, N.V.
4.1	Form of Terra Innovatum Global, N.V. Half Warrant (incorporated by reference to Exhibit 4.1 to the Current Report on Form 8-K filed on September 29, 2025).
4.2	Form of Terra Innovatum Global, N.V.. Quarter Warrant (incorporated by reference to Exhibit 4.2 to the Current Report on Form 8-K filed on September 29, 2025).
4.3*	Form of Bridge Warrants
10.1*	Form of Amended and Restated Registration Rights Agreement, dated October 9, 2025 by and among Terra Innovatum Global, N.V. and the holders party thereto
10.2	Sponsor Support Agreement, dated as of April 21, 2025, by and among GSR III Acquisition Corp., Terra Innovatum s.r.l, and GSR III Sponsor LLC. (incorporated by reference to Exhibit 10.1 to the Current Report on Form 8-K filed on April 25, 2025).
10.3*	First Amendment to the Sponsor Support Agreement, dated October 9, 2025, by and among GSR III Acquisition Corp., Terra Innovatum s.r.l, and GSR III Sponsor LLC.
10.4	Form of Securities Subscription Agreement (incorporated by reference to Exhibit 10.1 to the Current Report on Form 8-K filed on September 29, 2025).
10.5*	Assignment and Assumption Agreement, dated October 9, 2025
10.6#	Terra Innovatum Global, N.V. 2025 Equity Incentive Plan (incorporated by reference to Annex G to the Registration Statement on Form S-4 (File No. 333-287271) filed on September 11, 2025).
14*	Code<br> of Conduct and Ethics
21.1*	List of Subsidiaries.
99.1*	The unaudited pro forma condensed combined financial information of Terra and GSR III as of and for the six months ended June 30, 2025 and for the year ended December 31, 2024
99.2**	Joint Press Release, dated October 9, 2025.
99.3*	Audit Committee Charter
99.4*	Compensation Committee Charter
99.5*	Nominating and Corporate Governance Committee Charter
99.6*	Compensation Recovery Policy
99.7*	Insider Trading Policy
104*	Cover<br> Page Interactive Data File (formatted as Inline XBRL)
†	The<br> annexes, schedules, and certain exhibits to this Exhibit have been omitted pursuant to Item<br> 601(b)(2) of Regulation S-K. The Registrant hereby agrees to furnish supplementally a copy<br> of any omitted annex, schedule or exhibit to the SEC upon request.
---	---
*	Filed<br> herewith.
---	---
**	Furnished<br> herewith.
---	---
#	Indicates<br>management contract or compensatory plan.
---	---

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	TERRA INNOVATUM GLOBAL, N.V.
Date:<br> October 16, 2025	By:	/s/<br> Alessandro Petruzzi
	Name:	Alessandro<br> Petruzzi
	Title:	Chief<br> Executive Officer

Exhibit 3.1

Doorlopende tekstvan de statuten van Terra Innovatum Global N.V. zoals deze luiden na het verlijden van de notariële akte houdendegrensoverschrijdende omzetting en statutenwijziging, voor een waarnemer van mr. Michel Pieter van Agt, notaris te Amsterdam, op 6oktober 2025, welke grensoverschrijdende omzetting effectief geworden is op 7 oktober 2025.

STATUTEN

HOOFDSTUK 1 – DEFINITIES EN INTERPRETATIE

1	Definities
1.1	In deze statuten hebben de volgende woorden de volgende betekenis:
---	---

aandeel: een aandeel in het kapitaal van de vennootschap, tenzij het tegendeel blijkt, is daaronder begrepen elk gewoon aandeel en elk preferent aandeel;

aandeelhouder: een houder van een of meer aandelen, tenzij het tegendeel blijkt, is daaronder begrepen iedere houder van gewone aandelen en iedere houder van preferente aandelen;

accountant: een accountant als bedoeld in artikel 2:393 BW, of een organisatie waarin accountants als bedoeld in artikel 2:393 BW samenwerken;

algemene vergadering: het orgaan van de vennootschap bestaande uit aandeelhouders en alle andere vergadergerechtigden of een bijeenkomst van aandeelhouders en andere vergadergerechtigden, al naar gelang het geval;

bestuur: het bestuur van de vennootschap;

bestuurder: een uitvoerende bestuurder of een niet uitvoerende bestuurder;

bestuursreglement: het schriftelijk reglement vastgesteld door het bestuur als bedoeld in artikel 22.4;

bestuursverslag: het bestuursverslag van de vennootschap als bedoeld in artikel 2:391 BW;

BCA: de business combination agreement aangegaan op eenentwintig april tweeduizend vijfentwintig door en tussen GSR III Acquisition Corp. en Terra Innovatum s.r.l. en andere partijen die door ondertekening van toetredingsdocumentatie partij worden bij deze business combination agreement, zoals van tijd tot tijd gewijzigd of volledig opnieuw vastgesteld, en die contractuele afspraken bevat tussen de voornoemde partijen met betrekking tot, onder andere, de conversie van preferente aandelen in gewone aandelen;

bijzondere dividendreserve: heeft de betekenis zoals daaraan toegekend in artikel 35.1;

BW: het Burgerlijk Wetboek;

conversiebevestiging: heeft de betekenis zoals daaraan toegekend in artikel 7.4;

conversieverzoek: heeft de betekenis zoals daaraan toegekend in artikel 7.2;

dochtermaatschappij: een dochtermaatschappij van de vennootschap, als bedoeld in artikel 2:24a BW;

![](ex3-1_001.jpg)

gewoon aandeel: een gewoon aandeel in het kapitaal van de vennootschap;

groepsmaatschappij: een groepsmaatschappij van de vennootschap als bedoeld in artikel 2:24b BW;

handelsdag: een dag waarop alle effectenbeurzen waarop gewone aandelen op verzoek van of namens de vennootschap van tijd tot tijd (voorwaardelijk of onvoorwaardelijk) tot de handel zijn toegelaten, geopend zijn voor handel;

jaarrekening: de jaarrekening van de vennootschap zoals bedoeld in artikel 2:361 BW;

NCGC: de Nederlandse Corporate Governance Code, zoals van tijd tot tijd gewijzigd;

niet uitvoerende bestuurder: een lid van het bestuur benoemd als niet uitvoerende bestuurder;

registratiedatum: de achtentwintigste (28^e^) kalenderdag vóór de datum van een algemene vergadering;

preferent aandeel: een converteerbaar preferent aandeel in het kapitaal van de vennootschap;

schriftelijk: per brief, e-mail, of door een op andere wijze langs elektronische weg toegezonden leesbaar en reproduceerbaar bericht, mits de identiteit van de verzender met afdoende zekerheid kan worden vastgesteld;

soortvergadering: de vergadering van houders van aandelen van een bepaalde soort, en betekent bij toevoeging van een soort aandelen de soortvergadering van die soort;

soortvergadering preferente aandelen: de vergadering van houders van preferente aandelen;

statuten: deze statuten;

stemgerechtigden: aandeelhouders met stemrecht, vruchtgebruikers met stemrecht en pandhouders met stemrecht in de algemene vergadering;

uitvoerende bestuurder: een lid van het bestuur benoemd als uitvoerende bestuurder;

vennootschap: de vennootschap waarop deze statuten betrekking hebben;

vergadergerechtigden: aandeelhouders, vruchtgebruikers met vergaderrecht en pandhouders met vergaderrecht;

vergaderrecht: het recht om, in persoon of bij een schriftelijk gevolmachtigde, de algemene vergadering bij te wonen en daarin het woord te voeren.

2	Interpretatie
2.1	Verwijzingen naar artikelen worden geacht te verwijzen naar artikelen van deze statuten, tenzij het tegendeel blijkt.
---	---
2.2	Elke verwijzing naar een geslacht omvat alle geslachten.
---	---

2
![](ex3-1_001.jpg)

HOOFDSTUK II – NAAM, ZETEL EN DOEL

3	Naam en zetel
3.1	De naam van de vennootschap is Terra Innovatum Global N.V.
---	---
3.2	De vennootschap is gevestigd in Amsterdam.
---	---
4	Doel
---	---

De vennootschap heeft ten doel:

(a)	het ontwerpen, ontwikkelen en op de markt brengen van micromodulaire kernreactoren, rechtstreeks of via haar groepsmaatschappijen;
(b)	het leveren van technische en wetenschappelijke diensten op verschillende gebieden van de techniek, waaronder energie (ook op basis<br>van kernsplijting), werktuigbouwkunde, transport, afvalbeheer en milieuvriendelijke systemen en infrastructuren, rechtstreeks of via haar<br>groepsmaatschappijen;
---	---
(c)	het oprichten van, het op enigerlei wijze deelnemen in, het besturen van en het toezicht houden op ondernemingen en vennootschappen;
---	---
(d)	het financieren van ondernemingen en vennootschappen;
---	---
(e)	het lenen, uitlenen en bijeenbrengen van gelden, daaronder begrepen het uitgeven van obligaties, schuldbrieven of andere waardepapieren,<br>alsmede het aangaan van daarmee samenhangende overeenkomsten;
---	---
(f)	het verstrekken van adviezen en het verlenen van diensten aan groepsmaatschappijen en aan derden;
---	---
(g)	het verstrekken van garanties, het verbinden van de vennootschap en het bezwaren van activa van de vennootschap voor verplichtingen<br>van de vennootschap, groepsmaatschappijen en/of derden;
---	---
(h)	het verkrijgen, vervreemden, beheren en exploiteren van registergoederen en van vermogenswaarden in het algemeen;
---	---
(i)	het verhandelen van valuta, effecten en vermogenswaarden in het algemeen;
---	---
(j)	het ontwikkelen en verhandelen van patenten, merkrechten, licenties, know how en andere intellectuele en industriële eigendomsrechten;<br>en
---	---
(k)	het verrichten van alle soorten industriële, financiële en commerciële activiteiten,
---	---

en al hetgeen met vorenstaande verband houdt of daartoe bevorderlijk kan zijn, alles in de ruimste zin van het woord.

HOOFDSTUK III – AANDELENKAPITAAL

5	Maatschappelijk kapitaal
5.1	Het maatschappelijk kapitaal van de vennootschap bedraagt vijf miljoen achthonderdvierduizend euro (EUR 5.804.000,00).
---	---
5.2	Het maatschappelijk kapitaal van de vennootschap is verdeeld in vijfhonderd miljoen (500.000.000) gewone aandelen, met een nominaal<br>bedrag van één eurocent (EUR 0,01) elk en achtduizend veertig (8.040) preferente aandelen, met een nominaal bedrag van éénhonderd<br>euro (EUR 100,00) elk.
---	---

3
![](ex3-1_001.jpg)

5.3	Door de conversie van een of meer preferente aandelen in gewone aandelen als bedoeld in artikel 7, neemt het maatschappelijk kapitaal<br>af met het aantal geconverteerde preferente aandelen en neemt het maatschappelijk kapitaal toe met het aantal gewone aandelen waarin de<br>betreffende preferente aandelen zijn geconverteerd.
5.4	Binnen acht (8) kalenderdagen na een conversie van een of meer preferente aandelen in gewone aandelen, zal het bestuur (i) een kennisgeving<br>daarvan deponeren bij het handelsregister, welke kennisgeving ten minste het maatschappelijk kapitaal na de conversie moet bevatten en<br>(ii) de conversie registreren in het aandeelhoudersregister als bedoeld in artikel 7.
---	---
5.5	Aandeelbewijzen worden niet uitgegeven.
---	---
6	Aandeelhoudersregister
---	---
6.1	Het bestuur houdt een aandeelhoudersregister; het bestuur mag een bewaarder aanwijzen om het register namens het bestuur te houden.<br>Het register wordt regelmatig bijgewerkt. Het register kan in verschillende delen en op verschillende locaties worden gehouden. Het register<br>kan deels buiten Nederland worden gehouden ter voldoening aan de aldaar geldende wetgeving of ingevolge voorschriften van een effectenbeurs.
---	---
6.2	Het aandeelhoudersregister vermeldt van elke aandeelhouder de naam, het adres en de verdere door de wet vereiste of door het bestuur<br>passend geachte informatie. Aandeelhouders zullen tijdig de benodigde gegevens aan het bestuur verstrekken. De gevolgen van het niet,<br>of onjuist, verstrekken van dergelijke gegevens zijn voor rekening van de betreffende aandeelhouder.
---	---
6.3	Op verzoek van een aandeelhouder wordt door het bestuur aan hem kosteloos een schriftelijk bewijs verstrekt van de inhoud van het<br>aandeelhoudersregister met betrekking tot de op zijn naam geregistreerde aandelen.
---	---
6.4	De artikelen 6.2 en 6.3 zijn van overeenkomstige toepassing op vruchtgebruikers of pandhouders van een of meer aandelen, met uitzondering<br>van een houder van een pandrecht dat is gevestigd zonder erkenning door of betekening aan de vennootschap.
---	---
7	Conversie van preferente aandelen in gewone aandelen
---	---
7.1	Elk preferent aandeel kan worden geconverteerd in tienduizend (10.000) gewone aandelen, in overeenstemming met de bepalingen van dit<br>artikel 7.
---	---
7.2	Bij vervulling van de contractuele conversievoorwaarden zoals opgenomen in de BCA zoals (i) vrijwillig of (ii) op verzoek van een<br>houder van preferente aandelen (conversieverzoek) is vastgesteld door het bestuur, zal het bestuur de door de aandeelhouders gehouden<br>preferente aandelen converteren in gewone aandelen in overeenstemming met de verhouding zoals uiteengezet in artikel 7.1.
---	---
7.3	Het conversieverzoek dient schriftelijk te worden gedaan en vermeldt het aantal en de nummering van de te converteren preferente aandelen.
---	---
7.4	De conversie van een of meer preferente aandelen wordt pas van kracht na bevestiging van het bestuur dat aan de contractuele conversievoorwaarden<br>zoals opgenomen in de BCA is voldaan (conversiebevestiging).
---	---
7.5	De conversie van een preferent aandelen geschiedt per de datum van afgifte van een conversiebevestiging, dan wel op een zodanige latere<br>datum als vermeld door het bestuur in de conversiebevestiging.
---	---
7.6	Door de conversie van een preferent aandeel wordt aan dat preferente aandeel naar evenredigheid toe te rekenen deel van de bijzondere<br>dividendreserve overgeboekt naar de betreffende reserve(s) verbonden aan de gewone aandelen waarin dat preferente aandeel wordt geconverteerd.
---	---

4
![](ex3-1_001.jpg)

8	Uitgifte van aandelen
8.1	Aandelen worden uitgegeven ingevolge een besluit van het bestuur, indien het bestuur daartoe bij besluit van de algemene vergadering<br>voor een bepaalde duur is aangewezen en met inachtneming van de daarvoor geldende wettelijke voorschriften. Een dergelijke aanwijzing<br>door de algemene vergadering moet vermelden hoeveel aandelen mogen worden uitgegeven. De aanwijzing kan telkens voor bepaalde opeenvolgende<br>perioden worden verlengd, met inachtneming van de daarvoor geldende wettelijke voorschriften. Tenzij bij de aanwijzing anders is bepaald,<br>kan de aanwijzing niet worden ingetrokken.
---	---
8.2	Indien en voor zover het bestuur niet is aangewezen door de algemene vergadering, worden aandelen uitgegeven ingevolge een besluit<br>van de algemene vergadering. De algemene vergadering blijft naast het bestuur bevoegd te besluiten tot de uitgifte van aandelen indien<br>zulks uitdrukkelijk is bepaald in het besluit waarbij het bestuur wordt aangewezen als bevoegd te besluiten tot de uitgifte van aandelen<br>als omschreven in artikel 8.1.
---	---
8.3	De artikelen 8.1 en 8.2 zijn van overeenkomstige toepassing op het verlenen van rechten tot het nemen van aandelen, maar zijn niet<br>van toepassing op een uitgifte van aandelen aan een persoon die een voordien reeds verkregen recht tot het nemen van aandelen uitoefent.
---	---
8.4	Indien het besluit van de algemene vergadering tot uitgifte van aandelen of tot aanwijzing van de bevoegdheid tot uitgifte van aandelen<br>aan het bestuur als bedoeld in artikel 8.1 afbreuk doet aan de rechten van houders van aandelen van een bepaalde soort, is voor de geldigheid<br>van een dergelijk besluit van de algemene vergadering een voorafgaande of gelijktijdige goedkeuring vereist door de betreffende groep<br>van houders van aandelen van een bepaalde soort.
---	---
8.5	Een besluit van de algemene vergadering als bedoeld in dit artikel 7 kan slechts worden genomen op voorstel van het bestuur.
---	---
9	Voorkeursrechten
---	---
9.1	Iedere houder van gewone aandelen heeft bij uitgifte van gewone aandelen een voorkeursrecht naar evenredigheid van het gezamenlijke<br>bedrag van zijn gewone aandelen. Dit voorkeursrecht is niet van toepassing op:
---	---
(a)	gewone aandelen die worden uitgegeven aan werknemers van de vennootschap of van een groepsmaatschappij;
---	---
(b)	gewone aandelen die worden uitgegeven tegen inbreng anders dan in geld; en
---	---
(c)	gewone aandelen die worden uitgegeven aan een persoon die een eerder verkregen recht tot het nemen van gewone aandelen uitoefent.
---	---
9.2	Houders van preferente aandelen hebben geen voorkeursrecht op enige uitgifte van gewone aandelen en geen enkele aandeelhouder heeft<br>een voorkeursrecht op enige uitgifte van preferente aandelen.
---	---
9.3	Voorkeursrechten kunnen worden beperkt of uitgesloten bij besluit van het bestuur, indien het bestuur daartoe door algemene vergadering<br>voor een bepaalde duur is aangewezen en met inachtneming van de daarvoor geldende wettelijke voorschriften, en het bestuur tevens is aangewezen<br>als bevoegd te besluiten tot de uitgifte van aandelen overeenkomstig artikel 8.1. De aanwijzing kan telkens voor bepaalde opvolgende perioden<br>worden verlengd, met inachtneming van de daarvoor geldende wettelijke voorschriften. Tenzij bij de aanwijzing anders is bepaald, kan de<br>aanwijzing niet worden ingetrokken.
---	---

5
![](ex3-1_001.jpg)

9.4	Indien en voor zover het bestuur niet is aangewezen door de algemene vergadering, kunnen voorkeursrechten worden beperkt of uitgesloten<br>bij besluit van de algemene vergadering. De algemene vergadering blijft, naast het bestuur, bevoegd tot het beperken of uitsluiten van<br>voorkeursrechten indien dit specifiek is bepaald in het besluit waarin het bestuur wordt gemachtigd tot het beperken of uitsluiten van<br>voorkeursrechten zoals beschreven in artikel 9.2.
9.5	Een besluit van de algemene vergadering tot beperking of uitsluiting van voorkeursrechten en een besluit tot aanwijzing van het bestuur<br>daartoe, kan slechts worden genomen op voorstel van het bestuur en een dergelijk besluit vereist een meerderheid van ten minste twee derde<br>(2/3) van de uitgebrachte stemmen indien minder dan de helft van het geplaatste kapitaal van de vennootschap in de algemene vergadering<br>is vertegenwoordigd.
---	---
9.6	Onverminderd het bepaalde in artikel 2:96a BW, stelt de algemene vergadering, respectievelijk het bestuur, bij het nemen van een besluit<br>tot uitgifte van gewone aandelen vast op welke wijze en in welk tijdvak deze voorkeursrechten kunnen worden uitgeoefend.
---	---
9.7	Dit artikel 9.1 is van overeenkomstige toepassing op het verlenen van rechten tot het nemen van aandelen.
---	---
10	Storting op aandelen
---	---
10.1	Aandelen worden slechts uitgegeven tegen storting van het gehele bedrag waarvoor die aandelen worden uitgegeven en met inachtneming<br>van het bepaalde in de artikelen 2:80, 2:80a en 2:80b BW.
---	---
10.2	Storting op aandelen moet in geld geschieden voor zover niet een andere inbreng is overeengekomen. Storting anders dan in geld moet<br>geschieden met inachtneming van het bepaalde in artikel 2:94b BW. Storting in een andere valuta dan euro kan slechts geschieden met goedkeuring<br>van de vennootschap en met inachtneming van het bepaalde in artikel 2:93a BW.
---	---
10.3	Gewone aandelen uitgegeven aan (i) huidige of voormalige werknemers van de vennootschap of van een groepsmaatschappij, (ii) huidige<br>of voormalige bestuurders onder een voor hen geldende participatieregeling van de vennootschap en (iii) houders van een in overeenstemming<br>met artikel 8.3 verleend recht tot het nemen van gewone aandelen, kunnen worden volgestort ten laste van de reserves van de vennootschap,<br>zulks onverminderd de bepalingen van artikel 35.
---	---
10.4	Het bestuur kan rechtshandelingen als bedoeld in artikel 2:94 BW verrichten zonder de voorafgaande goedkeuring van de algemene vergadering.
---	---

HOOFDSTUK IV – EIGEN AANDELEN EN KAPITAALVERMINDERING

11	Verkrijging van eigen aandelen en vervreemding van aandelen
11.1	De vennootschap mag volgestorte aandelen verkrijgen (i) om niet of (ii) tegen betaling indien en voor zover de algemene vergadering<br>het bestuur daartoe heeft gemachtigd voor een bepaalde duur en met inachtneming van de daarvoor geldende wettelijke voorschriften. De<br>algemene vergadering stelt in de machtiging vast hoeveel aandelen mogen worden verkregen door de vennootschap, hoe zij mogen worden verkregen<br>en tussen welke grenzen de prijs moet liggen.
---	---
11.2	De machtiging van de algemene vergadering is niet vereist indien de vennootschap volgestorte aandelen verkrijgt om deze aandelen,<br>krachtens enige voor hen geldende participatieregeling, over te dragen aan werknemers in dienst van de vennootschap of van een groepsmaatschappij,<br>op de voorwaarde dat deze aandelen zijn opgenomen in een prijscourant van een effectenbeurs.
---	---
11.3	Elke vervreemding van aandelen door de vennootschap vereist een besluit van het bestuur. Een dergelijk besluit zal ook de voorwaarden<br>van de vervreemding bepalen.
---	---

6
![](ex3-1_001.jpg)

12	Kapitaalvermindering
12.1	De algemene vergadering kan slechts op voorstel van het bestuur besluiten tot vermindering van het geplaatste kapitaal van de vennootschap<br>door (i) het nominale bedrag van aandelen bij statutenwijziging te verminderen of (ii) intrekking van aandelen die de vennootschap zelf<br>houdt.
---	---
12.2	Een besluit van de algemene vergadering tot vermindering van het geplaatste kapitaal van de vennootschap, vereist een meerderheid<br>van ten minste twee derde (2/3) van de uitgebrachte stemmen, indien minder dan de helft van het geplaatste kapitaal van de vennootschap<br>in de algemene vergadering is vertegenwoordigd.
---	---
12.3	Een besluit van de algemene vergadering om het geplaatste kapitaal van de vennootschap te verminderen door intrekking van alle preferente<br>aandelen, behoeft de voorafgaande of gelijktijdige goedkeuring door de soortvergadering preferente aandelen.
---	---
12.4	Indien het besluit van de algemene vergadering tot vermindering van het geplaatste kapitaal van de vennootschap door het nominale<br>bedrag van aandelen bij statutenwijziging te verminderen, afbreuk doet aan de rechten van houders van aandelen van een bepaalde soort,<br>is voor de geldigheid van een dergelijk besluit van de algemene vergadering voorafgaande of gelijktijdige goedkeuring vereist van de betreffende<br>groep van houders van aandelen van een bepaalde soort.
---	---

HOOFDSTUK V – LEVERING VAN AANDELEN

13	Levering van aandelen
13.1	Voor de levering van aandelen is een daartoe bestemde akte vereist, alsmede, behoudens in het geval dat de vennootschap zelf bij die<br>rechtshandeling partij is, schriftelijke erkenning door de vennootschap van de levering. Met een dergelijke erkenning staat gelijk de<br>betekening van de leveringsakte, of van een notarieel of gewaarmerkt afschrift of uittreksel daarvan, aan de vennootschap.
---	---
13.2	Artikel 13.1 is van overeenkomstige toepassing op de vestiging van een pandrecht of vruchtgebruik op een aandeel, met dien verstande<br>dat een pandrecht ook kan worden gevestigd zonder erkenning door of betekening aan de vennootschap, in welk geval artikel 3:239 BW van<br>toepassing is en de erkenning door of betekening aan de vennootschap in de plaats treedt van de in artikel 3:239 lid 3 BW bedoelde mededeling.
---	---
13.3	Indien en zolang een of meer gewone aandelen zijn toegelaten tot de handel op de NASDAQ Stock Market, kan het bestuur besluiten dat<br>het goederenrechtelijke regime met betrekking tot de gewone aandelen wordt beheerst door het recht van de staat New York, Verenigde Staten<br>van Amerika, als gevolg waarvan de artikelen 13.1 en 13.2 niet van toepassing zijn op de gewone aandelen. Een dergelijk besluit en de<br>herroeping ervan zullen ter inzage beschikbaar zijn op de website van de vennootschap en bij het Nederlandse handelsregister.
---	---
14	Overdrachtsbeperkingen
---	---
14.1	Een overdracht van aandelen is niet onderhevig aan enige overdrachtsbeperking krachtens deze statuten.
---	---

7
![](ex3-1_001.jpg)

HOOFDSTUK VI – BEPERKTE RECHTEN OP AANDELEN

15	Pandrecht op aandelen
15.1	Gewone aandelen kunnen worden verpand. Preferente aandelen kunnen niet worden verpand.
---	---
15.2	Indien op een gewoon aandeel een pandrecht is gevestigd komt het aan dat gewone aandeel verbonden stemrecht toe aan de aandeelhouder,<br>tenzij het stemrecht bij de vestiging van het pandrecht aan de pandhouder is toegekend. Een pandhouder met stemrecht heeft vergaderrecht.
---	---
15.3	Een aandeelhouder die vanwege een pandrecht geen stemrecht heeft, heeft vergaderrecht. Een pandhouder zonder stemrecht heeft geen<br>vergaderrecht.
---	---
16	Vruchtgebruik op aandelen
---	---
16.1	Indien op een gewoon aandeel een vruchtgebruik is gevestigd komt het aan dat gewone aandeel verbonden stemrecht toe aan de aandeelhouder,<br>tenzij het stemrecht bij de vestiging van het vruchtgebruik aan de vruchtgebruiker is toegekend. Een vruchtgebruiker met stemrecht heeft<br>vergaderrecht.
---	---
16.2	Indien op een preferent aandeel een vruchtgebruik is gevestigd komt het aan dat preferente aandeel verbonden stemrecht toe aan de<br>aandeelhouder. Het aan het preferente aandeel verbonden stemrecht mag niet worden toegekend aan de vruchtgebruiker.
---	---
16.3	Een aandeelhouder die vanwege een vruchtgebruik geen stemrecht heeft, heeft vergaderrecht. Een vruchtgebruiker zonder stemrecht heeft<br>geen vergaderrecht.
---	---
17	Certificaten van aandelen
---	---

De vennootschap verleent geen medewerking aan de uitgifte van certificaten van aandelen.

HOOFDSTUK VII – BESTUUR EN TOEZICHT

18	Bestuur: samenstelling, benoeming, schorsing en ontslag
18.1	De vennootschap wordt bestuurd door het bestuur. Het bestuur bestaat uit één (1) of meer uitvoerende bestuurders en<br>twee (2) of meer niet uitvoerende bestuurders. Het bestuur stelt het aantal uitvoerende bestuurders en het aantal niet uitvoerende bestuurders<br>vast. Alleen natuurlijke personen kunnen bestuurder zijn.
---	---
18.2	De uitvoerende bestuurders en niet uitvoerende bestuurders worden als zodanig benoemd door de algemene vergadering uit een bindende<br>voordracht door het bestuur. Een voordracht door het bestuur vermeldt of een persoon wordt voorgedragen voor benoeming tot uitvoerende<br>bestuurder of niet uitvoerende bestuurder. De persoon voorgedragen voor benoeming wordt benoemd door een besluit van de algemene vergadering<br>genomen met een gewone meerderheid van de uitgebrachte stemmen.
---	---
18.3	De algemene vergadering kan te allen tijde een bindende voordracht tot benoeming van een bestuurder terzijde stellen met een gewone<br>meerderheid van de uitgebrachte stemmen die ten minste één derde (1/3) van het geplaatste kapitaal van de vennootschap vertegenwoordigen.<br>Indien de voordracht één (1) kandidaat voor een vacature omvat, leidt een besluit omtrent de voordracht tot de benoeming<br>van de kandidaat, tenzij de voordracht terzijde wordt geschoven. Indien de bindende voordracht tot benoeming een bestuurder terzijde wordt<br>gesteld, kan een nieuwe bindende voordracht worden gemaakt.
---	---

8
![](ex3-1_001.jpg)

18.4	Een bestuurder wordt benoemd voor een termijn van maximaal één (1) jaar, met dien verstande dat zijn termijn eindigt<br>onmiddellijk na sluiting van de jaarlijkse algemene vergadering gehouden in het jaar na zijn benoeming. Een bestuurder kan worden herbenoemd<br>met inachtneming van de vorige zin. Een niet uitvoerende bestuurder kan in functie zijn voor een termijn van ten hoogste twaalf (12) jaar,<br>al dan niet onderbroken, tenzij de algemene vergadering op voorstel van het bestuur anders besluit.
18.5	De algemene vergadering kan iedere bestuurder te allen tijde schorsen of ontslaan. Een besluit van de algemene vergadering tot schorsing<br>of ontslag van een bestuurder anders dan op voordracht van het bestuur vereist een meerderheid van ten minste twee derde (2/3) van de<br>uitgebrachte stemmen. Het bestuur kan een uitvoerende bestuurder te allen tijde schorsen.
---	---
18.6	Een schorsing kan een of meer keren worden verlengd, maar kan in totaal niet langer dan drie (3) maanden duren. Indien aan het<br>einde van die periode geen besluit is genomen over het opheffen van de schorsing of over het ontslag, zal de schorsing eindigen. Een schorsing<br>kan te allen tijde door de algemene vergadering worden opgeheven.
---	---
19	Bestuur: belet of ontstentenis
---	---
19.1	In geval van belet of ontstentenis van een uitvoerende bestuurder, zijn de overblijvende uitvoerende bestuurders tijdelijk belast<br>met de uitvoerende bestuurstaken van de vennootschap, met dien verstande dat het bestuur een tijdelijke vervanger kan aanwijzen. In geval<br>van belet of ontstentenis van alle uitvoerende bestuurders, zijn de niet uitvoerende bestuurders tijdelijk belast met de uitvoerende bestuurstaken<br>van de vennootschap, met dien verstande dat het bestuur een of meer tijdelijke vervangers kan aanwijzen.
---	---
19.2	In geval van belet of ontstentenis van een niet uitvoerende bestuurder, zijn de overblijvende niet uitvoerende bestuurders van de<br>vennootschap tijdelijk belast met de taken en bevoegdheden van die niet uitvoerende bestuurder, met dien verstande dat het bestuur een<br>tijdelijke vervanger kan aanwijzen. In geval van belet of ontstentenis van alle niet uitvoerende bestuurders, is de algemene vergadering<br>bevoegd een of meerdere natuurlijke personen aan te wijzen aan wie tijdelijk de taken en bevoegdheden van niet uitvoerende bestuurders<br>toekomen.
---	---
19.3	Er is in ieder geval sprake van belet van een bestuurder zoals bedoeld in de artikelen 19.1 en 19.2:
---	---
(a)	gedurende de periode waarvoor de bestuurder schriftelijk heeft aangegeven dat sprake is van belet;
---	---
(b)	gedurende de schorsing van de bestuurder; of
---	---
(c)	gedurende perioden waarin de vennootschap geen contact met de bestuurder kan leggen (waaronder begrepen als gevolg van ziekte), mits<br>een dergelijke periode langer duurt dan vijf (5) opeenvolgende kalenderdagen (of een dergelijke andere periode in redelijkheid bepaald<br>door het bestuur).
---	---
20	Bestuur: CEO, voorzitter van het bestuur en andere titels
---	---
20.1	Het bestuur wijst een uitvoerende bestuurder aan als CEO.
---	---
20.2	Het bestuur wijst een niet uitvoerende bestuurder aan als voorzitter van het bestuur. Het bestuur kan een niet uitvoerende bestuurder<br>aanwijzen als vicevoorzitter.
---	---
20.3	Het bestuur kan ook andere titels toekennen aan bestuurders.
---	---

9
![](ex3-1_001.jpg)

21	Bestuur: bezoldiging
21.1	De vennootschap heeft een beleid met betrekking tot de bezoldiging van uitvoerende bestuurders en niet uitvoerende bestuurders. Het<br>bezoldigingsbeleid wordt door de algemene vergadering vastgesteld op voorstel van het bestuur. Een besluit tot vaststelling van het bezoldigingsbeleid<br>vereist een gewone meerderheid van de uitgebrachte stemmen.
---	---
21.2	De bezoldiging van de uitvoerende bestuurders wordt vastgesteld door het bestuur met inachtneming van het door de algemene vergadering<br>vastgestelde bezoldigingsbeleid. De uitvoerende bestuurders nemen niet deel aan de beraadslaging en besluitvorming ten aanzien van de<br>vaststelling van de bezoldiging van de uitvoerende bestuurders.
---	---
21.3	De bezoldiging van de niet uitvoerende bestuurders wordt vastgesteld door het bestuur met inachtneming van het door de algemene vergadering<br>vastgestelde bezoldigingsbeleid.
---	---
21.4	Een voorstel ten aanzien van regelingen van bezoldigingen in de vorm van aandelen of rechten tot het nemen van aandelen wordt door<br>het bestuur ter goedkeuring aan de algemene vergadering voorgelegd. Dit voorstel bepaalt ten minste het maximale aantal aandelen of rechten<br>tot het nemen van aandelen dat aan bestuurders kan worden toegekend en welke criteria gelden voor toekenning of wijziging.
---	---
22	Bestuur: taken en plichten
---	---
22.1	Het bestuur is belast met het besturen van de vennootschap en heeft daartoe binnen de grenzen van de wet alle bevoegdheden welke bij<br>deze statuten niet aan anderen zijn toegekend. Bij de vervulling van hun taak richten de bestuurders zich naar het belang van de vennootschap<br>en de met haar verbonden onderneming.
---	---
22.2	De uitvoerende bestuurders zijn primair verantwoordelijk voor de dagelijkse gang van zaken binnen de vennootschap. De niet uitvoerende<br>bestuurders houden toezicht op (i) het beleid en de taakuitoefening van de uitvoerende bestuurders en (ii) de algemene gang van zaken<br>van de vennootschap en geven advies en richting aan de uitvoerende bestuurders. De uitvoerende bestuurders zullen tijdig aan de niet uitvoerende<br>bestuurders de informatie verstrekken die nodig is om hun taak uit te oefenen.
---	---
22.3	De bestuurders vervullen voorts alle taken die bij of krachtens de wet of deze statuten aan hen zijn en worden toebedeeld.
---	---
22.4	Het bestuur stelt met inachtneming van deze statuten een bestuursreglement vast met betrekking tot zijn interne organisatie, de wijze<br>waarop besluiten worden genomen, enige quorumvereisten, de samenstelling, taken en organisatie van commissies en alle andere aangelegenheden<br>die het bestuur, de uitvoerende bestuurders, de niet uitvoerende bestuurders en de door het bestuur ingestelde commissies betreffen.
---	---
22.5	Het bestuur kan in het bestuursreglement of anderszins schriftelijk zijn taken en bevoegdheden onder de bestuurders verdelen, met<br>dien verstande dat de volgende taken en bevoegdheden niet aan uitvoerende bestuurders mogen worden toebedeeld:
---	---
(a)	het toezicht houden op de uitoefening van de taak van de uitvoerende bestuurders;
---	---
(b)	het doen van een voordracht voor de benoeming van bestuurders;
---	---
(c)	het vaststellen van de bezoldiging van een uitvoerende bestuurder; en
---	---
(d)	het verlenen van een opdracht aan een accountant om de jaarrekening te onderzoeken.
---	---

10
![](ex3-1_001.jpg)

22.6	Onverminderd het bepaalde in deze statuten, zijn aan de goedkeuring van de algemene vergadering onderworpen de besluiten van het bestuur<br>omtrent een belangrijke verandering van de identiteit of het karakter van de vennootschap of de met haar verbonden onderneming, waaronder<br>in ieder geval:
(a)	overdracht van de onderneming of vrijwel de gehele onderneming aan een derde;
---	---
(b)	het aangaan of verbreken van enige duurzame samenwerking van de vennootschap of een dochtermaatschappij met een andere rechtspersoon<br>of vennootschap dan wel als volledig aansprakelijke vennoot in een personenvennootschap, indien deze samenwerking of verbreking van ingrijpende<br>betekenis is voor de vennootschap; en
---	---
(c)	het nemen of afstoten van een deelneming in het kapitaal van een vennootschap ter waarde van ten minste een derde (1/3) van het bedrag<br>van de activa van de vennootschap volgens de geconsolideerde balans met toelichting volgens de laatst vastgestelde jaarrekening, door<br>de vennootschap of een dochtermaatschappij.
---	---
23	Bestuur: besluitvorming
---	---
23.1	Besluiten van het bestuur worden genomen met een gewone meerderheid van de uitgebrachte stemmen, tenzij deze statuten of het bestuursreglement<br>een versterkte meerderheid vereisen. Iedere bestuurder heeft één (1) stem. Bij staking van stemmen is het voorstel verworpen.
---	---
23.2	Een bestuurder kan in een vergadering van het bestuur alleen worden vertegenwoordigd door een schriftelijk gevolmachtigde andere bestuurder.
---	---
23.3	Vergaderingen van het bestuur kunnen worden gehouden door middel van een vergadering van bestuurders in persoon of door middel van<br>telefoon, videoconferentie of enige andere elektronische communicatie, mits alle bestuurders die aan een dergelijke vergadering deelnemen<br>in staat zijn gelijktijdig met elkaar te communiceren. Deelname aan een vergadering die op een van de voorgaande wijzen wordt gehouden,<br>geldt als aanwezigheid op die vergadering.
---	---
23.4	Een document waaruit blijkt dat een of meer besluiten door het bestuur zijn genomen en dat door de voorzitter van het bestuur of door<br>de voorzitter en de secretaris van de desbetreffende vergadering is ondertekend, geldt als geldig bewijs van die besluiten.
---	---
23.5	Het bestuur kan ook buiten vergadering besluiten nemen, mits deze besluiten schriftelijk of anderszins worden vastgelegd en geen van<br>de stemgerechtigde bestuurders zich tegen deze wijze van besluitvorming verzet.
---	---
23.6	Een bestuurder neemt niet deel aan de beraadslaging en besluitvorming ingeval van een direct of indirect persoonlijk tegenstrijdig<br>belang tussen die bestuurder en de vennootschap en de met haar verbonden onderneming, of ingeval van betrokkenheid bij een transactie<br>met een verbonden partij in de zin van artikel 2:169 lid 4 BW. Indien het bestuur geen besluit kan nemen omdat alle bestuurders niet aan<br>de beraadslaging en besluitvorming kunnen deelnemen als gevolg van een dergelijk tegenstrijdig belang, of omdat alle bestuurders betrokken<br>zijn bij een transactie met een verbonden partij in de zin van artikel 2:169 lid 4 BW, wordt het besluit niettemin door het bestuur genomen.
---	---
23.7	Het bestuur kan krachtens het bestuursreglement of anderszins schriftelijk bepalen dat een of meer bestuurders rechtsgeldig besluiten<br>kunnen nemen omtrent zaken die tot hun taak behoren in de zin van artikel 2:129a lid 3 BW.
---	---

11
![](ex3-1_001.jpg)

24	Bestuur: vrijwaring
24.1	De vennootschap vrijwaart iedere huidige of voormalige bestuurder in elke voorziene of aanhangige actie, rechtszaak, procedure of<br>onderzoek ter zake van elke vordering tegen die bestuurder die verband houdt met de uitoefening van zijn respectievelijke taken als bestuurder,<br>voor alle:
---	---
(a)	kosten en uitgaven, met inbegrip van, maar niet beperkt tot, onderbouwde honoraria van advocaten, die redelijkerwijs zijn gemaakt<br>in verband met het voeren van verweer door die bestuurder in de desbetreffende actie, rechtszaak, procedure of onderzoek of een schikking<br>daarvan;
---	---
(b)	aansprakelijkheden, verliezen, schaden, boeten, straffen en andere claims en/of financiële gevolgen van (gerechtelijke of arbitrale)<br>uitspraken tegen die bestuurder, met uitzondering van eventuele reputatieschade en (andere) immateriële schade; en
---	---
(c)	betalingen door die bestuurder en/of enige andere financiële gevolgen die voortvloeien uit een schikking van een dergelijke actie,<br>rechtszaak, procedure of onderzoek, met uitzondering van reputatieschade en (andere) immateriële schade, onder de voorwaarde van<br>voorafgaande schriftelijke goedkeuring door de vennootschap van een dergelijke schikking (welke goedkeuring niet op onredelijke gronden<br>zal worden onthouden),
---	---

mits hij te goeder trouw handelde en op een wijze waarvan hij in redelijkheid meende dat die in het belang, of althans niet tegen het belang, van de vennootschap was of buiten zijn mandaat, en, met betrekking tot enigerlei strafrechtelijke actie of procedure geen redelijke aanleiding had te menen dat zijn gedrag onwettig was.

24.2	Elke vrijwaring door de vennootschap als bedoeld in artikel 24.1 wordt slechts gegeven na vaststelling door het bestuur dat in het<br>licht van alle omstandigheden van het geval de betreffende bestuurder in aanmerking komt voor vrijwaring aangezien hij de gedragsnormen<br>van artikel 24.1 in acht heeft genomen.
24.3	Gevrijwaarde bedragen als bedoeld in artikel 24.1 onder (a) tot en met (c) kunnen worden betaald door de vennootschap vóór<br>de uiteindelijke uitspraak in, of afwikkeling van, de betreffende voorziene of aanhangige actie, rechtszaak of procedure tegen die betreffende<br>bestuurder, na een besluit van het bestuur met betrekking tot het betreffende geval.
---	---
24.4	Een huidige of voormalige bestuurder heeft geen recht op de in dit artikel 24 bedoelde vrijwaring, indien en voor zover:
---	---
(a)	de Nederlandse wet een dergelijke vrijwaring niet toestaat;
---	---
(b)	door een bevoegde rechter, rechterlijk college of, in geval van arbitrage, een arbiter of arbitraal college in een einduitspraak,<br>waartegen geen rechtsmiddelen (meer) openstaan, is vastgesteld dat het handelen of nalaten van de huidige of voormalige bestuurder kan<br>worden aangemerkt als opzettelijk, frauduleus, grof nalatig, bewust roekeloos of ernstig verwijtbaar, tenzij zulks in de gegeven omstandigheden<br>naar maatstaven van redelijkheid en billijkheid onaanvaardbaar zou zijn;
---	---
(c)	de kosten of het vermogensverlies van de (huidige of voormalige) bestuurder zijn/is gedekt door een verzekering en de verzekeraar<br>is overgegaan tot uitbetaling van de kosten of het vermogensverlies; of
---	---
(d)	de betreffende procedure door de vennootschap en/of een groepsmaatschappij aanhangig is gemaakt bij de betreffende rechter, rechterlijk<br>college of, in geval van arbitrage, arbiter of arbitraal college,
---	---

in welk geval hij onverwijld enig bedrag dat aan hem (vooruit, al naar gelang het geval) door de vennootschap is betaald onder dit artikel 24, zal terugbetalen.

12
![](ex3-1_001.jpg)

25	Vertegenwoordiging
25.1	Het bestuur is bevoegd de vennootschap te vertegenwoordigen. Iedere uitvoerende bestuurder is eveneens bevoegd de vennootschap te<br>vertegenwoordigen.
---	---
25.2	Het bestuur kan functionarissen met algemene of beperkte vertegenwoordigingsbevoegdheid aanstellen. Iedere functionaris is bevoegd<br>de vennootschap te vertegenwoordigen, met inachtneming van de beperkingen die hem worden opgelegd. Het bestuur bepaalt de titel van iedere<br>functionaris. Deze functionarissen kunnen worden ingeschreven in het handelsregister onder vermelding van de omvang van hun vertegenwoordigingsbevoegdheid.
---	---

HOOFDSTUK VIII – ALGEMENE VERGADERING

26	Algemene vergadering
26.1	Algemene vergaderingen worden gehouden in Amsterdam, Rotterdam of Haarlemmermeer (inclusief Luchthaven Schiphol).
---	---
26.2	De jaarlijkse algemene vergadering wordt elk jaar gehouden binnen zes (6) maanden na afloop van het boekjaar van de vennootschap.<br>Andere algemene vergaderingen worden gehouden zo dikwijls het bestuur of de voorzitter van het bestuur zulks noodzakelijk acht.
---	---
27	Algemene vergadering: bijeenroeping
---	---
27.1	Algemene vergaderingen worden bijeengeroepen door het bestuur of de voorzitter van het bestuur.
---	---
27.2	Een of meer aandeelhouders en/of andere vergadergerechtigden die alleen of gezamenlijk ten minste het door de wet voor dit doel voorgeschreven<br>gedeelte van het geplaatste kapitaal van de vennootschap vertegenwoordigen, kunnen het bestuur schriftelijk, onder nauwkeurige opgave<br>van de te behandelen onderwerpen, verzoeken een algemene vergadering bijeen te roepen. Indien het bestuur niet de nodige maatregelen heeft<br>getroffen opdat de algemene vergadering binnen de wettelijke termijn na het verzoek gehouden kan worden, kunnen de verzoekende aandeelhouders<br>en/of andere vergadergerechtigden op hun verzoek door de voorzieningenrechter van de rechtbank worden gemachtigd tot de bijeenroeping<br>van een algemene vergadering.
---	---
28	Algemene vergadering: oproeping en agenda
---	---
28.1	De oproeping tot een algemene vergadering wordt gedaan door het bestuur door middel van een aankondiging met inachtneming van de wettelijke<br>oproepingstermijn en in overeenstemming met de wet.
---	---
28.2	Bij de oproeping tot een algemene vergadering worden vermeld de te behandelen onderwerpen, welke onderwerpen ter bespreking en welke<br>onderwerpen ter stemming zijn, de plaats en het tijdstip van de vergadering, de procedure voor deelname aan de vergadering al dan niet<br>bij schriftelijk gevolmachtigde, het adres van de website van de vennootschap en, indien van toepassing, de procedure voor deelname aan<br>de vergadering en uitoefening van het stemrecht door middel van een elektronisch communicatiemiddel als bedoeld in artikel 29.4, en met<br>inachtneming van hetgeen terzake in de wet is bepaald.
---	---
28.3	Bij de oproeping tot een algemene vergadering wordt tevens de registratiedatum vermeld alsmede de wijze waarop de vergadergerechtigden<br>zich kunnen laten registreren en de wijze waarop zij hun rechten kunnen uitoefenen.
---	---
28.4	Een onderwerp waarvan de behandeling schriftelijk is verzocht door een of meer aandeelhouders en/of andere vergadergerechtigden die<br>alleen of gezamenlijk ten minste het door de wet voor dit doel voorgeschreven gedeelte van het geplaatste kapitaal van de vennootschap<br>vertegenwoordigen, wordt opgenomen in de oproeping tot de algemene vergadering of wordt op dezelfde wijze aangekondigd als de overige<br>onderwerpen ter bespreking, mits de vennootschap het (met redenen omklede) verzoek niet later dan zestig (60) kalenderdagen voor de dag<br>van de vergadering heeft ontvangen. Dergelijke schriftelijke verzoeken moeten voldoen aan de door het bestuur vastgestelde voorwaarden<br>zoals gepubliceerd op de website van de vennootschap.
---	---

13
![](ex3-1_001.jpg)

29	Algemene vergadering: toegang
29.1	De vergadergerechtigden en de stemgerechtigden die op de registratiedatum voor een algemene vergadering als zodanig zijn ingeschreven<br>in een daartoe door het bestuur aangewezen register, gelden voor die algemene vergadering als vergadergerechtigden respectievelijk stemgerechtigden,<br>ongeacht wie ten tijde van de algemene vergadering de rechthebbenden op de aandelen zijn.
---	---
29.2	Als een persoon het vergaderrecht en stemrecht in een algemene vergadering wil uitoefenen, dan moet die persoon de vennootschap uiterlijk<br>op de in de oproeping tot de algemene vergadering genoemde dag en wijze schriftelijk in kennis stellen van zijn voornemen daartoe.
---	---
29.3	Het bestuur kan in de oproeping tot een algemene vergadering bepalen dat een stem die voorafgaand aan de vergadering wordt uitgebracht<br>door middel van een elektronisch communicatiemiddel of bij brief, wordt gelijkgesteld met een ter vergadering uitgebrachte stem. Een dergelijke<br>stem kan niet worden uitgebracht vóór de registratiedatum van de algemene vergadering.
---	---
29.4	Het bestuur kan besluiten dat iedere vergadergerechtigde bevoegd is om, in persoon of bij schriftelijk gevolmachtigde, door middel<br>van een elektronisch communicatiemiddel aan de algemene vergadering deel te nemen, daarin het woord te voeren en, indien van toepassing,<br>het stemrecht uit te oefenen, op voorwaarde dat deze persoon via hetzelfde elektronisch communicatiemiddel kan worden geïdentificeerd<br>en rechtstreeks kennis kan nemen van de verhandelingen ter vergadering en, indien van toepassing, het stemrecht uit te oefenen. Het bestuur<br>kan voorwaarden verbinden aan het gebruik van het elektronisch communicatiemiddel, mits deze voorwaarden redelijk en noodzakelijk zijn<br>voor de identificatie van de vergadergerechtigden en de betrouwbaarheid en veiligheid van de communicatie. De voorwaarden worden in de<br>oproeping tot een algemene vergadering opgenomen en op de website van de vennootschap gepubliceerd.
---	---
29.5	De bestuurders zijn bevoegd de algemene vergadering bij te wonen en hebben als zodanig een raadgevende stem in de algemene vergadering.
---	---
29.6	De voorzitter van de algemene vergadering beslist omtrent alle kwesties die verband houden met de toelating tot de algemene vergadering.<br>De voorzitter van de algemene vergadering kan derden toelaten tot de algemene vergadering.
---	---
29.7	De vennootschap kan bepalen dat enig persoon, alvorens hij wordt toegelaten tot een algemene vergadering, zichzelf moet identificeren<br>door middel van een geldig paspoort of door middel van een andere wijze van identificatie en/of dergelijke veiligheidsmaatregelen moet<br>ondergaan welke de vennootschap passend acht onder de gegeven omstandigheden.
---	---
29.8	De algemene vergadering kan gevoerd worden in het Nederlands of het Engels, zoals bepaald door de voorzitter van de algemene vergadering.
---	---
30	Algemene vergadering: voorzitter, secretaris en notulen
---	---
30.1	De algemene vergadering wordt voorgezeten door de voorzitter van het bestuur of een andere daartoe door het bestuur aangewezen bestuurder.<br>Indien de voorzitter van het bestuur niet op de vergadering aanwezig is en geen andere bestuurder door het bestuur is aangewezen om de<br>algemene vergadering voor te zitten, wijst de algemene vergadering zelf een voorzitter aan.
---	---

14
![](ex3-1_001.jpg)

30.2	De voorzitter van de algemene vergadering wijst een secretaris van de algemene vergadering aan.
30.3	Van het verhandelde in een algemene vergadering worden door de secretaris notulen gehouden, tenzij op verzoek van het bestuur een<br>notarieel proces-verbaal van de algemene vergadering wordt opgemaakt. De notulen worden vastgesteld door de voorzitter en de secretaris<br>van de algemene vergadering en ten blijke daarvan door hen ondertekend. Een document waaruit blijkt dat een of meer besluiten door de<br>algemene vergadering zijn genomen en dat door de voorzitter en de secretaris van de desbetreffende vergadering is ondertekend, geldt als<br>geldig bewijs van die besluiten.
---	---
31	Algemene vergadering: besluitvorming
---	---
31.1	Ieder gewoon aandeel geeft recht op het uitbrengen van één (1) stem tijdens de algemene vergadering. Ieder preferent<br>aandeel geeft recht op het uitbrengen van tienduizend (10.000) stemmen tijdens de algemene vergadering.
---	---
31.2	Voor zover de wet of deze statuten geen versterkte meerderheid voorschrijven, worden alle besluiten van de algemene vergadering genomen<br>met een gewone meerderheid van de uitgebrachte stemmen.
---	---
31.3	De voorzitter van de algemene vergadering bepaalt de wijze van stemming.
---	---
31.4	Onthoudingen, blanco stemmen en ongeldige stemmen worden niet als stemmen geteld.
---	---
31.5	Het oordeel van de voorzitter van de algemene vergadering omtrent de uitslag van een stemming is beslissend.
---	---
31.6	Over alle geschillen betreffende de stemmingen waarin bij de wet of deze statuten niet is voorzien, beslist de voorzitter van de algemene<br>vergadering.
---	---
31.7	In de algemene vergadering kan geen stem worden uitgebracht voor een aandeel dat toebehoort aan de vennootschap of een dochtermaatschappij;<br>evenmin voor een aandeel waarvan de vennootschap of een dochtermaatschappij de certificaten houdt. De vennootschap of een dochtermaatschappij<br>kan geen stem uitbrengen voor een aandeel waarop zij een pandrecht of een vruchtgebruik heeft. Pandhouders en vruchtgebruikers van aandelen<br>die toebehoren aan de vennootschap of een dochtermaatschappij zijn evenwel niet van het stemrecht uitgesloten, indien het pandrecht of<br>vruchtgebruik was gevestigd voordat het aandeel aan de vennootschap of een dochtermaatschappij toebehoorde.
---	---
31.8	Bij de vaststelling hoeveel stemmen door aandeelhouders worden uitgebracht, hoeveel aandeelhouders aanwezig of vertegenwoordigd zijn,<br>of welk gedeelte van het geplaatste kapitaal van de vennootschap in de algemene vergadering is vertegenwoordigd, wordt geen rekening gehouden<br>met aandelen waarvoor krachtens de wet of deze statuten geen stem kan worden uitgebracht.
---	---
32	Soortvergaderingen
---	---
32.1	De bepalingen van deze statuten met betrekking tot algemene vergaderingen, met uitzondering van de artikelen 26.2 en 29.5, zijn van<br>overeenkomstige toepassing op een soortvergadering van houders van preferente aandelen en andere personen die gerechtigd zijn een dergelijke<br>vergadering bij te wonen, met dien verstande dat de desbetreffende vergadering haar eigen voorzitter benoemt, en voorts met dien verstande<br>dat zolang preferente aandelen niet zijn toegelaten tot de notering van en de handel op een effectenbeurs met medewerking van de vennootschap:
---	---
(a)	de oproeping tot een vergadering als bedoeld in dit artikel niet later geschiedt dan op de vijftiende (15^e^) dag voor die<br>van de vergadering en de oproeping geschiedt aan de adressen als opgenomen in het aandeelhoudersregister;
---	---

15
![](ex3-1_001.jpg)

(b)	besluiten schriftelijk kunnen worden genomen zonder een vergadering te houden zoals bedoeld in dit artikel, mits dergelijke besluiten<br>worden genomen met algemene stemmen van alle stemgerechtigde houders van preferente aandelen; en
(c)	geldige besluiten kunnen worden genomen indien niet is voldaan aan de formaliteiten voor het bijeenroepen en houden van vergaderingen<br>als bedoeld in dit artikel, indien deze besluiten met algemene stemmen zijn genomen in een vergadering waarin alle geplaatste en uitstaande<br>preferente aandelen zijn vertegenwoordigd.
---	---

HOOFDSTUK IX – BOEKJAAR, JAARREKENING EN ACCOUNTANT

33	Boekjaar en jaarrekening
33.1	Het boekjaar van de vennootschap valt samen met het kalenderjaar.
---	---
33.2	Jaarlijks, binnen de daartoe door de wet gestelde termijn, maakt het bestuur de jaarrekening op. De jaarrekening wordt vergezeld met<br>de verklaring van de accountant als bedoeld in artikel 34.2, het bestuursverslag en de overige gegevens voor zover deze gegevens zijn<br>vereist.
---	---
33.3	De jaarrekening wordt ondertekend door de bestuurders; ontbreekt de handtekening van een of meer van hen, dan wordt daarvan onder<br>opgave van redenen melding gemaakt.
---	---
33.4	De algemene vergadering stelt de jaarrekening vast.
---	---
34	Accountant
---	---
34.1	De algemene vergadering geeft aan een accountant opdracht om de jaarrekening te onderzoeken. Indien de algemene vergadering niet overgaat<br>tot het verlenen van een dergelijke opdracht aan een accountant, dan is het bestuur daartoe bevoegd. De uitvoerende bestuurders nemen<br>niet deel aan de beraadslaging en besluitvorming over de verlening van de opdracht tot onderzoek van de jaarrekening aan een accountant.
---	---
34.2	De aan de accountant verleende opdracht kan slechts worden ingetrokken door de algemene vergadering en, indien het bestuur de opdracht<br>heeft verleend, door het bestuur, om gegronde redenen en overeenkomstig artikel 2:393 lid 2 BW.
---	---
34.3	De accountant brengt omtrent zijn onderzoek verslag uit aan het bestuur en geeft de uitslag van zijn onderzoek weer in een verklaring<br>omtrent de getrouwheid van de jaarrekening.
---	---

HOOFDSTUK X – RESERVES, RESULTAAT EN UITKERINGEN

35	Reserves, winst en uitkeringen
35.1	De vennootschap houdt een aparte dividendreserve aan voor de preferente aandelen (bijzondere dividendreserve). De preferente<br>aandelen geven geen recht op enige andere reserve van de vennootschap. Voor een uitkering uit de bijzondere dividendreserve of de gedeeltelijke<br>of volledige vrijgave van een dergelijke reserve is een voorafgaand voorstel van het bestuur en een daaropvolgend besluit van de soortvergadering<br>van preferente aandelen vereist.
---	---
35.2	Uitkering van winst geschiedt na vaststelling van de jaarrekening waaruit blijkt dat zij geoorloofd is.
---	---
35.3	Uitkeringen kunnen slechts geschieden voor zover het eigen vermogen van de vennootschap groter is dan het bedrag van het gestorte<br>en opgevraagde deel van het kapitaal vermeerderd met de reserves die krachtens de wet en deze statuten moeten worden aangehouden.
---	---

35.4	Het bestuur is bevoegd vast te stellen welk deel van de winst zal worden gereserveerd, met inachtneming van het reserverings- en dividendbeleid<br>van de vennootschap. De vennootschap kan een reserverings- en dividendbeleid hebben dat door het bestuur wordt vastgesteld en gewijzigd.
35.5	De winst die overblijft na reservering overeenkomstig artikel 35.4 wordt eerst aangewend voor toewijzing en toevoeging aan de bijzondere<br>dividendreserve van een bedrag gelijk aan één procent (1%) van het totale nominale bedrag van alle uitstaande preferente<br>aandelen minus enig bedrag toegevoegd aan de bijzondere dividendreserve ingevolge toepassing van artikel 35.9 met betrekking tot enige<br>tussentijdse uitkeringen gedaan gedurende het boekjaar waarop de jaarrekening waaruit de winst blijkt betrekking heeft. De berekening<br>van het bedrag dat moet worden toegewezen en toegevoegd aan de bijzondere dividendreserve geschiedt naar tijdsgelang. Indien preferente<br>aandelen worden uitgegeven gedurende het boekjaar waarop de toekenning en toevoeging betrekking heeft, dan wordt het aan de bijzondere<br>dividendreserve toe te kennen en toe te voegen bedrag met betrekking tot deze nieuw uitgegeven preferente aandelen berekend vanaf de datum<br>waarop deze preferente aandelen zijn uitgegeven tot de laatste dag van het betreffende boekjaar. De preferente aandelen geven geen enkel<br>ander recht op de winst.
---	---
35.6	De algemene vergadering kan besluiten tot uitkering van de na toepassing van artikelen 35.4 en 35.5 overgebleven winst. Indien<br>de algemene vergadering niet besluit deze winst geheel of gedeeltelijk uit te keren, wordt de winst (of elke resterende winst na uitkering)<br>ook gereserveerd.
---	---
35.7	De algemene vergadering kan slechts op voorstel van het bestuur besluiten tot uitkering aan de aandeelhouders van een dividend in<br>natura of in de vorm van aandelen.
---	---
35.8	Het bestuur, of de algemene vergadering op voorstel van het bestuur, kan besluiten tot het doen van uitkeringen ten laste van de agioreserve<br>of andere uitkeerbare reserves die de vennootschap aanhoudt.
---	---
35.9	Het bestuur kan besluiten tot het doen van tussentijdse uitkeringen op aandelen, indien (i) uit een overeenkomstig de wettelijke voorschriften<br>opgemaakte tussentijdse vermogensopstelling blijkt dat aan het vereiste van artikel 35.2 is voldaan, (ii) een bedrag gelijk aan één<br>procent (1%) van de totale nominale waarde van alle uitstaande preferente aandelen, vastgesteld op de dividendregistratiedatum die door<br>het bestuur voor een dergelijke tussentijdse uitkering wordt vastgesteld, wordt toegevoegd aan de bijzondere dividendreserve voordat de<br>tussentijdse uitkering wordt gedaan en (iii) alle (overige) toepasselijke wettelijke bepalingen met betrekking tot een dergelijke tussentijdse<br>uitkering zijn nageleefd. Het bedrag dat overeenkomstig de voorgaande zin aan de bijzondere dividendreserve moet worden toegevoegd, wordt<br>verlaagd, maar nooit onder nul (0), met enig bedrag toegevoegd aan de bijzondere dividendreserve op grond van toepassing van dit artikel<br>35.9 met betrekking tot tussentijdse uitkeringen die gedurende hetzelfde boekjaar zijn gedaan.
---	---
35.10	Het bestuur, of de algemene vergadering op voorstel van het bestuur, kan besluiten dat een uitkering op aandelen geheel of gedeeltelijk<br>niet in geld maar in natura of in de vorm van aandelen zal worden gedaan, of dat aandeelhouders de keuze wordt gegeven om de uitkering<br>in geld of in natura en/of in de vorm van aandelen te ontvangen (zulks met inachtneming van de artikelen 7 en 9), en kan de voorwaarden<br>vaststellen waaronder een dergelijke keuze aan de aandeelhouders kan worden geboden.
---	---
35.11	Bij de berekening van het bedrag van enige uitkering op aandelen, tellen de aandelen die de vennootschap in haar kapitaal houdt niet<br>mee, tenzij die aandelen bezwaard zijn met een vruchtgebruik of een pandrecht.
---	---

17
![](ex3-1_001.jpg)

36	Mededelingen en betalingen
36.1	De datum waarop dividenden en andere uitkeringen betaalbaar worden gesteld, wordt aangekondigd overeenkomstig de wet en gepubliceerd<br>op de website van de vennootschap.
---	---
36.2	Uitkeringen worden op een door het bestuur bepaalde dag betaalbaar gesteld.
---	---
36.3	De personen die gerechtigd zijn tot een uitkering zijn de desbetreffende aandeelhouders, vruchtgebruikers van aandelen en pandhouders<br>van aandelen, op een datum bepaald door het bestuur voor dat doel. Deze datum zal niet eerder zijn dan de datum waarop de uitkering was<br>aangekondigd.
---	---
36.4	Uitkeringen waarover vijf (5) jaren en één (1) dag nadat zij opeisbaar zijn geworden niet is beschikt, vervallen aan<br>de vennootschap en worden aan de reserves toegevoegd.
---	---
36.5	Het bestuur kan bepalen dat uitkeringen op aandelen in euro dan wel in een andere valuta betaalbaar worden gesteld.
---	---

HOOFDSTUK XI – STATUTENWIJZIGING, ONTBINDING EN VEREFFENING

37	Statutenwijziging
37.1	De algemene vergadering kan op voorstel van het bestuur besluiten deze statuten te wijzigen.
---	---
37.2	Wanneer aan de algemene vergadering een voorstel tot wijziging van deze statuten wordt gedaan, moet zulks bij de oproeping tot die<br>vergadering worden vermeld en moet een afschrift van het voorstel, waarin de voorgestelde wijziging woordelijk is opgenomen, ten kantore<br>van de vennootschap ter inzage worden neergelegd en kosteloos verkrijgbaar worden gesteld voor aandeelhouders en andere vergadergerechtigden,<br>tot de afloop van de vergadering. Van een wijziging van deze statuten wordt een notariële akte opgemaakt.
---	---
38	Ontbinding en vereffening
---	---
38.1	De algemene vergadering kan op voorstel van het bestuur besluiten de vennootschap te ontbinden.
---	---
38.2	In geval van ontbinding van de vennootschap ingevolge een besluit van de algemene vergadering, worden de bestuurders vereffenaars<br>van het vermogen van de ontbonden vennootschap. De algemene vergadering kan besluiten andere personen tot vereffenaars te benoemen.
---	---
38.3	Gedurende de vereffening blijven de bepalingen van deze statuten voor zover mogelijk van kracht.
---	---
38.4	Hetgeen na voldoening van de schulden van de ontbonden vennootschap is overgebleven, wordt overgedragen naar rato van het aantal gewone<br>aandelen en preferente aandelen dat door iedere aandeelhouder wordt gehouden.
---	---

18
![](ex3-1_001.jpg)

Unofficial translationof the articles of association of Terra Innovatum Global N.V. as they read after execution of the deed of cross-border conversion andamendment of these articles of association before a deputy of Michel Pieter van Agt, civil law notary in Amsterdam, the Netherlands,on 6 October 2025, which cross-border conversion became effective on 7 October 2025.

Please note thatthis is an unofficial office translation, in which an attempt has been made to be as literal as possible without jeopardizing theoverall continuity. Inevitably, differences may occur in translation, and if so, the Dutch text will by law govern. The definitionsin article 1.1 of this document are listed in the English alphabetical order which may differ from the Dutch alphabetical order.Inevitably, however, differences may occur in translation and if they do, the Dutch text will govern by law. In this translation,Dutch legal concepts are expressed in English terms and not in their original Dutch terms. The concepts concerned may not beidentical to concepts described by the English terms as such terms may be understood under the laws of other jurisdictions.

ARTICLES OF ASSOCIATION:

CHAPTER I – DEFINITIONS AND INTERPRETATION

1	Definitions
1.1	In these Articles of Association the following words shall have the following meanings:
---	---

Annual Accounts: the Company’s annual accounts as referred to in Section 2:361 DCC;

Articles of Association: these articles of association;

Auditor: an auditor as referred to in Section 2:393 DCC, or an organization in which auditors referred to in Section 2:393 DCC work together;

BCA: the business combination agreement entered into on the twenty-first day of April two thousand twenty-five by and among GSR III Acquisition Corp. and Terra Innovatum s.r.l., and such other parties that will sign joinders to this business combination agreement, as amended from time to time or completely readopted, and which contains contractual arrangements between the aforementioned parties in respect of, among others, the conversion of Preferred Shares into Ordinary Shares;

Board: the Company’s board of directors;

Board Regulations: the written rules and regulations adopted by the Board as referred to in Article 22.4;

Class Meeting: the meeting of holders of Shares of a specific class, and if a specific class is added it means the meeting of that specific class;

Class Meeting Preferred Shares: the meeting of holders of Preferred Shares;

Company: the Company to which these Articles of Association pertain;

Conversion Confirmation: has the meaning assigned thereto in Article 7.4;

Conversion Request: has the meaning assigned thereto in Article 7.2;

DCC: the Dutch Civil Code;

DCGC: the Dutch Corporate Governance Code, as amended from time to time;

Director: an Executive Director or a Non-Executive Director;

19
![](ex3-1_001.jpg)

Executive Director: a member of the Board appointed as executive director;

General Meeting: the corporate body of the Company consisting of Shareholders and all other Persons with Meeting Right or a meeting of Shareholders and other Persons with Meeting Right, as the case may be;

Group Company: a group company of the Company as referred to in Section 2:24b DCC;

in writing: by letter, by e-mail, or by a legible and reproducible message otherwise electronically sent, provided that the identity of the sender can be sufficiently established;

Management Report: the Company's management report as referred to in Section 2:391 DCC;

Meeting Right: the right, either in person or by proxy authorized in writing, to attend and address the General Meeting;

Non-Executive Director: a member of the Board appointed as non-executive director;

Ordinary Share: an ordinary share in the Company’s share capital;

Persons with Meeting Right: Shareholders, holders of a usufruct with Meeting Right and holders of a right of pledge with Meeting Right;

Persons with Voting Rights: Shareholders with voting rights, holders of a usufruct with voting rights and holders of a right of pledge with voting rights in the General Meeting;

Preferred Share: a convertible preferred share in the Company’s share capital;

Record Date: the twenty-eighth (28^th^) calendar day prior to the date of a General Meeting;

Share: a share in the Company’s share capital; unless the contrary is expressed this shall include each Ordinary Share and each Preferred Share;

Shareholder: a holder of one or more Shares, unless the contrary is expressed this shall include each holder of Ordinary Shares and each holder of Preferred Shares;

Special Dividend Reserve: has the meaning assigned thereto in Article 35.1;

Subsidiary: a subsidiary of the Company as referred to in Section 2:24a DCC;

Trading Day: a day on which all of the stock exchanges, on which the Ordinary Shares upon the request of, or on behalf of, the Company have been (conditionally or unconditionally) admitted to trading from time to time, are open for trading;

2	Construction
2.1	References to Articles shall be deemed to refer to articles of these Articles of Association, unless the contrary is apparent.
---	---
2.2	Any reference to a gender includes all genders.
---	---

20
![](ex3-1_001.jpg)

CHAPTER II – NAME, REGISTERED OFFICE AND OBJECTS

3	Name and registered office
3.1	The Company's name is Terra Innovatum Global N.V.
---	---
3.2	The registered office of the Company is in Amsterdam, the Netherlands.
---	---
4	Objects
---	---

The objects of the Company are:

(d)	to design, develop and market micromodular nuclear reactors directly or through its Group Companies;
(e)	to provide technical and scientific services in various fields of engineering, including energy (also based on nuclear fission), mechanical<br>engineering, transportation, waste management, and environmentally sustainable systems and infrastructures, directly or through its Group<br>Companies;
---	---
(f)	to incorporate, to participate in any way whatsoever in, to manage, to supervise businesses and companies;
---	---
(g)	to finance businesses and companies;
---	---
(h)	to borrow, to lend and to raise funds, including the issue of bonds, promissory notes or other securities or evidence of indebtedness,<br>as well as to enter into agreements in connection with aforementioned activities;
---	---
(i)	to render advice and services to Group Companies and to third parties;
---	---
(j)	to grant guarantees, to bind the Company and to pledge its assets for obligations of the Company, Group Companies and/or third parties;
---	---
(k)	to acquire, alienate, manage and exploit registered property and items of property in general;
---	---
(l)	to trade in currencies, securities and items of property in general;
---	---
(m)	to develop and trade in patents, trade marks, licenses, know-how and other intellectual and industrial property rights; and
---	---
(n)	to perform any and all activities of an industrial, financial or commercial nature, and to do all that is connected therewith or may be conducive<br>thereto, all to be interpreted in the broadest sense.
---	---

CHAPTER III – SHARE CAPITAL

5	Authorized capital
5.1	The authorized capital of the Company amounts to five million eight hundred four thousand euro (EUR 5,804,000).
---	---
5.2	The authorized capital of the Company is divided into five hundred million (500,000,000) Ordinary Shares, with a nominal value of<br>one eurocent (EUR 0.01) each and eight thousand forty (8,040) Preferred Shares, with a nominal value of one hundred euro (EUR 100) each.
---	---
5.3	Upon the conversion of one or more Preferred Shares into Ordinary Shares referred to in Article 7, the authorized capital shall decrease<br>with the number of Preferred Shares so converted and shall increase with the number of Ordinary Shares into which such Preferred Shares<br>were converted.
---	---

21
![](ex3-1_001.jpg)

5.4	Within eight (8) calendar days after a conversion of one or more Preferred Shares into Ordinary Shares, the Board shall (i) file a<br>notification thereof with the Dutch trade register, which notification must at least include the authorized capital following the conversion,<br>and (ii) register the conversion in the shareholders’ register as referred to in Article 7.
5.5	No share certificates shall be issued.
---	---
6	Shareholders’ register
---	---
6.1	The Board must keep a shareholders’ register; the Board may appoint a registrar to keep the register on its behalf. The register<br>must be regularly updated. The shareholders’ register may be kept in several copies and in several places. Part of the register<br>may be kept outside the Netherlands to comply with applicable local law or pursuant to stock exchange rules.
---	---
6.2	Each Shareholder's name, address and further information as required by law or considered appropriate by the Board are recorded in<br>the shareholders’ register. Shareholders shall provide the Board with the necessary particulars in a timely fashion. Any consequences<br>of not, or incorrectly, notifying such particulars will be the responsibility of the Shareholder concerned.
---	---
6.3	If a Shareholder so requests, the Board shall provide the Shareholder, free of charge, with written evidence of the information in<br>the shareholders’ register concerning the Shares registered in the Shareholder's name.
---	---
6.4	The Articles 6.2 and 6.3 shall apply by analogy to holders of a usufruct or right of pledge on one or more Shares, with the exception<br>of a holder of a right of pledge created without acknowledgement by or service of notice upon the Company.
---	---
7	Conversion of Preferred Shares into Ordinary Shares
---	---
7.1	Each Preferred Share can be converted into ten thousand (10,000) Ordinary Shares, subject to the provisions of this Article 7.
---	---
7.2	Upon fulfilment of the contractual conversion conditions as included in the BCA as determined by the Board (i) voluntarily or (ii)<br>at the request of a holder of Preferred Shares (Conversion Request), the Board shall convert the Preferred Shares held by the Shareholders<br>into Ordinary Shares in the ratio as set out in Article 7.1.
---	---
7.3	The Conversion Request shall be made in writing and shall specify the number and numbering of Preferred Shares to be converted.
---	---
7.4	The conversion of one or more Preferred Shares will only take effect upon the issuance by the Board of a confirmation that the contractual<br>conversion conditions as included in the BCA are met (Conversion Confirmation).
---	---
7.5	The conversion of a Preferred Share shall take place as of the date of the issuance of a Conversion Confirmation, or on such later<br>date as the Board shall indicate in the Conversion Confirmation.
---	---
7.6	Upon the conversion of a Preferred Share, a proportionate part of the Special Dividend Reserve attached to that Preferred Share will<br>be reallocated to the respective reserve(s) attached to the Ordinary Shares that the Preferred Share is being converted into.
---	---

22
![](ex3-1_001.jpg)

8	Issuance of Shares
8.1	Shares shall be issued pursuant to a resolution of the Board if the Board has been designated thereto by the General Meeting for a<br>specific period and with due observance of applicable statutory provisions. Such designation by the General Meeting must state the number<br>of Shares that may be issued. The designation may be extended by specific consecutive periods with due observance of applicable statutory<br>provisions. Unless otherwise stipulated at its grant, the designation may not be withdrawn.
---	---
8.2	If and insofar as the Board is not designated by the General Meeting, Shares shall be issued pursuant to a resolution of the General<br>Meeting. The General Meeting shall, in addition to the Board, remain authorized to issue Shares if such is specifically stipulated in<br>the resolution authorizing the Board to issue Shares as described in Article 8.1.
---	---
8.3	The Articles 8.1 and 8.2 shall apply by analogy to the granting of rights to subscribe for Shares, but shall not apply to an issue<br>of Shares to a person exercising a previously granted right to subscribe for Shares.
---	---
8.4	If the resolution of the General Meeting to issue Shares or to designate the authority to issue Shares to the Board as referred to<br>in Article 8.1 is detrimental to the rights of holders of a specific class of Shares, the validity of such resolution of the General Meeting<br>requires a prior or simultaneous approval by the group of holders of such class of Shares.
---	---
8.5	A resolution of the General Meeting as referred to in this Article 7 can only be adopted at the proposal of the Board.
---	---
9	Pre-emptive rights
---	---
9.1	Each holder of Ordinary Shares shall have a pre-emptive right on any issuance of Ordinary Shares in proportion to the aggregate amount<br>of its Ordinary Shares. This pre-emptive right does not apply to:
---	---
(o)	Ordinary Shares issued to employees of the Company or a Group Company;
---	---
(p)	Ordinary Shares that are issued against payment other than in cash; and
---	---
(q)	Ordinary Shares issued to a person exercising a previously granted right to subscribe for Ordinary Shares.
---	---
9.2	Holders of Preferred Shares shall have no pre-emptive right on any issuance of Ordinary Shares and no Shareholder shall have a pre-emptive<br>right on any issuance of Preferred Shares.
---	---
9.3	Pre-emptive rights may be limited or excluded by a resolution of the Board if the Board has been designated thereto by the General<br>Meeting for a specific period and with due observance of applicable statutory provisions, and the Board has also been designated to issue<br>Shares in accordance with Article 8.1. The designation may be extended by specific consecutive periods with due observance of applicable<br>statutory provisions. Unless otherwise stipulated at its grant, the designation may not be withdrawn.
---	---
9.4	If and insofar as the Board is not designated by the General Meeting, pre-emptive rights may be limited or excluded by a resolution<br>of the General Meeting. The General Meeting shall, in addition to the Board, remain authorized to limit or exclude pre-emptive rights<br>if such is specifically stipulated in the resolution authorizing the Board to limit or exclude pre-emptive rights as described in Article<br>9.2.
---	---

23
![](ex3-1_001.jpg)

9.5	A resolution of the General Meeting to limit or exclude pre-emptive rights and a resolution to designate the Board thereto, can only<br>be adopted at the proposal of the Board and shall require a majority of at least two-thirds (2/3) of the votes cast if less than half<br>of the issued capital of the Company is represented at the General Meeting.
9.6	When adopting a resolution to issue Ordinary Shares, the General Meeting or the Board shall determine how and during which period<br>these pre-emptive rights may be exercised, subject to Section 2:96a DCC.
---	---
9.7	This Article 9.1 shall apply by analogy to the granting of rights to subscribe for Shares.
---	---
10	Payment on Shares
---	---
10.1	Shares may only be issued against payment in full of the amount at which such Shares are issued and with due observance of the provisions<br>of the Sections 2:80, 2:80a and 2:80b DCC.
---	---
10.2	Payment on Shares must be made in cash if no alternative contribution has been agreed. Payment other than in cash must be made in<br>accordance with the provisions of Section 2:94b DCC. Payment in a currency other than euro may only be made with the consent of the Company<br>and with due observance of the provisions of Section 2:93a DCC.
---	---
10.3	Ordinary Shares issued to (i) current or former employees of the Company or a Group Company, (ii) current or former Directors under<br>an equity compensation plan of the Company and (iii) holders of a right to subscribe for Ordinary Shares granted in accordance with Article<br>8.3 may be paid-up at the expense of the reserves of the Company, notwithstanding the provisions of Article 35.
---	---
10.4	The Board may perform legal acts as referred to in Section 2:94 DCC without the prior approval of the General Meeting.
---	---

CHAPTER IV – OWN SHARES AND CAPITAL REDUCTION

11	Share repurchase and disposal of Shares
11.1	The Company may repurchase fully paid-up Shares (i) for no consideration or (ii) against consideration if and insofar as the Board<br>has been authorized thereto by the General Meeting for a specific period and with due observance of applicable statutory provisions. The<br>General Meeting shall determine in its authorization how many Shares the Company may repurchase, in what manner and at what price range.
---	---
11.2	The authorization by the General Meeting is not required if the Company repurchases fully paid-up Shares for the purpose of transferring<br>these Shares to employees of the Company or a Group Company under any applicable equity compensation plan, provided that those Shares<br>are quoted on an official list of a stock exchange.
---	---
11.3	Any disposal of Shares by the Company shall require a resolution of the Board. Such resolution shall also stipulate any conditions<br>of the disposal.
---	---

24
![](ex3-1_001.jpg)

12	Capital reduction
12.1	The General Meeting may only at the proposal of the Board resolve to reduce the Company’s issued capital by (i) reducing the<br>nominal value of Shares through amendment of the Articles of Association or (ii) cancelling Shares held by the Company itself.
---	---
12.2	A resolution of the General Meeting to reduce the Company’s issued capital, shall require a majority of at least two-thirds<br>(2/3) of the votes cast if less than half of the issued capital of the Company is represented at the General Meeting.
---	---
12.3	A resolution of the General Meeting to reduce the Company’s issued capital by cancelling all Preferred Shares, shall require<br>a prior or simultaneous approval by the Class Meeting Preferred Shares.
---	---
12.4	If the resolution of the General Meeting to reduce the Company’s issued capital by reducing the nominal value of Shares through<br>amendment of these Articles of Association, as referred to above, is detrimental to the rights of holders of a specific class of Shares,<br>the validity of such resolution of the General Meeting requires a prior or simultaneous approval by the group of holders of such class<br>of Shares.
---	---

CHAPTER V – TRANSFER OF SHARES

13	Transfer of Shares
13.1	The transfer of Shares shall require a deed executed for that purpose and, save in the event the Company itself is a party to such<br>legal act, written acknowledgement by the Company of the transfer. Service of notice of such deed to the Company or of a true copy or<br>extract of such deed will be the equivalent of such acknowledgement.
---	---
13.2	Article 13.1 shall apply mutatis mutandis to the creation of a right of pledge or usufruct on a Share, provided that a right<br>of pledge may also be created without acknowledgement by or service of notice upon the Company, in which case Section 3:239 DCC applies<br>and the acknowledgement by or service of notice upon the Company shall replace the announcement as referred to in Section 3:239(3) DCC.
---	---
13.3	If and as long as one or more Ordinary Shares are admitted to trading on the NASDAQ Stock Market, the Board may resolve that the laws<br>of the State of New York, United States of America, shall apply to the property law aspects of the Ordinary Shares, as a result of which<br>the articles 13.1 and 13.2 shall not apply to the Ordinary Shares. Such resolution and the revocation thereof shall be made available<br>for inspection on the Company’s website and at the Dutch trade register.
---	---
14	Transfer restrictions
---	---

A transfer of Shares is not subject to any transfer restrictions under these Articles of Association.

25
![](ex3-1_001.jpg)

CHAPTER VI – LIMITED RIGHTS TO SHARES

15	Right of pledge on Shares
15.1	Ordinary Shares can be pledged. Preferred Shares cannot be pledged.
---	---
15.2	If an Ordinary Share is encumbered with a right of pledge, the voting rights attached to that Ordinary Share shall vest in the Shareholder,<br>unless at the creation of the right of pledge the voting rights were granted to the pledgee. A pledgee with voting rights shall have Meeting<br>Right.
---	---
15.3	A Shareholder who as a result of a right of pledge does not have voting rights, shall have Meeting Right. A pledgee without voting<br>rights shall not have Meeting Right.
---	---
16	Usufruct on Shares
---	---
16.1	If a usufruct is created on a Ordinary Share, the voting rights attached to that Ordinary Share shall vest in the Shareholder, unless<br>at the creation of the usufruct the voting rights were granted to the usufructuary. A usufructuary with voting rights shall have Meeting<br>Right.
---	---
16.2	If a usufruct is created on a Preferred Share, the voting rights attached to that Preferred Share shall vest in the Shareholder. The<br>voting rights attached to a Preferred Share may not be granted to the usufructuary.
---	---
16.3	A Shareholder who as a result of a usufruct does not have voting rights, shall have Meeting Right. A usufructuary without voting rights<br>shall not have Meeting Right.
---	---
17	Depositary receipts
---	---

The Company shall not cooperate with the issuance of depositary receipts for Shares.

CHAPTER VII – MANAGEMENT AND SUPERVISION

18	Board: composition, appointment, suspension and dismissal
18.1	The Company shall be managed by the Board. The Board shall consist of one (1) or more Executive Directors and two (2) or more Non-Executive<br>Directors. The number of Executive Directors and the number of Non-Executive Directors shall be determined by the Board. Only individuals<br>may be Directors.
---	---
18.2	The Executive Directors and Non-Executive Directors shall be appointed as such by the General Meeting at the binding nomination of<br>the Board. A nomination by the Board shall state whether a person is nominated for appointment as Executive Director or Non-Executive<br>Director. The person so nominated is appointed by a resolution adopted by the General Meeting with a simple majority of the votes cast.
---	---
18.3	The General Meeting may at all times overrule the binding nomination for appointment of a Director by a simple majority of the votes<br>cast, representing at least one/third (1/3) of the issued capital of the Company. If the nomination comprises one (1) candidate for a<br>vacancy, a resolution concerning the nomination shall result in the appointment of the candidate, unless the nomination is overruled.<br>If the binding nomination for appointment of a Director is overruled, a new binding nomination may be made.
---	---
18.4	A Director shall be appointed for a maximum period of one (1) year, provided that his term of office shall lapse immediately after<br>the close of the annual General Meeting held in the year after his appointment. A Director may be reappointed with due observance of the<br>preceding sentence. A Non-Executive Director may be in office for a period not exceeding twelve (12) years, which period may or may not<br>be interrupted, unless at the proposal of the Board the General Meeting resolves otherwise.
---	---

26
![](ex3-1_001.jpg)

18.5	The General Meeting may at all times suspend or dismiss any Director. A resolution of the General Meeting to suspend or dismiss a<br>Director other than at the proposal of the Board requires a two-thirds (2/3) majority of the votes cast. The Board may at all times suspend<br>an Executive Director.
18.6	A suspension may be extended one or more times, but may not last longer than three (3) months in aggregate. If at the end of that<br>period, no decision has been taken on termination of the suspension or on dismissal, the suspension shall end. A suspension can be terminated<br>by the General Meeting at any time.
---	---
19	Board: vacancy or inability
---	---
19.1	If the seat of an Executive Director is vacant or upon the inability of an Executive Director, the remaining Executive Directors shall<br>temporarily be entrusted with the executive management of the Company, provided that the Board may provide for a temporary replacement.<br>If the seats of all Executive Directors are vacant or upon the inability of all Executive Directors, the executive management of the Company<br>shall temporarily be entrusted to the Non-Executive Directors, provided that the Board may provide for one or more temporary replacements.
---	---
19.2	If the seat of a Non-Executive Director is vacant or upon inability of a Non-Executive Director, the remaining Non-Executive Directors<br>shall temporarily be entrusted with the performance of the duties and the exercise of the authorities of that Non-Executive Director,<br>provided that the Board may provide for a temporary replacement. If the seats of all Non-Executive Directors are vacant or upon inability<br>of all Non-Executive Directors, the General Meeting shall be authorized to temporarily entrust the performance of the duties and the exercise<br>of the authorities of the Non-Executive Directors to one or more other individuals.
---	---
19.3	A Director shall in any event be unable to act within the meaning of the Articles 19.1 and 19.2:
---	---
(r)	during the period for which the Director has claimed inability in writing;
---	---
(s)	during the Director's suspension; or
---	---
(t)	during periods when the Company has not been able to contact the Director (including as a result of illness), provided that such period<br>lasted longer than five (5) consecutive calendar days (or such other period as reasonably determined by the Board).
---	---
20	Board: CEO, chairperson of the Board and other titles
---	---
20.1	The Board shall designate an Executive Director as CEO
---	---
20.2	The Board shall designate a Non-Executive Director as chairperson of the Board. The Board may designate a Non-Executive Director as<br>vice-chairperson.
---	---
20.3	The Board may also grant other titles to Directors.
---	---
21	Board: remuneration
---	---
21.1	The Company has a policy in respect of the remuneration of Executive Directors and Non-Executive Directors. The remuneration policy<br>is adopted by the General Meeting at the proposal of the Board. A resolution to adopt the remuneration policy requires a simple majority<br>of the votes cast.
---	---
21.2	The remuneration of the Executive Directors shall be determined by the Board with observance of the remuneration policy adopted by<br>the General Meeting. The Executive Directors shall not participate in the deliberations and decision-making regarding the determination<br>of the remuneration of the Executive Directors.
---	---
21.3	The remuneration of the Non-Executive Directors shall be determined by the Board with observance of the remuneration policy adopted<br>by the General Meeting.
---	---
21.4	A proposal with respect to remuneration schemes in the form of Shares or rights to subscribe for Shares shall be submitted by the<br>Board to the General Meeting for its approval. Such proposal shall state at least the maximum number of Shares or rights to subscribe<br>for Shares that may be granted to Directors and the criteria for making or amending such grants.
---	---

27
![](ex3-1_001.jpg)

22	Board: tasks and duties
22.1	The Board shall be entrusted with the management of the Company and shall for such purpose have all the powers within the limits of<br>the law that are not granted by these Articles of Association to others. In the performance of their tasks, the Directors shall be guided<br>by the interests of the Company and the enterprise connected with it.
---	---
22.2	The Executive Directors are primarily responsible for all day-to-day operations of the Company. The Non-Executive Directors supervise<br>(i) the Executive Directors’ policy and performance of duties and (ii) the Company's general affairs and its business, and render<br>advice and direction to the Executive Directors. The Executive Directors shall timely provide the Non-Executive Directors with the information<br>they need to carry out their duties.
---	---
22.3	The Directors furthermore perform any duties allocated to them under or pursuant to the law or these Articles of Association.
---	---
22.4	With due observance of these Articles of Association, the Board shall adopt Board Regulations dealing with its internal organization,<br>the manner in which decisions are taken, any quorum requirements, the composition, duties and organization of committees and any other<br>matters concerning the Board, the Executive Directors, the Non-Executive Directors and committees established by the Board.
---	---
22.5	The Board may allocate its duties and powers among the Directors pursuant to the Board Regulations or otherwise in writing, provided<br>that the following duties and powers may not be allocated to the Executive Directors:
---	---
(u)	supervising the performance of the Executive Directors;
---	---
(v)	making a nomination for the appointment of Directors;
---	---
(w)	determining an Executive Director's remuneration; and
---	---
(x)	instructing an auditor to audit the Annual Accounts.
---	---
22.6	Without prejudice to any other provisions of these Articles of Association, the Board shall require the approval of the General Meeting<br>for resolutions regarding a significant change in the identity or nature of the Company or the enterprise connected with it, including<br>in any event:
---	---
(y)	the transfer of the business enterprise, or practically the entire business enterprise, to a third party;
---	---
(z)	concluding or cancelling any long-lasting cooperation of the Company or a Subsidiary with any other legal person or company or as<br>a fully-liable general partner in a partnership, provided that such cooperation or cancellation thereof is of material significance to<br>the Company; and
---	---
(aa)	acquiring or disposing of a participating interest in the share capital of a company with a value of at least one-third (1/3) of the<br>Company’s assets, as shown in the consolidated balance sheet with explanatory notes thereto according to the last adopted Annual<br>Accounts, by the Company or a Subsidiary.
---	---

28
![](ex3-1_001.jpg)

23	Board: decision-making
23.1	Resolutions of the Board shall be adopted by a simple majority of the votes cast, unless these Articles of Association or the Board<br>Regulations provide for a qualified majority. Each Director shall have one (1) vote. If there is a tie vote, the proposal shall be rejected.
---	---
23.2	At a meeting of the Board, a Director may only be represented by another Director holding a proxy in writing.
---	---
23.3	Meetings of the Board may be held by means of an assembly of Directors in person or by telephone, video conference or any other means<br>of electronic communication, provided that all Directors participating in such meeting are able to communicate with each other simultaneously.<br>Participation in a meeting held in any of the foregoing ways shall constitute presence at such meeting.
---	---
23.4	A document stating that one or more resolutions have been adopted by the Board and signed by the chairperson of the Board or by the<br>chairperson and secretary of the particular meeting constitutes valid proof of those resolutions.
---	---
23.5	The Board may also adopt resolutions outside of a meeting, provided that such resolutions are recorded in writing or otherwise and<br>that none of the Directors entitled to vote objects to this manner of decision-making.
---	---
23.6	A Director shall not participate in deliberations and the decision-making process in the event of a direct or indirect personal conflict<br>of interest between that Director and the Company and the enterprise connected with it, or in the event of being involved in a related<br>party transaction within the meaning of Section 2:169(4) DCC. If the Board is unable to adopt a resolution as a result of all Directors<br>being unable to participate in the deliberations and decision-making process due to such a conflict of interest, or due to all Directors<br>being involved in a related party transaction within the meaning of Section 2:169(4) DCC, the decision shall nevertheless be taken by<br>the Board.
---	---
23.7	The Board may determine pursuant to the Board Regulations or otherwise in writing that one or more Directors can lawfully adopt resolutions<br>concerning matters belonging to their duties within the meaning of Section 2:129a(3) DCC.
---	---
24	Board: indemnification
---	---
24.1	The Company shall indemnify each current or former Director in any anticipated or pending action, suit, proceeding or investigation<br>for any claim against that Director that such Director may derive from exercising his respective duties as a Director for any and all:
---	---
(bb)	costs and expenses, including but not limited to substantiated attorneys’ fees, reasonably incurred in relation to that Director’s<br>defenses in the relevant action, suit, proceeding or investigation or a settlement thereof;
---	---
(cc)	liabilities, losses, damages, fines, penalties and other claims and/or financial effects of judgements against that Director, excluding<br>any reputational damages and (other) immaterial damages; and
---	---
(dd)	payments by that Director and/or any other financial effects resulting from a settlement of such action, suit, proceeding or investigation,<br>excluding any reputational damages and (other) immaterial damages, subject to prior written approval of such settlement by the Company<br>(such approval not to be unreasonably withheld), provided he acted in good faith and in a manner he reasonably<br>believed to be in, or not opposed to, the best interests of the Company or out of his mandate, and, with respect to any criminal action<br>or proceeding, had no reasonable cause to believe his conduct was unlawful.
---	---

29
![](ex3-1_001.jpg)

24.2	Any indemnification by the Company referred to in Article 24.1 shall be made only upon a determination by the Board that indemnification<br>of the Director is proper under the circumstances because he had met the applicable standard of conduct set forth in Article 24.1.
24.3	Indemnified amounts referred to in Article 24.1 under (a) until (c) inclusive may be paid by the Company in advance of the final disposition<br>of the relevant anticipated or pending action, suit or proceeding against that Director, upon a resolution of the Board with respect to<br>the specific case.
---	---
24.4	A Director, current or former, shall not be entitled to any indemnification as mentioned in this Article 24, if and to the extent:
---	---
(ee)	Dutch law would not permit such indemnification;
---	---
(ff)	a competent court, a judicial tribunal or, in case of an arbitration, an arbitrator or arbitral panel has established by final judgement<br>that is not open to challenge or appeal, that the acts or omissions of the current or former Director can be considered intentional, fraudulent,<br>grossly negligent, willfully reckless or seriously culpable, unless this would in the given circumstances be unacceptable according to<br>the standards of reasonableness and fairness;
---	---
(gg)	the costs or the decrease in assets of the current or former Director are/is covered by an insurance and the insurer started payment<br>of the costs or the decrease in assets; or
---	---
(hh)	the Company and/or a Group Company brought the procedure in question up before the relevant court, judicial tribunal or, in case of<br>an arbitration, arbitrator or arbitral panel, in which event he shall immediately repay any amount paid<br>to him (in advance, as the case may be) by the Company under this Article 24.
---	---
25	Representation
---	---
25.1	The Company shall be represented by the Board. Any Executive Director shall also be authorized to represent the Company.
---	---
25.2	The Board may appoint officers with general or limited power to represent the Company. Each officer shall be competent to represent<br>the Company, subject to the restrictions imposed on him. The Board shall determine each officer's title. Such officers may be registered<br>with the Dutch trade register, indicating the scope of their power to represent the Company.
---	---

CHAPTER VIII – GENERAL MEETING

26	General Meeting
26.1	General Meetings can be held in Amsterdam, Rotterdam or Haarlemmermeer (including Schiphol Airport).
---	---
26.2	The annual General Meeting shall be held each year within six (6) months after the end of the Company’s financial year. Other<br>General Meetings shall be held as often as the Board or the chairperson of the Board necessary.
---	---

30
![](ex3-1_001.jpg)

27	General Meeting: convocation
27.1	General Meetings are convened by the Board or the chairperson of the Board.
---	---
27.2	One or more Shareholders and/or other Persons with Meeting Right who individually or jointly represent at least the part of the Company's<br>issued capital prescribed by law for this purpose, may request the Board in writing to convene a General Meeting setting out in detail<br>the matters to be discussed. If the Board has not taken the steps necessary to ensure that the General Meeting could be held within the<br>relevant statutory period after the request, the requesting Shareholders and/or other Persons with Meeting Right may at their request<br>be authorized by the preliminary relief judge of the district court to convene a General Meeting.
---	---
28	General Meeting: notice and agenda
---	---
28.1	The notice of a General Meeting shall be given by the Board by means of an announcement with due observance of the statutory notice<br>period and in accordance with the law.
---	---
28.2	The notice of a General Meeting shall state the items to be dealt with, the items to be discussed and which items to be voted on,<br>the place and time of the meeting, the procedure for participating at the meeting whether or not by written proxy-holder, the address<br>of the website of the Company and, if applicable, the procedure for participating at the meeting and exercising one’s right to vote<br>by electronic means of communication as referred to in Article 29.4, with due observance of the relevant provisions of the law.
---	---
28.3	The notice of a General Meeting shall also state the Record Date and the manner in which the Persons with Meeting Right may procure<br>their registration and exercise their rights.
---	---
28.4	A subject for discussion which has been requested in writing by one or more Shareholders and/or other Persons with Meeting Right who<br>individually or jointly represent at least the part of the Company's issued capital prescribed by law for this purpose, shall be included<br>in the notice of the General Meeting or shall be notified in the same manner as the other subjects for discussion, provided the Company<br>has received the request (including the reasons for such request) not later than sixty (60) calendar days before the day of the meeting.<br>Such written requests must comply with the conditions stipulated by the Board as published on the Company’s website.
---	---
29	General Meeting: admittance
---	---
29.1	Those Persons with Meeting Right and those Persons with Voting Rights who are listed on the Record Date for a General Meeting as such<br>in a register designated for that purpose by the Board, are deemed Persons with Meeting Right or Persons with Voting Rights, respectively,<br>for that General Meeting, regardless of who is entitled to the Shares at the date of the General Meeting.
---	---
29.2	In order for a person to be able to exercise Meeting Right and the right to vote in a General Meeting, that person must notify the<br>Company in writing of his intention to do so no later than on the date and in the manner mentioned in the notice convening the General<br>Meeting.
---	---
29.3	The Board may determine in the notice of a General Meeting that any vote cast prior to the meeting by means of electronic communication<br>or by means of a letter, shall be deemed to be a vote cast in the meeting. Such a vote may not be cast prior to the Record Date for the<br>General Meeting.
---	---

31
![](ex3-1_001.jpg)

29.4	The Board may determine that each Person with Meeting Right has the right, in person or represented by a written proxy, to take part<br>in, address and, to the extent applicable, to vote at the General Meeting by means of electronic communication, provided that such person<br>can be identified via the same electronic means and is able to directly observe the proceedings and, to the extent applicable, to vote<br>at the meeting. The Board may attach conditions to the use of the electronic communication, provided that these conditions are reasonable<br>and necessary for the identification of the Person with Meeting Right and for the reliability and security of the communication. The conditions<br>must be included in the notice of a General Meeting and be published on the Company’s website.
29.5	The Directors are authorized to attend the General Meeting and shall, as such, have an advisory vote at the General Meeting.
---	---
29.6	The chairperson of the General Meeting decides on all matters relating to admission to the General Meeting. The chairperson of the<br>General Meeting may admit third parties to the General Meeting.
---	---
29.7	The Company may direct that any person, before being admitted to a General Meeting, identifies himself by means of a valid passport<br>or other means of identification and/or should be submitted to such security arrangements as the Company may consider to be appropriate<br>under the given circumstances.
---	---
29.8	The General Meeting may be conducted in Dutch or English as determined by the chairperson of the General Meeting.
---	---
30	General Meeting: chairperson, secretary and minutes
---	---
30.1	The General Meeting shall be presided over by the chairperson of the Board or another Director designated for that purpose by the<br>Board. If the chairperson of the Board is not present at the meeting and no other Director has been designated by the Board to preside<br>over the General Meeting, the General Meeting itself shall appoint a chairperson.
---	---
30.2	The chairperson of the General Meeting shall appoint a secretary of the General Meeting.
---	---
30.3	Minutes of the proceedings at a General Meeting shall be kept by the secretary, unless a notarial record of the General Meeting is<br>prepared at the request of the Board. The minutes shall be adopted by the chairperson and the secretary of the General Meeting and shall<br>be signed by them as evidence thereof. A document stating that one or more resolutions have been adopted by the General Meeting and signed<br>by the chairperson and secretary of the particular meeting constitutes valid proof of those resolutions.
---	---
31	General Meeting: decision-making
---	---
31.1	Each Ordinary Share confers the right to cast one (1) vote at the General Meeting. Each Preferred Share confers the right to cast<br>ten thousand (10,000) votes at the General Meeting.
---	---
31.2	To the extent the law or these Articles of Association do not require a qualified majority, all resolutions of the General Meeting<br>shall be adopted by a simple majority of the votes cast.
---	---
31.3	The chairperson of the General Meeting shall decide on the method of voting.
---	---
31.4	Abstentions, blank votes and invalid votes shall not be counted as votes.
---	---

32
![](ex3-1_001.jpg)

31.5	The ruling by the chairperson of the General Meeting on the outcome of a vote shall be decisive.
31.6	All disputes concerning voting for which neither the law nor these Articles of Association provide a solution are decided by the chairperson<br>of the General Meeting.
---	---
31.7	No votes may be cast at the General Meeting for a Share held by the Company or a Subsidiary, nor for any Share for which the Company<br>or a Subsidiary holds the depositary receipts. The Company or a Subsidiary may not cast a vote in respect of a Share on which it holds<br>a right of pledge or a usufruct. However, holders of a right of pledge or a usufruct on Shares held by the Company or a Subsidiary are<br>not excluded from voting, if the right of pledge or the usufruct was created before the Share belonged to the Company or a Subsidiary.
---	---
31.8	When determining how many votes are cast by Shareholders, how many Shareholders are present or represented, or which part of the Company's<br>issued capital is represented at the General Meeting, no account shall be taken of Shares for which, pursuant to the law or these Articles<br>of Association, no vote can be cast.
---	---
32	Class Meetings
---	---

The provisions of these Articles of Association with respect to General Meetings, save for the Articles 26.2 and 29.5, shall apply mutatis mutandis to a Class Meeting Preferred Shares and other persons entitled to attend such meeting, provided that the applicable meeting shall appoint its own chairperson, and furthermore provided that for as long as Preferred Shares are not admitted to listing and trading on a stock exchange with the cooperation of the Company:

(a)	notice of a meeting as referred to in this Article shall be given no later than on the fifteenth (15th) day before the date of the<br>meeting and the convocation notice shall be sent to the addresses as included in the shareholders’ register;
(b)	resolutions may be adopted in writing without holding a meeting as referred to in this Article, provided such resolutions are adopted<br>by the unanimous vote of all holders of Preferred Shares entitled to vote; and
---	---
(c)	valid resolutions may be adopted if the formalities for convening and holding of meetings as referred to in this Article have not<br>been complied with, if adopted by unanimous vote in a meeting at which all issued and outstanding Preferred Shares are represented.
---	---

CHAPTER IX – FINANCIAL YEAR, ANNUAL ACCOUNTS AND AUDITOR

33	Financial year and annual accounts
33.1	The Company's financial year shall be the calendar year.
---	---
33.2	Annually, within the term set by law, the Board shall prepare the Annual Accounts. The Annual Accounts must be accompanied by a statement<br>of the auditor as referred to in Article 34.2, the Management Report, and the additional information to the extent that this information<br>is required.
---	---
33.3	The Annual Accounts shall be signed by the Directors; if one or more of their signatures is lacking, this shall be stated, giving<br>the reasons therefor.
---	---
33.4	The Annual Accounts shall be adopted by the General Meeting.
---	---

33
![](ex3-1_001.jpg)

34	Auditor
34.1	The General Meeting shall instruct an Auditor to audit the Annual Accounts. If the General Meeting fails to issue the instructions<br>to an Auditor, the Board shall be authorized to do so. The Executive Directors shall not participate in the deliberations and decision-making<br>regarding instructing an Auditor to audit the Annual Accounts.
---	---
34.2	The instructions issued to the Auditor may only be revoked by the General Meeting and, if the Board issued the instructions, by the<br>Board, for valid reasons and in accordance with Section 2:393(2) DCC.
---	---
34.3	The Auditor shall report the findings of the audit to the Board and present the results of the audit in a statement on the true and<br>fair view provided by the Annual Accounts.
---	---

CHAPTER X – RESERVES, PROFITS AND DISTRIBUTIONS

35	Reserves, profits and distributions
35.1	The Company shall maintain a separate dividend reserve for the Preferred Shares (Special Dividend Reserve). The Preferred Shares<br>shall not carry any entitlement to any other reserve of the Company. Any distribution out of the Special Dividend Reserve or the partial<br>or full release of such reserve will require a prior proposal from the Board and a subsequent resolution of the Class Meeting Preferred<br>Shares.
---	---
35.2	Distribution of profits shall be made after adoption of the Annual Accounts from which it appears that the same is permitted.
---	---
35.3	Distributions may be made only to the extent the Company's equity exceeds the sum of its paid up and called up part of its issued<br>capital and the reserves which must be maintained pursuant to the law or these Articles of Association.
---	---
35.4	The Board may determine which part of the profits shall be reserved, with due observance of the Company’s policy on reserves<br>and dividends. The Company may have a policy on reserves and dividends to be determined and amended by the Board.
---	---
35.5	The profits remaining after reservation in accordance with Article 35.4 shall first be applied to allocate and add to the Special<br>Dividend Reserve an amount equal to one percent (1%) of the aggregate nominal value of all outstanding Preferred Shares minus any amount<br>added to the Special Dividend Reserve pursuant to application of Article 35.9 in respect of any interim distributions made during the<br>financial year to which the Annual Accounts from which the profits appear relate. The calculation of the amount to be allocated and added<br>to the Special Dividend Reserve shall occur on a time-proportionate basis. If Preferred Shares are issued during the financial year to<br>which the allocation and addition pertains, then the amount to be allocated and added to the Special Dividend Reserve in respect of these<br>newly issued Preferred Shares shall be calculated as from the date on which such Preferred Shares were issued until the last day of the<br>financial year concerned. The Preferred Shares shall not carry any other entitlement to the profits.
---	---
35.6	The General Meeting may resolve to distribute any part of the profits remaining after application of the Articles 35.4 and 35.5. If<br>the General Meeting does not resolve to distribute these profits in whole or in part, such profits (or any profits remaining after distribution)<br>shall also be reserved.
---	---
35.7	The General Meeting may only resolve to distribute to the Shareholders a dividend in kind or in the form of Shares at the proposal<br>of the Board.
---	---
35.8	The Board, or the General Meeting at the proposal of the Board, may resolve to make distributions from the share premium reserve or<br>other distributable reserves maintained by the Company.
---	---

34
![](ex3-1_001.jpg)

35.9	The Board may resolve to make interim distributions on Shares, provided that (i) an interim statement of assets and liabilities drawn<br>up in accordance with the statutory requirements shows that the requirement of Article 35.2 has been fulfilled, (ii) an amount equal to<br>one percent (1%) of the aggregate nominal value of all outstanding Preferred Shares, determined as at the dividend record date determined<br>by the Board for such interim distribution, is added to the Special Dividend Reserve before the interim distribution is made, and (iii)<br>any (other) applicable statutory provisions pertaining to such interim distribution have been observed. The amount to be added to the<br>Special Dividend Reserve in accordance with the foregoing sentence shall be reduced, but never below zero (0), by any amount added to<br>the Special Dividend Reserve pursuant to application of this Article 35.9 in respect of any interim distributions made during that same<br>financial year.
35.10	The Board, or the General Meeting at the proposal of the Board, may resolve that a distribution on Shares shall not be paid in whole<br>or in part in cash but in kind or in the form of Shares, or decide that Shareholders shall be given the option to receive the distribution<br>in cash or in kind and/or in the form of Shares (and with due observance of Articles 7 and 9), and may determine the conditions under<br>which such option can be given to the Shareholders.
---	---
35.11	In calculating the amount of any distribution on Shares, Shares held by the Company shall be disregarded, unless such Shares are encumbered<br>with a usufruct or right of pledge.
---	---
36	Notices and payments
---	---
36.1	The date on which dividends and other distributions shall be made payable shall be announced in accordance with the law and published<br>on the Company’s website.
---	---
36.2	Distributions shall be payable on the date determined by the Board.
---	---
36.3	The persons entitled to a distribution shall be the relevant Shareholders, holders of a usufruct on Shares and holders of a right<br>of pledge on Shares, at a date to be determined by the Board for that purpose. This date shall not be earlier than the date on which the<br>distribution was announced.
---	---
36.4	Distributions which have not been claimed upon the expiry of five (5) years and one (1) day after the date when they became payable<br>will be forfeited to the Company and will be carried to the reserves.
---	---
36.5	The Board may determine that distributions on Shares will be made payable either in euro or in another currency.
---	---

CHAPTER XI – AMENDMENT OF THE ARTICLES OF ASSOCIATION, DISSOLUTIONAND LIQUIDATION

37	Amendment of the Articles of Association
37.1	The General Meeting may resolve to amend these Articles of Association at the proposal of the Board.
---	---
37.2	If a proposal to amend these Articles of Association is to be submitted to the General Meeting, the notice of such meeting must state<br>so and a copy of the proposal, including the verbatim text thereof, shall be deposited and kept available at the Company's office for<br>inspection by, and must be made available free of charge to Shareholders and other Persons with Meeting Right, until the conclusion of<br>the meeting. An amendment of these Articles of Association shall be laid down in a notarial deed.
---	---
38	Dissolution and liquidation
---	---
38.1	The General Meeting may resolve to dissolve the Company at the proposal of the Board.
---	---
38.2	If the Company is dissolved pursuant to a resolution of the General Meeting, the Directors shall become liquidators of the dissolved<br>Company's property. The General Meeting may decide to appoint other persons as liquidators.
---	---
38.3	During liquidation, to the extent possible these Articles of Association shall continue to apply.
---	---
38.4	The balance remaining after payment of the debts of the dissolved Company shall be transferred pro rata in proportion to the<br>number of Ordinary Shares and Preferred Shares held by each Shareholder.
---	---

Exhibit 3.2

BOARDREGULATIONS

TERRA INNOVATUM GLOBALN.V.

dated as of 10 October 2025

Board Regulations Terra Innovatum Global N.V.	1/15

BOARD REGULATIONS

TERRA INNOVATUM GLOBAL N.V.

1	Introduction
1.1	These Regulations are the regulations of the Board. The Board deems it useful to further regulate its<br>duties and responsibilities in these Regulations. These Regulations are established pursuant to article 22.4 of the Articles of Association.
---	---
1.2	These Regulations are complementary to the rules and regulations (from time to time) applicable to the<br>Board and its Directors as set out in applicable legislation and the Articles of Association.
---	---
1.3	These Regulations were adopted by the Board on 9 October 2025 and are effective as from 10 October 2025<br>and shall remain in full force and effect until amended or terminated (in whole or in part).
---	---
1.4	Capitalized terms used herein have the meaning set forth in the list of definitions attached as Schedule<br>1.
---	---
1.5	Reference to Clauses shall be deemed to refer to clauses of these Regulations, unless the contrary is<br>apparent.
---	---
1.6	Any reference to a gender shall include all genders.
---	---
1.7	The attached Schedules form an integral part of these Regulations.
---	---
1.8	These Regulations are based on the DCGC as adopted by the Corporate Governance Code Monitoring Committee<br>in March 2025. The DCGC contains principles and best practice provisions that apply to the Company’s corporate governance structure.<br>The ‘Comply or Explain’- report of the Company in accordance with the DCGC shall be made available in the Company’s<br>annual report and/or on the Company’s website. The report shall explain (i) any deviations from the DCGC, (ii) the reason for such<br>deviations, (iii) if the deviation is of a temporary nature and will continue for more than one financial year, an indication of when<br>the Company intends to comply with the principle or the best practice provision again, and (iv) where applicable, a description of the<br>alternative measure taken either explaining how that measure attains the purpose of the principle or the best practice provision or clarifying<br>how the measure contributes to good corporate governance of the Company.
---	---
2	Collective responsibility and division of duties
---	---
2.1	The Directors shall be collectively responsible for the management of the Company, the general affairs<br>of the Company’s business and the general affairs of the Group Companies.
---	---
2/15
---
2.2	In performing its duties, the Board shall be guided by the interests of the Company and its affiliated<br>enterprise, and shall take into account the relevant interests of the Company’s stakeholders (including but not limited to its Shareholders).
---	---
2.3	The division of duties within the Board shall be determined (and amended, as necessary) by the Board,<br>provided that the day-to-day management of the Company shall be entrusted to the Executive Directors and further provided that the duty<br>to supervise the performance by the Directors of their duties cannot be taken away from the Non-Executive Directors. The manner in which<br>duties are divided among the Directors shall be set out in these Regulations and in one or more additional documents. An individual Director<br>may only exercise such powers as are explicitly conferred or delegated upon him and he may never exercise powers beyond those exercisable<br>by the Board as a whole.
---	---
2.4	Each Director shall be accountable to the Board for the performance of his or her duties and shall therefore<br>report to the Board on a regular basis and in such a manner as to give the Board a proper insight into the performance of his duties,<br>the foregoing also in view of the Board’s collective responsibility.
---	---
2.5	Each Director shall have the right to receive from the other Directors and from the employees any information<br>on matters that the Director considers useful or appropriate in connection with his collective responsibility for the management of the<br>Company. Each Director shall consult with the other Directors where the performance of his duties affects the duties of the other Directors<br>or where the significance of the matter requires consultation with the other Directors.
---	---
2.6	The Board is responsible for the continuity of the Company and its affiliated enterprise and for the sustainable<br>long-term value creation by the Company and its affiliated enterprise. The Board shall take into account the impact of the activities<br>of the Company and its affiliated enterprise have on people and the environment and, to that end, shall balance the interests of the relevant<br>stakeholders.
---	---
2.7	The Executive Directors shall discuss with the Audit Committee and report to the Board on the effectiveness<br>of the design and operation of the internal risk management and control systems.
---	---
2.8	The Board shall ensure that internal procedures are established and maintained to ensure that all relevant<br>information is brought to the attention of the Board in a timely manner.
---	---
2.9	Each Director shall provide the Company with such information as is necessary to enable the Company to<br>comply with applicable laws and regulations (including the rules of any stock exchange on which the Company may be listed).
---	---
2.10	The Board shall include the Management Report with the Annual Accounts. The Management Report shall in<br>any event contain the information required by applicable law or by the DCGC.
---	---
3/15
---
3	Executive Directors
---	---

The Executive Directors shall be entrusted with the day-to-day management of the Company and the enterprise connected with it, under collective responsibility of the Board as a whole.

4	Non-Executive Directors
4.1	The Non-Executive Directors shall supervise (i) the Executive Directors’ policies and performance<br>of the duties and of (ii) the general affairs and business of the Company, and provide advice and guidance to the Executive Directors.<br>This supervisory role may not be taken away from the Non-Executive Directors by a division of duties.
---	---
4.2	The Non-Executive Directors shall prepare and publish a Non-Executive Directors’ Report on its functioning<br>and activities and that of the Committees during the preceding financial year. The Non-Executive Directors’ Report may form part<br>of the Management Report, or be included in a separate report.
---	---
5	Composition of the Board
---	---
5.1	The Board shall consist of one or more Executive Directors and two or more Non-Executive Directors. The<br>number of Executive Directors and the number of Non-Executive Directors shall be determined by the Board.
---	---
5.2	The Board shall designate one of the Non-Executive Directors as Chairperson, who shall ensure the proper<br>functioning of the Board as a whole. The Board shall designate one of the Non-Executive Directors as Vice-Chairperson. In addition, the<br>Board shall appoint one of the Executive Directors as CEO, who shall ensure the proper functioning of the Executive Directors. In addition,<br>the Board may also grant other titles to Directors, such as in case of an Executive Director specifically in charge of the Company’s financial<br>affairs as Chief Financial Officer or CFO.
---	---
5.3	The composition and size of the Board shall be such that the requisite expertise, background and competencies<br>are present for the Board, and that with respect to the Non-Executive Directors, the requisite independence is present, to carry out their<br>duties properly and enable the Non-Executive Directors to act independently and critically vis-à-vis one another, the Executive<br>Directors and any particular interest involved.
---	---
5.4	The Non-Executive Directors, in principle in conjunction with the Nominating and Corporate Governance<br>Committee shall prepare the Board Profile taking into account the nature and the activities of the enterprise affiliated with the Company.<br>The Board Profile shall address:
---	---
(a)	the desired expertise and background of the Executive Directors and Non-Executive Directors;
---	---
(a)	the desired diverse composition of the Board;
---	---
(b)	the size of the Board; and
---	---
4/15
---
(c)	the independence of the Non-Executive Directors.
---	---
5.5	In composing the Board, the following requirements should in any case be observed:
---	---
(a)	any one of the criteria referred to in Clause 5.6 (a) through (e) should apply to no more than one Non-Executive<br>Director;
---	---
(b)	the total number of Non-Executive Directors to whom the criteria referred to in Clause 5.6 are applicable<br>shall be less than half of the total number of Non-Executive Directors;
---	---
(c)	for each Shareholder, or group of affiliated Shareholders, who directly or indirectly hold more than 10%<br>of the issued Shares, there is at most one Non-Executive Director who can be considered to be affiliated with or representing them as<br>stipulated in Clause 5.6 (f) and (g); and
---	---
(d)	subject to Clause 5.2, the Chairperson of the Board may not be a former Executive Director and should<br>be independent within the meaning of the DCGC.
---	---
5.6	A Non-Executive Director shall not be considered independent from the Company under the DCGC if such Non-Executive<br>Director, his spouse, registered partner or life companion, foster child or relative by blood or marriage up to the second degree:
---	---
(a)	has been an employee of the Company or Executive Director or an employee or member of the management board<br>of an issuing institution associated with the Company (as referred to in Section 5:48 of the Financial Supervision Act (Wet op hetfinancieel toezicht)) in the five years prior to the appointment;
---	---
(b)	receives personal financial compensation from the Company, or an entity associated with it, other than<br>the compensation received for the work performed as a Non-Executive Director and insofar as this is not in the normal course of business;
---	---
(c)	has had an important business relationship with the Company or an entity associated with it in the year<br>prior to the appointment. This includes in any event the case where the Non-Executive Director, or the firm of which he is a shareholder,<br>partner, associate or advisor, has acted as advisor to the Company (consultant, external auditor, civil notary or lawyer) and the case<br>where the Non-Executive Director is a management board member or an employee of a bank with which the Company has a lasting and significant<br>relationship;
---	---
(d)	has been a member of the management board of a company in which a Director is a supervisory board member;
---	---
(e)	has temporarily performed management duties during the previous twelve months in the absence or incapacity<br>of Executive Directors;
---	---
5/15
---
(f)	has a shareholding in the Company of at least ten percent, taking into account the shareholding of natural<br>persons or legal entities collaborating with him on the basis of an express or tacit, verbal or written agreement; or
---	---
(g)	is a member of the management board or supervisory board – or is a representative in some other<br>way – of a legal entity which directly or indirectly holds at least ten percent of the Shares, unless the entity is a Subsidiary,
---	---

and a Non-Executive Director shall furthermore not be considered independent from the Company if such Non-Executive Director, his spouse, registered partner or life companion, foster child or relative by blood or marriage up to the second degree fails to satisfy the independence requirements applicable to the Company pursuant to the rules of any national securities exchange on which its equity securities may be listed.

6	Appointment, reappointment and term of office of Directors
6.1	The Directors shall be appointed and reappointed in the manner as provided in the Articles of Association.
---	---
6.2	If a nomination for appointment is made by the Board, the nomination states the reasons. Only individuals<br>may be nominated by the Board for appointment as Director. A Director shall be appointed for a term of one year, provided that his term<br>of office shall lapse immediately after the close of the annual General Meeting held in the year after his appointment. A Director may<br>be reappointed subject to the preceding sentence.
---	---
6.3	The Board shall prepare a retirement and resignation rota to prevent, to the extent possible, simultaneous<br>reappointments, which shall be amended from time to time in case circumstances change. The retirement and resignation rota shall be aimed<br>at retaining the balance in the requisite expertise, experience and diversity. Due regard shall be given to the Board Profile. The Non-Executive<br>Directors shall resign in accordance with the retirement and resignation rota.
---	---
6.4	In the event of the absence or inability to act of one or more Directors, the powers of the Board remain<br>intact, provided that:
---	---
(a)	if the seat of an Executive Director is vacant or upon the inability of an Executive Director, the remaining<br>Executive Directors shall temporarily be entrusted with the executive management of the Company, provided that the Board may provide for<br>a temporary replacement. If the seats of all Executive Directors are vacant or upon the inability of all Executive Directors, the executive<br>management of the Company shall temporarily be entrusted to the Non-Executive Directors, provided that the Board may provide for one or<br>more temporary replacements; and
---	---
(b)	if the seat of a Non-Executive Director is vacant or upon inability of a Non-Executive Director, the remaining<br>Non-Executive Directors shall temporarily be entrusted with the performance of the duties and the exercise of the authorities of that<br>Non-Executive Director, provided that the Board may provide for a temporary replacement. If the seats of all Non-Executive Directors are<br>vacant or upon inability of all Non-Executive Directors, the General Meeting shall be authorized to temporarily entrust the performance<br>of the duties and the exercise of the authorities of the Non-Executive Directors to one or more other individuals.
---	---
6/15
---
6.5	Non-Executive Directors who take on the management of the Company temporarily, where the Executive Directors<br>are absent or unable to fulfill their duties, shall (temporarily) resign as Non-Executive Director in order to do so.
---	---
7	Responsibilities CEO
---	---

With due observance of Article 2.3, the CEO has all powers, authorities, tasks and discretions (including the power to sub-delegate) that are not explicitly allocated to the full Board. Matters not expressly allocated to the full Board are considered matters that fully fall within the tasks delegated to the CEO and may, therefore, be validly resolved upon (rechtsgeldig over worden besloten) by the CEO without involvement of the full Board being required. Such resolution shall constitute a resolution of the Board. The CEO shall inform the Board promptly after having adopted a resolution in accordance with this Article 7. The Board may opt to limit the authority granted to the CEO by means of an amendment to these regulations.

8	Responsibilities Chairperson and Company Secretary
8.1	The Chairperson shall, on behalf of the Board, act as the main contact for the Directors and Shareholders<br>regarding the functioning of the Board.
---	---
8.2	The Chairperson shall:
---	---
(a)	determine the agenda for the meetings of the Board;
---	---
(b)	chair the meetings of the Board;
---	---
(c)	ensure the appointment of the Vice-Chairperson by the Board;
---	---
(d)	oversee and ensure the proper functioning and adequate performance of the Board and its Committees;
---	---
(e)	ensure the adequate and timely submission of information to the Directors as necessary to perform their<br>duties;
---	---
(f)	co-ordinate the Board’s decision-making process and ensure that there is sufficient time for consultation,<br>deliberations and decision-making;
---	---
(g)	arrange for the induction and education or training program for the Directors and ensure that the induction<br>or training program is followed;
---	---
7/15
---
(h)	act on behalf of the Board as main contact for the General Meeting and ensure that contact with the Executive<br>Directors and the General Meeting is productive and that the results thereof are timely and prudently communicated to the other Directors;
---	---
(i)	initiate and ensure the annual evaluation of the functioning of the Board and its Directors;
---	---
(j)	ensure that the Board performs its activities in respect of culture and sustainable long-term value creation;
---	---
(k)	receive and decide on reported (potential) Conflicts of Interest;
---	---
(l)	ensure that any actual or suspected material misconduct and irregularities are reported to the Board without<br>delay;
---	---
(m)	ensure that the Non-Executive Directors are involved closely, and at an early stage, in any merger or<br>acquisition situations;
---	---
(n)	receive and decide on reported alleged irregularities relating to the functioning of the Directors;
---	---
(o)	assure effective communication with Shareholders; and
---	---
(p)	ensure the orderly and efficient conduct of the General Meeting.
---	---
8.3	The Vice-Chairperson shall deputize for the Chairperson as and when required, and shall have the powers<br>and perform the duties of the Chairperson in the latter’s absence. The Vice-Chairperson shall act as contact for Directors concerning<br>the functioning of the Chairperson.
---	---
8.4	The Board shall be supported by a Company Secretary, who shall be appointed and dismissed by the Board<br>from outside its members.
---	---
8.5	The Company Secretary shall be primarily responsible for:
---	---
(a)	compliance of the Board’s functioning with the law, the Articles of Association and the rules and regulations<br>issued pursuant thereto (including the DCGC and these Regulations);
---	---
(b)	facilitating the provision of information to the Board;
---	---
(c)	assisting the Chairperson in the organization of the affairs of the Board, including the provision of<br>information, meeting agendas, evaluations and training programs; and
---	---
(d)	assisting the chairperson of the Committees in managing the activities of the Board, including but not<br>limited to the coordination and provision of relevant information, meeting agendas, performance evaluations and training programs.
---	---
8/15
---
8.6	In the event the Company Secretary is absent or unable to act, the powers of the Company Secretary under<br>these Regulations shall be exercised by a Non-Executive Director other than the Chairperson, to be designated for such purposes by the<br>Board.
---	---
9	Board committees
---	---
9.1	The Board shall appoint from among its Non-Executive Directors an Audit Committee, a Remuneration Committee<br>and a Nominating and Corporate Governance Committee. The Board may appoint additional standing and/or ad hoc committees, as it<br>deems necessary and appropriate. The Board shall remain collectively responsible for decisions prepared by its Committees and accountable<br>for the performance.
---	---
9.2	The Board shall draw up charters for each Committee which may be amended by the Board at any time.
---	---
9.3	Should one or more Committees not be instituted, their respective practice and principles as set forth<br>in the relevant charters shall apply mutatis mutandis to the Non-Executive Directors.
---	---
9.4	The Board shall receive from each Committee a report of its deliberations and findings.
---	---
10	Board meetings (agenda, teleconferencing, attendance, minutes) and resolutions
---	---
10.1	The Board shall hold meetings on a regular basis at a time to be determined by the Board and whenever<br>the Chairperson has requested a meeting. Meetings of the Board may be held by means of an assembly of Directors in person at a formal<br>meeting or by conference call, video conference or by any other means of communication, provided that all Directors participating in such<br>meeting are able to communicate with each other simultaneously. Participation in a meeting held in any of the above ways shall constitute<br>presence at such meeting.
---	---
10.2	An attendance register shall be kept and signed by the Company Secretary, or in his absence or inability<br>to act, by a person designated by the chairperson of the meeting, and shall include the names of the Directors who attended the meeting<br>in person and, if applicable, the names of the Directors who participated in such meeting by conference call, video conference or by any<br>other means of communication.
---	---
10.3	Meetings of the Board shall be convened in due time by the Chairperson or the CEO. Each other Director<br>may request the Chairperson to convene a meeting.
---	---
10.4	The Chairperson, and in his absence the Vice-Chairperson, shall chair the meeting. In the absence of the<br>abovementioned persons, the meeting shall appoint one of the Non-Executive Directors to chair the meeting.
---	---
10.5	At a meeting of the Board, a Director may only be represented by another Director holding a proxy in writing,<br>and such authorization shall constitute presence by proxy at such meeting. A Director may not act as a proxy for more than one Director.
---	---
9/15
---
10.6	The Chairperson shall determine the agenda for each meeting. Each other Director may submit to the Chairperson<br>items to be discussed in the meeting. An item to be discussed which has not been submitted on time or is not supported by sufficient documentation<br>shall not be placed on the agenda.
---	---
10.7	At the request of a Director and with the agreement of the majority of the other Directors, urgent matters<br>may be discussed immediately or in an additional meeting.
---	---
10.8	The Directors should attend the meetings of the Board. Where they are unable to attend and the minutes<br>require explanation, the chairperson of the meeting shall inform them about the resolutions passed and the discussions held in that meeting.
---	---
10.9	The Company Secretary may attend the meetings of the Board. The Chairperson may decide to allow others<br>to attend a meeting as well.
---	---
10.10	Minutes of meetings of the Board shall be kept by the Company Secretary. The minutes of the meeting shall<br>be adopted by the Board at the same meeting or at a subsequent meeting. A document stating that one or more resolutions have been adopted<br>by the Board and signed by the Chairperson or by the chairperson and the secretary of the particular meeting constitutes valid proof of<br>those resolutions. The minutes shall be signed for adoption by the chairperson and the secretary of the meeting and shall be dispatched<br>to all Directors as soon as practically possible. The Company Secretary may issue and sign extracts of the adopted minutes which shall<br>constitute evidence of such resolution vis-à-vis third parties.
---	---
10.11	Resolutions of the Board shall require a simple majority of the votes cast by Directors present or represented<br>at the meeting, provided that Directors who have a Conflict of Interest shall not take part in the voting. If there is a tie vote, the<br>proposal shall be rejected.
---	---
10.12	With due observance of these Regulations and the Articles of Association, resolutions of the Board may<br>be adopted outside of a meeting, provided that such resolutions are recorded in writing or otherwise and that none of the Directors entitled<br>to vote objects to this manner of decision-making. The Company Secretary shall keep a record of each resolution adopted outside of a meeting.<br>The adoption of resolutions outside of a meeting must be reported at the next meeting.
---	---
11	Conflict of Interest
---	---
11.1	A Director shall not participate in the discussions and/or decision-making process on a subject or transaction<br>in relation to which he has a direct or indirect personal conflict of interest with the Company within the meaning of Section 2:129(6)<br>DCC or if the Chairperson or the Vice-Chairperson, has determined pursuant to the Clauses 11.4 and 11.5 that a reported (potential) conflict<br>of interest qualifies as a conflict of interest (Conflict of Interest). Such transaction must be concluded on terms which are customary<br>in the market concerned and be approved by the Board. The Chairperson shall procure that transactions in respect of which Directors have<br>a Conflict of Interest will be mentioned to in the Management Report with reference to the Conflict of Interest and a declaration that<br>this Clause 11 was complied with.
---	---
10/15
---
11.2	A Director shall be deemed to have a (potential) Conflict of Interest, if:
---	---
(a)	he has a personal material financial interest in a company with which the Company intends to enter into<br>a transaction;
---	---
(b)	he has a family law relationship (familierechtelijke verhouding) with a management board member<br>of a company with which the Company intends to enter into a transaction;
---	---
(c)	he is a member of the management or supervisory board of, or holds similar office with, a company with<br>which the Company intends to enter into a transaction;
---	---
(d)	under applicable law, including the rules of any exchange on which Shares may be listed, such conflict<br>of interest exists or is deemed to exist; or
---	---
(e)	the Chairperson, or if applicable, the Vice-Chairperson, at his sole discretion has ruled that such Conflict<br>of Interest exists or is deemed to exist.
---	---

The mere fact that a Director holds Shares or is entitled to obtain Shares, is in itself insufficient to determine that a Conflict of Interest exists to which Clause 11.1 applies.

11.3	To prevent Conflicts of Interest, Directors shall in any case refrain from:
(a)	competing with the Company or its Subsidiaries and their affiliated enterprise;
---	---
(b)	demanding or accepting substantial gifts from the Company or its Subsidiaries, for themselves or their<br>spouse, registered partner or other life companion, foster child or relative by blood or marriage up to the second degree;
---	---
(c)	providing unjustified advantages to third parties at the expense of the Company or its Subsidiaries;
---	---
(d)	taking advantage of business opportunities to which the Company or its Subsidiaries are entitled for themselves<br>or for their spouse, registered partner or other life companion, foster child or relative by blood or marriage up to the second degree.
---	---
11.4	Each Director (other than the Chairperson) shall immediately report any (potential) Conflict of Interest<br>concerning a Director to the Chairperson. The Director with such (potential) Conflict of Interest must provide the Chairperson with all<br>information relevant to the conflict, including information relating to his spouse, registered partner or life companion, foster child<br>or relative by blood or marriage up to the second degree. The Chairperson will determine whether a reported (potential) Conflict of Interest<br>qualifies as a Conflict of Interest to which Clause 11.1 applies.
---	---
11.5	In case the Chairperson has a (potential) Conflict of Interest he shall immediately report such (potential)<br>Conflict of Interest to the Vice-Chairperson. The Chairperson must provide the Vice-Chairperson with all information relevant to the (potential)<br>Conflict of Interest, including information relating to his spouse, registered partner, life companion, foster child or relative by blood<br>or marriage up to the second degree. The Vice-Chairperson will determine whether a reported (potential) Conflict of Interest qualifies<br>as a Conflict of Interest to which Clause 11.1 applies.
---	---
11/15
---
12	Relationship with the General Meeting
---	---
12.1	In accordance with the Articles of Association, General Meetings may be convened by the Board. The person(s)<br>convening the meeting shall ensure that it is held in due time and that the Shareholders and other persons with meeting rights are informed<br>by means of a shareholders circular of all facts and circumstances relevant to the item(s) on the agenda.
---	---
12.2	The Board shall provide the General Meeting with any information it may require concerning an item on<br>the agenda, unless important interests (zwaarwegende belangen) of the Company or any law, rules or regulations applicable to the<br>Company prevent it from doing so. The Board shall specify the reasons for invoking such important interests.
---	---
12.3	The Board shall adopt a policy regarding bilateral contacts with the General Meeting and with Shareholders.<br>If a Shareholder engages in a dialogue with the Company outside the context of a General Meeting, the Shareholder shall disclose his/its<br>full share position (long and short and through derivatives) at the request of the Company.
---	---
12.4	The Board shall adopt a policy for effective dialogue with the stakeholders of the Company, to ensure<br>that the interests of the relevant stakeholders are considered when determining the sustainability aspects of the Company’s strategy.
---	---
12.5	The Board shall be responsible for the corporate governance structure of the Company and must give account<br>to the General Meeting in relation to such structure. Each year the broad outline of the Company’s corporate governance structure shall<br>be set forth in a separate chapter of the Management Report. In this chapter the Company will confirm the principles and best practices<br>of the DCGC directed at the Board were followed and if not, the reason for not doing so shall be explained which explanation shall in<br>any event include the following elements:
---	---
(a)	any deviations from the DCGC;
---	---
(b)	the reason for such deviations;
---	---
(c)	if the departure is of a temporary nature and will continue for more than one financial year, an indication<br>of when the Company intends to comply with the principle or the best practice provision again; and
---	---
(d)	where applicable, a description of the alternative measure taken,<br>either explaining how that measure achieves the purpose of the principle or the best practice provision or clarifying how the measure<br>contributes to good corporate governance of the Company. Each significant change in the Company’s corporate governance structure and<br>the compliance of the DCGC shall be addressed in a separate item on the agenda for consideration by the General Meeting.
---	---
12/15
---
13	Confidentiality
---	---

Each Director shall treat all information and documents obtained within the framework of their position as Director with the necessary discretion and, in the case of classified information, with the appropriate secrecy. Classified information shall not be disclosed outside the Board, made public or otherwise made available to third parties, even after resignation from the Board, unless it has been made public by the Company or it has been established that the information is already in the public domain.

14	Non-compliance and amendment
14.1	The Board may amend these Regulations.
---	---
14.2	Without prejudice to the provisions in the Articles of Association, the Board may from time to time decide<br>in its sole discretion, not to comply with and adhere to these rules pursuant to a resolution of the Board to that effect. Such decisions<br>shall be explained in the Management Report.
---	---
14.3	Where these Regulations are inconsistent with Dutch law or the Articles of Association, the latter shall<br>prevail. Where these Regulations conform to the Articles of Association but are inconsistent with Dutch law, the latter shall prevail.
---	---
14.4	If one or more provisions of these Regulations are or become invalid, this shall not affect the validity<br>of the remaining provisions. The Board may replace the invalid provisions by provisions, which are valid, and the effect of which, given<br>the contents and purpose of these Regulations is, to the greatest extent possible, similar to that of the invalid provisions.
---	---
15	Governing law and jurisdiction
---	---

These Regulations shall be governed by and construed in accordance with the law of the Netherlands. The courts of Amsterdam, the Netherlands, shall have exclusive jurisdiction to settle any dispute arising from or in connection with these Regulations (including any dispute regarding the existence, validity or termination of these Regulations).

16	Website

These Regulations, and any amendments thereto, shall be published on the Company’s website.

13/15

Schedule 1

List of Definitions

In these Regulations, the following terms have the following meanings:

Annual Accounts	the Company’s annual accounts of the Company as referred to in Section 2:361 DCC;
Articles of Association	the articles of association of the Company, as amended from time to time;
Auditor	an auditor as referred to in Section 2:393 DCC, or an organization in which auditors referred to in Section 2:393 DCC work together;
Audit Committee	the audit committee of the Board;
Board	the Company’s board of directors;
Board Profile	the profile prepared by the Board on its composition prepared in accordance with best practice provision 2.1.1 of the DCGC, which shall be published on the Company’s website, as amended from time to time;
Chairperson	the Non-Executive Director designated by the Board as chairperson of the Board and who serves as chairperson of the Board (voorzitter) as referred to under Dutch law;
CEO	the Executive Director designated by the Board as chairperson and chief executive officer (CEO);
Committees	the Audit Committee, the Remuneration Committee and the Nominating and Corporate Governance Committee;
Company	Terra Innovatum Global N.V., a public limited liability company under Dutch law, having its official seat in Amsterdam, the Netherlands, registered with the Dutch trade register under number 98523554;
Company Secretary	the secretary of the Company;
Conflict of Interest	has the meaning attributed thereto in Clause 11;
DCC	the Dutch Civil Code;
DCGC	the Dutch corporate governance code, as amended from time to time;
14/15
---
Director	an Executive Director or a Non-Executive Director;
---	---
Executive Director	a member of the Board appointed as executive director;
General Meeting	the corporate body of the Company consisting of Shareholders and all other persons with meeting right or a meeting of Shareholders and other persons with meeting right, as the case may be;
Management Report	the Company’s management report as referred to in Section 2:391 DCC;
Nominating and Corporate Governance Committee	the nominating and corporate governance committee of the Board;
Non-Executive Director	a member of the Board appointed as non-executive director;
Non-Executive Directors’ Report	the report prepared and published by the Non-Executive Directors and as referred to in Clause 4.2;
Regulations	these regulations of the Board, as amended from time to time;
Remuneration Committee	the remuneration committee of the Board;
Share	a share in the Company’s share capital; unless the contrary is expressed this shall include each ordinary share and each preferred share in the share capital of the Company;
Shareholder	a holder of one or more Shares, unless the contrary is expressed this shall include each holder of ordinary shares and each holder of preferred Shares in the share capital of the Company;
Subsidiary	a subsidiary of the Company as referred to in Section 2:24a DCC;
Vice-Chairperson	the Director appointed as vice-chairperson of the Board;
written or in writing	by letter, by e-mail, or by a legible and reproducible message otherwise electronically sent, provided that the identity of the sender can be sufficiently established.
15/15
---

Exhibit 4.3

Terra Innovatum Global N.V.

Warrant To Purchase Ordinary Shares

Date of Issuance: October 9, 2025 (“Issuance Date”)

Terra Innovatum Global N.V., a public company (naamloze vennootschap) under Dutch law (the “Company”), hereby certifies that, for good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, [NAME], the registered holder hereof or its permitted assigns (the “Holder”), is entitled, subject to the terms set forth below, to purchase from the Company, at the Exercise Price (as defined below) then in effect, upon exercise of this Warrant to Purchase Ordinary Shares (the “Warrant”), at any time or times on or after the Issuance Date, but not after 11:59 p.m., New York time, on October 9, 2028 (the “Expiration Date”), up to [NUMBER] ordinary shares (the “Warrant Shares"), of the Company (“Ordinary Shares”), following the consummation of the business combination GSR III Acquisition Corp., a Cayman Islands exempted company and Terra Innovatum s.r.l., an Italian limited liability company (Italian Società a responsabilitàlimitata) (“Terra”). This Warrant is issued pursuant to that certain Letter Agreement, dated as of [•] (the “Note Date”), by and among Terra and the Holder, as amended from time to time (the “Note Conversion Agreement”).

1. EXERCISE OF WARRANT.

(a) Mechanics of Exercise. Subject to the terms and conditions hereof, this Warrant may be exercised by the Holder on any day on or after the Issuance Date and on or before the Expiration Date, in whole or in part, by delivery (whether via e-mail or otherwise) of a written notice, in the form attached hereto as Exhibit A (the “Exercise Notice”), of the Holder’s election to exercise this Warrant. Promptly following an exercise of this Warrant as aforesaid, the Holder shall deliver payment to the Company of an amount equal to the Exercise Price in effect on the date of such exercise multiplied by the number of Warrant Shares as to which this Warrant was so exercised (the “Aggregate Exercise Price”) in cash or via wire transfer of immediately available funds. The Holder shall not be required to deliver the original of this Warrant in order to effect an exercise hereunder. Execution and delivery of an Exercise Notice with respect to less than all of the Warrant Shares shall have the same effect as cancellation of the original of this Warrant and issuance of a new Warrant evidencing the right to purchase the remaining number of Warrant Shares. Execution and delivery of an Exercise Notice for all of the then-remaining Warrant Shares shall have the same effect as cancellation of the original of this Warrant after delivery of the Warrant Shares in accordance with the terms hereof. Promptly following the Company’s receipt of an Exercise Notice, the Company shall issue or cause to be issued the applicable number of Warrant Shares to the Holder and cause such Warrant Shares to be registered in book-entry form in the name of the Holder on the Company’s share register (which book-entry records shall contain an appropriate notation concerning transfer restrictions of the Warrant Shares, in accordance with applicable securities laws of the states of the United States and other applicable jurisdictions), and will provide to the Holder evidence of such issuance from the Company’s transfer agent.

(b) Exercise Price. For purposes of this Warrant, “Exercise Price” means $[*]^1^, subject to adjustment as provided herein.

(c) Further Assurances. The Company shall in all cases use its reasonable best efforts to comply with the delivery requirements set forth herein and shall do all things and take all actions reasonably requested by the Holder in furtherance thereof.

^1^ The Exercise Price is $11.50 or $15.00, as applicable

(d) Reservation of Shares. So long as this Warrant remains outstanding, the Company shall at all times keep reserved for issuance under this Warrant a number of Ordinary Shares at least equal to 100% of the maximum number of Ordinary Shares as shall be necessary to satisfy the Company’s obligation to issue Ordinary Shares under the Warrant (after giving effect to any partial exercise(s) hereof).

2. ADJUSTMENT OF EXERCISE PRICE AND NUMBER OF WARRANT SHARES. The Exercise Price and number of Warrant Shares issuable upon exercise of this Warrant are subject to adjustment from time to time as set forth in this Section 2.

(a) Stock Dividends and Splits. If the Company, at any time on or after the Note Date, (i) pays a stock dividend on one or more classes of its then outstanding Ordinary Shares or otherwise makes a distribution on any class of capital stock that is payable in Ordinary Shares, (ii) subdivides (by any stock split, stock dividend, recapitalization or otherwise) one or more classes of its then outstanding Ordinary Shares into a larger number of shares or (iii) combines (by combination, reverse stock split or otherwise) one or more classes of its then outstanding Ordinary Shares into a smaller number of shares, then in each such case the Exercise Price shall be multiplied by a fraction of which the numerator shall be the number of Ordinary Shares outstanding immediately before such event and of which the denominator shall be the number of Ordinary Shares outstanding immediately after such event. Any adjustment made pursuant to clause (i) of this paragraph shall become effective immediately after the record date for the determination of stockholders entitled to receive such dividend or distribution, and any adjustment pursuant to clause (ii) or (iii) of this paragraph shall become effective immediately after the effective date of such subdivision or combination. If any event requiring an adjustment under this paragraph occurs during the period that an Exercise Price is calculated hereunder, then the calculation of such Exercise Price shall be adjusted appropriately to reflect such event.

(b) Number of Warrant Shares. Simultaneously with any adjustment to the Exercise Price pursuant to Section 2(a), the number of Warrant Shares that may be purchased upon exercise of this Warrant shall be increased or decreased proportionately, so that after such adjustment the aggregate Exercise Price payable hereunder for the adjusted number of Warrant Shares shall be the same as the aggregate Exercise Price in effect immediately prior to such adjustment (without regard to any limitations on exercise contained herein).

(c) Calculations. All calculations under this Section 2 shall be made by rounding to the nearest cent or the nearest 1/100^th^ of a share, as applicable. The number of Ordinary Shares outstanding at any given time shall not include shares owned or held by or for the account of the Company, and the disposition of any such shares shall be considered an issuance or sale of Ordinary Shares.

NONCIRCUMVENTION. The Company hereby covenants and agrees that the Company will not, by amendment of its Amended and Restated Articles of Association, Bylaws or through any reorganization, transfer of assets, consolidation, merger, scheme of arrangement, dissolution, issuance or sale of securities, or any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms of this Warrant, and will at all times in good faith carry out all the provisions of this Warrant and take all action as may be required to protect the rights of the Holder. Without limiting the generality of the foregoing, the Company (a) shall not increase the par value of any Ordinary Shares receivable upon the exercise of this Warrant above the Exercise Price then in effect, and (b) shall take all such actions as may be necessary or appropriate in order that the Company may validly and legally issue fully paid and non-assessable Ordinary Shares upon the exercise of this Warrant.

2
WARRANT HOLDER NOT DEEMED A STOCKHOLDER. Except as otherwise specifically provided herein, the Holder, solely in its capacity as a holder of this Warrant, shall not be entitled to vote or receive dividends or be deemed the holder of share capital of the Company for any purpose, nor shall anything contained in this Warrant be construed to confer upon the Holder, solely in its capacity as the Holder of this Warrant, any of the rights of a stockholder of the Company or any right to vote, give or withhold consent to any corporate action (whether any reorganization, issue of stock, reclassification of stock, consolidation, merger, conveyance or otherwise), receive notice of meetings, receive dividends or subscription rights, or otherwise, prior to the issuance to the Holder of the Warrant Shares which it is then entitled to receive upon the due exercise of this Warrant. In addition, nothing contained in this Warrant shall be construed as imposing any liabilities on the Holder to purchase any securities (upon exercise of this Warrant or otherwise) or as a stockholder of the Company, whether such liabilities are asserted by the Company or by creditors of the Company. Notwithstanding this Section 4, the Company shall provide the Holder with copies of the same notices and other information given to the stockholders of the Company generally, contemporaneously with the giving thereof to the stockholders.

REISSUANCE OF WARRANTS.

(a) Transfer of Warrant. If this Warrant is to be transferred, the Holder shall surrender this Warrant to the Company, whereupon the Company will forthwith issue and deliver upon the order of the Holder a new Warrant (in accordance with Section 5(d)), registered as the Holder may request, representing the right to purchase the number of Warrant Shares being transferred by the Holder and, if less than the total number of Warrant Shares then underlying this Warrant is being transferred, a new Warrant (in accordance with Section 5(d)) to the Holder representing the right to purchase the number of Warrant Shares not being transferred.

(b) Lost, Stolen or Mutilated Warrant. Upon receipt by the Company of evidence reasonably satisfactory to the Company of the loss, theft, destruction or mutilation of this Warrant (as to which a written certification and the indemnification contemplated below shall suffice as such evidence), and, in the case of loss, theft or destruction, of any indemnification undertaking by the Holder to the Company in customary and reasonable form and, in the case of mutilation, upon surrender and cancellation of this Warrant, the Company shall execute and deliver to the Holder a new Warrant (in accordance with Section 5(d)) representing the right to purchase the Warrant Shares then underlying this Warrant.

(c) Exchangeable for Multiple Warrants. This Warrant is exchangeable, upon the surrender hereof by the Holder at the principal office of the Company, for a new Warrant or Warrants (in accordance with Section 5(d)) representing in the aggregate the right to purchase the number of Warrant Shares then underlying this Warrant, and each such new Warrant will represent the right to purchase such portion of such Warrant Shares as is designated by the Holder at the time of such surrender; provided, however, no warrants for fractional Ordinary Shares shall be given.

(d) Issuance of New Warrants. Whenever the Company is required to issue a new Warrant pursuant to the terms of this Warrant, such new Warrant (i) shall be of like tenor with this Warrant, (ii) shall represent, as indicated on the face of such new Warrant, the right to purchase the Warrant Shares then underlying this Warrant (or in the case of a new Warrant being issued pursuant to Section 5(a) or Section 5(c), the Warrant Shares designated by the Holder which, when added to the number of Ordinary Shares underlying the other new Warrants issued in connection with such issuance, does not exceed the number of Warrant Shares then underlying this Warrant), (iii) shall have an issuance date, as indicated on the face of such new Warrant which is the same as the Issuance Date, and (iv) shall have the same rights and conditions as this Warrant.

NOTICES. Whenever notice is required to be given under this Warrant, unless otherwise provided herein, such notice shall be given in accordance with the Note Conversion Agreement. The Company shall provide the Holder with prompt written notice of all actions taken pursuant to this Warrant (other than the issuance of Ordinary Shares upon exercise in accordance with the terms hereof), including in reasonable detail a description of such action and the reason therefor.

3

AMENDMENT AND WAIVER. Except as otherwise provided herein, the provisions of this Warrant may be amended and the Company may take any action herein prohibited, or omit to perform any act herein required to be performed by it, only if the Company has obtained the written consent of the Holder. No waiver shall be effective unless it is in writing and signed by an authorized representative of the waiving party.

SEVERABILITY. If any provision of this Warrant is prohibited by law or otherwise determined to be invalid or unenforceable by a court of competent jurisdiction, the provision that would otherwise be prohibited, invalid or unenforceable shall be deemed amended to apply to the broadest extent that it would be valid and enforceable, and the invalidity or unenforceability of such provision shall not affect the validity of the remaining provisions of this Warrant so long as this Warrant as so modified continues to express, without material change, the original intentions of the parties as to the subject matter hereof and the prohibited nature, invalidity or unenforceability of the provision(s) in question does not substantially impair the respective expectations or reciprocal obligations of the parties or the practical realization of the benefits that would otherwise be conferred upon the parties. The parties will endeavor in good faith negotiations to replace the prohibited, invalid or unenforceable provision(s) with a valid provision(s), the effect of which comes as close as possible to that of the prohibited, invalid or unenforceable provision(s).
GOVERNING LAW. This Warrant shall be governed by and construed and enforced in accordance with, and all questions concerning the construction, validity, interpretation and performance of this Warrant shall be governed by, the internal laws of the State of New York, without giving effect to any provision of law or rule (whether of the State of New York or any other jurisdictions) that would cause the application of the laws of any jurisdictions other than the State of New York. The Company hereby irrevocably waives personal service of process and consents to process being served in any such suit, action or proceeding by mailing a copy thereof to the Company at the address set forth in the Note Conversion Agreement and agrees that such service shall constitute good and sufficient service of process and notice thereof. The Company hereby irrevocably submits to the exclusive jurisdiction of the state and federal courts sitting in The City of New York, Borough of Manhattan, for the adjudication of any dispute hereunder or in connection herewith or with any transaction contemplated hereby or discussed herein, and hereby irrevocably waives, and agrees not to assert in any suit, action or proceeding, any claim that it is not personally subject to the jurisdiction of any such court, that such suit, action or proceeding is brought in an inconvenient forum or that the venue of such suit, action or proceeding is improper. Nothing contained herein shall be deemed to limit in any way any right to serve process in any manner permitted by law. THE COMPANY HEREBY IRREVOCABLY WAIVES ANYRIGHT IT MAY HAVE TO, AND AGREES NOT TO REQUEST, A JURY TRIAL FOR THE ADJUDICATION OF ANY DISPUTE HEREUNDER OR IN CONNECTION WITH ORARISING OUT OF THIS WARRANT OR ANY TRANSACTION CONTEMPLATED HEREBY.

10.CONSTRUCTION; HEADINGS. This Warrant shall be deemed to be jointly drafted by the Company and the Holder and shall not be construed against any person as the drafter hereof. The headings of this Warrant are for convenience of reference and shall not form part of, or affect the interpretation of, this Warrant.

11. REMEDIES. The remedies provided in this Warrant shall be cumulative and in addition to all other remedies available under this Warrant at law or in equity (including a decree of specific performance and/or other injunctive relief), and nothing herein shall limit the right of the Holder to pursue actual and consequential damages for any failure by the Company to comply with the terms of this Warrant. The Company covenants to the Holder that there shall be no characterization concerning this instrument other than as expressly provided herein. Amounts set forth or provided for herein with respect to payments, exercises and the like (and the computation thereof) shall be the amounts to be received by the Holder and shall not, except as expressly provided herein, be subject to any other obligation of the Company (or the performance thereof).

12. TRANSFER. This Warrant may not be offered for sale, sold, transferred or assigned without the prior written notice of the Holder to the Company.

[Signaturepage follows]

INWITNESS WHEREOF, the Company has caused this Warrant to Purchase Ordinary Shares to be duly executed as of the Issuance Date set out above.

TERRA INNOVATUM GLOBAL N.V.
By:
	Name:	Alessandro Petruzzi
	Title:	Chief Executive Officer

[Signature Page to Warrant – [NAME]]

EXHIBIT A

EXERCISE NOTICE

TO BE EXECUTED BY THE REGISTERED HOLDER TO EXERCISE THIS

WARRANT TO PURCHASE ORDINARY SHARES

TERRAINNOVATUM GLOBAL N.V.

The undersigned holder hereby elects to exercise the Warrant to Purchase Ordinary Shares (the “Warrant”) of Terra Innovatum Global N.V., a public company (naamloze vennootschap) under Dutch law (the “Company”), as specified below. Capitalized terms used herein and not otherwise defined shall have the respective meanings set forth in the Warrant.

Exercise Price. The Holder intends that payment of the Aggregate Exercise Price shall be made with respect to _________________ Warrant Shares.
Payment of Exercise Price. The Holder shall pay the Aggregate Exercise Price in the sum of $___________________ to the Company in accordance with the terms of the Warrant.
Delivery of Warrant Shares. The Company shall deliver to Holder, or its designee or agent as specified below, __________ Ordinary Shares in accordance with the terms of the Warrant. Delivery shall be made to Holder, or for its benefit, as follows:

Issue to:
Date: ____________ __, ____
---	---
Name of Registered Holder
By:
	Name:
	Title:
	Tax ID:
	E-mail Address:

Exhibit 10.1

AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENT

THIS AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENT (this “Agreement”), dated as of October 9, 2025, is made and entered into by and among GSR III Acquisition Corp. (the “GSR III”), Terra Innovatum s.r.l., an Italian Società a responsabilità limitata (“Terra OpCo), each individual identified on the signature pages hereto as a “Management Holder” (each, a “Management Holder” and together, the “ManagementHolders”), each individual identified on the signature pages hereto as a “Moonshot Holder” (each, a “MoonshotHolder” and together, the “Moonshot Holders”), and GSR III Sponsor LLC, a Delaware limited liability company (the “Sponsor” and, together with the Management Holders and the Moonshot Holders, and any person or entity who is identified on the signature pages hereto as a “Holder” or hereafter becomes a party to this Agreement pursuant to Section 6.2 of this Agreement, the “Holders” and each, a “Holder”). Each capitalized term used, but not defined herein shall have meaning ascribed to such term in the Business Combination Agreement.

RECITALS

WHEREAS, GSR III, Polaris Advisory Partners LLC, as successor in name to SPAC Advisory Partners, LLC (the “Underwriter”) and the Sponsor are party to that certain Registration Rights Agreement, dated as of November 7, 2024 (the “Original Agreement”);

WHEREAS, GSR III, Terra OpCo and such other parties that will sign joinders to the Business Combination Agreement in accordance with the certain Terra Pre-Closing Restructuring Plan (as described therein) have entered into that certain Business Combination Agreement, dated as of April 21, 2025 (as amended, supplemented and/or restated from time to time, the “Business Combination Agreement”);

WHEREAS, pursuant to the Business Combination Agreement and prior to or at the Closing Date, GSR III, Terra OpCo and such other parties that will sign joinders to the Business Combination Agreement, entered into the series of reorganizations and equity issuances and purchases described in the Business Combination Agreement (the “Business Combination”);

WHEREAS, pursuant to the amended and restated memorandum and articles of incorporation of GSR III (as may be amended and restated from time to time, the “GSRCharter”), GSR III is authorized to issue the following classes of stock: 200,000,000 GSR III Class A Ordinary Shares, 20,000,000 GSR III Class B Ordinary Shares and (i) 1,000,000 GSR III Preference Shares;

WHEREAS, simultaneously with the closing of its initial public offering, GSR III issued and sold 422,500 private placement units (the “GSR III PrivatePlacement Units”) that consist of 422,500 GSR III Class A Ordinary Shares and rights to receive 60,357 GSR III Class A Ordinary Shares after the conversion of the right per unit to acquire one-seventh of one share upon the consummation of a qualifying initial business combination (“GSR III Rights”);

WHEREAS, in connection with the Business Combination, each issued and outstanding GSR III Ordinary Share will be exchanged into one share, par value EUR 0.01 per share (each, a “Company Ordinary Share”) of Terra Innovatum Global N.V., a Dutch public limited liability company (a naamloze vennootschap) (the “Company”), with GSR III becoming a wholly owned Subsidiary of the Company;

WHEREAS, the Company or other surviving parent entity listed as a public company on Nasdaq shall assume the obligations of GSR III under this Agreement; and

WHEREAS, in connection with the consummation of the transactions described above, GSR III, Underwriter and Sponsor desire to amend and restate the Original Agreement in its entirety as set forth herein, and GSR III and the Holders desire to enter into this Agreement, pursuant to which GSR III shall grant the Holders certain registration rights with respect to certain securities of the Company, as set forth in this Agreement.

NOW, THEREFORE, in consideration of the representations, covenants and agreements contained herein, and certain other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto, intending to be legally bound, hereby agree as follows:

Article I

DEFINITIONS

1.1 Definitions. Capitalized terms used herein but not defined in this Agreement shall have the meanings ascribed to them in the Business Combination Agreement. The terms defined in this Article I shall, for all purposes of this Agreement, have the respective meanings set forth below:

“Action” means any claim, action, suit, charge, audit, examination, assessment, arbitration, mediation or inquiry, or any proceeding or investigation, by or before any Governmental Authority.

“AdverseDisclosure” means any public disclosure of material non-public information, which disclosure, in the good faith judgment of the chief executive officer or principal financial officer of the Company, after consultation with counsel to the Company, (a) would be required to be made in any Registration Statement or Prospectus in order for the applicable Registration Statement or Prospectus not to contain any Misstatement, as applicable, (b) would not be required to be made at such time if the Registration Statement were not being filed, declared effective or used, as the case may be, and (c) as to which the Company has a bona fide business purpose for not making such information public.

“Affiliate” means, with respect to any person, any other person who directly or indirectly, through one or more intermediaries, controls, is controlled by, or is under common control with, such person. The term “control” means the possession, directly or indirectly, of the power to direct or cause the direction of the management and policies of a person, whether through the ownership of voting securities, by contract or otherwise, and the terms “controlled” and “controlling” have meanings correlative thereto.

“Agreement” has the meaning given in the Preamble hereto.

“AutomaticShelf Registration Statement” has the meaning set forth in Rule 405 promulgated by the Commission pursuant to the Securities Act.

“BeneficiallyOwn” has the meaning set forth in Rule 13d-3 promulgated under the Exchange Act.

“Board” means the board of directors of the Company.

“Business Combination” has the meaning given in the Recitals hereto.

“Business Day” means a day other than a Saturday, Sunday or other day on which commercial banks in New York, New York are authorized or required by law to close.

“ClosingDate” means the date on which the Closing shall occur.

“Commission” means the Securities and Exchange Commission.

“Company” means from and after the consummation of Conversion, Terra Innovatum Global N.V., a Dutch public limited liability company (naamlozevennootschap), as organized under the laws of The Netherlands and treated as a tax resident of Italy for tax purposes.

“CompanyOrdinary Share Trading Price” means the VWAP of the Company’s Ordinary Share for any five Trading Days within any 20 Trading Days period.

“DemandingHolder” has the meaning given in subsection 2.1.3.

“End of SuspensionNotice” has the meaning given in subsection 4.4.2.

“ExchangeAct” means the Securities Exchange Act of 1934, as it may be amended from time to time.

“FormS-1 Shelf” has the meaning given in subsection 2.1.1.

“FormS-3 Shelf” has the meaning given in subsection 2.1.1.

“GovernmentalAuthority” means any federal, national, state, provincial or municipal government, or any political subdivision thereof, and any agency, commission, department, board, bureau, official, minister, arbitral body (public or private), tribunal or court, whether national, state, provincial, local, foreign or multinational, exercising executive, legislative, judicial, regulatory or administrative functions of a nation, state, province or municipal government, or any political subdivision thereof, including any authority having governmental or quasi-governmental powers, domestic or foreign.

“GSR III” has the meaning given in the preamble hereto.

“HolderInformation” has the meaning given in subsection 5.1.2.

“Holders” has the meaning given in the Preamble hereto, for so long as such person or entity holds any Registrable Securities.

“Lock-Up” has the meaning given in subsection 3.1.2.

“Lock-Up Period” shall mean the period beginning on the Closing Date and ending in four consecutive equal quarterly installments following the Closing Date, in accordance with the following schedule:

(a) one-fourth of the securities subject to the Lock-Up shall be released from the Lock-Up upon the earlier of (i) the Company Ordinary Share Trading Price being greater than $12 or (ii) the Company issuing its first quarterly earnings release that occurs at least 120 days after the Closing Date;

(b) one-fourth of the securities subject to the Lock-Up shall be released from the Lock-Up upon the earlier of (i) the Company Ordinary Share Trading Price being greater than $14 or (ii) the Company issuing its second quarterly earnings release that occurs at least 120 days after the Closing Date;

(c) one-fourth of the securities subject to the Lock-Up shall be released from the Lock-Up upon the earlier of (i) the Company Ordinary Share Trading Price being greater than or (ii) the Company issuing its third quarterly earnings release that occurs at least 120 days after the Closing Date; and

(d) one-fourth of the securities subject to the Lock-Up shall be released from the Lock-Up upon the earlier of (i) the Company Ordinary Share Trading Price being greater than $18 or (ii) the Company issuing its fourth quarterly earnings release that occurs at least 120 days after the Closing Date

“Lock-Up Shares” has the meaning given in subsection 3.1.2.

“Management Holders” has the meaning given in the Preamble hereto.

“MaximumNumber of Securities” has the meaning given in subsection 2.1.4.

“MinimumTakedown Threshold” has the meaning given in subsection 2.1.3.

“Misstatement” means:

(a) with respect to a Registration Statement, an untrue statement of a material fact or an omission to state a material fact necessary in order to make the statements made, in the light of the circumstances under which they were made, not misleading; and

(b) with respect to a Prospectus, an untrue statement of a material fact or an omission to state of a material fact required to be stated therein or necessary to make the statements therein not misleading.

“Non-RedemptionAgreements” means agreements between GSR III and certain shareholders of GSR III pursuant to which such GSR III shareholders agree not to request redemption of their respective shares of Class A ordinary shares in connection with the Business Combination.

“Opt-Out Notice” has the meaning given in Section 6.17.

“Original Agreement” has the meaning given in the Recitals hereto.

“PermittedTransferee” means, in the case of any Holder, a person to whom, or entity to which, Registrable Securities are transferred by such Holder; provided that (a) such transfer does not violate the Company’s governing documents, or any agreements between such Holder and the Company or any of the Company’s subsidiaries and (b) such transferee shall only be a Permitted Transferee if and to the extent the transferor designates the transferee as a Permitted Transferee entitled to rights hereunder pursuant to subsection 6.2.3.

“PiggybackRegistration” has the meaning given in subsection 2.2.1.

“Prospectus” means the prospectus included in any Registration Statement (including, without limitation, a prospectus that includes any information previously omitted from a prospectus filed as part of an effective Registration Statement in reliance on Rules 430A or 430B under the Securities Act or any successor rule thereto), as supplemented by any and all prospectus supplements and as amended by any and all post-effective amendments and including all material incorporated by reference in such prospectus.

“RegistrableSecurity” means (a) any outstanding Company Ordinary Shares held by a Holder immediately following the Closing Date (which shall include all GSR III Ordinary Shares issuable upon the conversion of any GSR III Rights outstanding on the date of this Agreement); (b) any outstanding Company Ordinary Shares acquired by a Holder following the date hereof to the extent that such securities are “restricted securities” (as defined in Rule 144) or are otherwise held by an “affiliate” (as defined in Rule 144) of the Company; and (c) any other Company Ordinary Shares of the Company or any of its subsidiaries issued or issuable with respect to any securities referenced in clause (a), (b), (c), or (d) above by way of a stock dividend or stock split or in connection with a conversion, distribution, exchange, reclassification, recapitalization, merger, consolidation, spin-off, reorganization or similar transaction; provided, however, that, as to any particular Registrable Security, such securities shall cease to constitute Registrable Securities upon the earliest to occur of the date on which such securities: (i) have been sold, transferred, disposed of or exchanged pursuant to an effective Registration Statement, pursuant to Rule 144 under the Securities Act or any other exemption from registration under the securities laws of the United States; (ii) cease to be outstanding; and (iii) may be sold without registration pursuant to Rule 144 under the Securities Act (but without the requirement to comply with any volume, manner of sale limitations or the Company being in compliance with the filing of all periodic reports and other reports under the Exchange Act).

“Registration” means a registration, including any related Shelf Takedown, effected by preparing and filing a registration statement, prospectus or similar document in compliance with the requirements of the Securities Act, and the applicable rules and regulations promulgated thereunder, and such registration statement becoming effective.

“RegistrationExpenses” means the out-of-pocket expenses of a Registration, including, without limitation, the following:

(a)	all registration and filing fees (including fees with respect to filings required to be made with the<br>Financial Industry Regulatory Authority, Inc.) and any securities exchange on which the Company Ordinary Shares is then listed;
(b)	fees and expenses of compliance with securities or blue sky laws (including reasonable fees and disbursements<br>of counsel for the Underwriters in connection with blue sky qualifications of Registrable Securities);
---	---
(c)	printing, messenger, telephone and delivery expenses;
---	---
(d)	reasonable fees and disbursements of counsel for the Company;
---	---
(e)	reasonable fees and disbursements of all independent registered public accountants of the Company incurred<br>specifically in connection with such Registration;
---	---
(f)	reasonable fees and expenses of one legal counsel selected by the majority-in-interest of the Demanding<br>Holders in an Underwritten Offering; and
---	---
(g)	the costs and expenses of the Company relating to analyst and investor presentations or any “road<br>show” undertaken in connection with the Registration and/or marketing of the Registrable Securities.
---	---

“RegistrationStatement” means any registration statement that covers the Registrable Securities pursuant to the provisions of this Agreement, including the Prospectus included in such registration statement, amendments (including post-effective amendments) and supplements to such registration statement, and all exhibits to and all material incorporated by reference in such registration statement.

“RequestingHolder” means any Holder requesting piggyback rights pursuant to this Agreement with respect to an Underwritten Shelf Takedown.

“SecuritiesAct” means the Securities Act of 1933, as amended from time to time.

“Shelf” has the meaning given in subsection 2.1.1.

“ShelfRegistration” means a registration of securities pursuant to a registration statement filed with the Commission in accordance with and pursuant to Rule 415 promulgated under the Securities Act (or any successor rule then in effect).

“ShelfTakedown” means an Underwritten Shelf Takedown or any proposed transfer or sale using a Registration Statement, including a Piggyback Registration.

“Sponsor” has the meaning given in the Preamble hereto.

“SubsequentShelf Registration” has the meaning given in subsection 2.1.2.

“Suspension Event” has the meaning given in subsection 4.4.2.

“Suspension Notice” has the meaning given in subsection 4.4.2.

“Suspension Period” has the meaning given in subsection 4.4.2.

“BusinessCombination Agreement” has the meaning given in the Recitals hereto.

“Transfer” means, when used as a noun, the (a) sale of, offer to sell, contract or agreement to sell, hypothecate, pledge, grant of any option to purchase or otherwise dispose of or agreement to dispose of, directly or indirectly, or establishment or increase of a put equivalent position or liquidation with respect to or decrease of a call equivalent position within the meaning of Section 16 of the Exchange Act with respect to, any security, or (b) entry into any swap or other arrangement that transfers to another, in whole or in part, any of the economic consequences of ownership of any security, whether any such transaction is to be settled by delivery of such securities, in cash or otherwise. The terms “Transferee,” “Transferor,” “Transferred,” and other forms of the word “Transfer” shall have the correlative meanings.

“Underwriter” means any investment banker(s) and manager(s) appointed to administer the offering of any Registrable Securities as principal in an Underwritten Offering.

“UnderwrittenOffering” means a Registration in which securities of the Company are sold to an Underwriter in a firm commitment underwriting for distribution to the public.

“UnderwrittenShelf Takedown” has the meaning given in subsection 2.1.3.

“VWAP” means, for any security as of any date(s), the dollar volume-weighted average price for such on the principal securities exchange or securities market on which such security is then traded during the period beginning at 9:30:01 a.m., New York time, and ending at 4:00:00 p.m., New York time, as reported by Bloomberg through its “HP” function (set to weighted average) or, if the foregoing does not apply, the dollar volume-weighted average price of such security in the over-the-counter market on the electronic bulletin board for such security during the period beginning at 9:30:01 a.m., New York time, and ending at 4:00:00 p.m., New York time, as reported by Bloomberg, or, if no dollar volume-weighted average price is reported for such security by Bloomberg for such hours, the average of the highest closing bid price and the lowest closing ask price of any of the market makers for such security as reported by OTC Markets Group Inc. If the VWAP cannot be calculated for such security on such date(s) on any of the foregoing bases, the VWAP of such security on such date(s) shall be the fair market value per share on such date(s) as reasonably determined by a nationally recognized independent investment banking firm mutually agreed between the Company and GSR III.

“Terra Opco” has the meaning given in the Preamble hereto.

“Well-KnownSeasoned Issuer” has the meaning set forth in Rule 405 promulgated by the Commission pursuant to the Securities Act.

“WithdrawalNotice” has the meaning given in subsection 2.1.5.

Article II

REGISTRATIONS

2.1 Shelf Registration.

2.1.1 Filing. The Company shall use its commercially reasonable efforts to file, within 60 days of the Closing Date or such earlier date as required in accordance with any Non-Redemption Agreement, a Registration Statement for a Shelf Registration on Form S-3 (the “FormS-3 Shelf”) or, if the Company is not eligible to use a Registration Statement on Form S-3, a Shelf Registration Statement on Form S-1 (the “Form S-1 Shelf,” and together with the Form S-3 Shelf, as applicable (and any Subsequent Shelf Registration), the “Shelf”), in each case, covering the resale of all the Registrable Securities (determined as of two Business Days prior to such filing) on a delayed or continuous basis. The Company shall use its commercially reasonable efforts to cause the Shelf to become effective as soon as practicable after such filing, but in no event later than 90 days after the initial filing thereof (or 120 days after the initial filing thereof if the Commission notifies the Company that it will “review” the Shelf) or such other earlier date as required in accordance with any Non-Redemption Agreement. The Shelf shall provide for the resale of the Registrable Securities included therein pursuant to any method or combination of methods legally available to, and requested by, any Holder. The Company shall maintain the Shelf in accordance with the terms hereof, and shall prepare and file with the SEC such amendments, including post-effective amendments, and supplements as may be necessary to keep such Shelf continuously effective, available for use and in compliance with the provisions of the Securities Act until such time as there are no longer any Registrable Securities. In the event the Company files a Form S-1 Shelf, the Company shall use its reasonable best efforts to convert the Form S-1 Shelf (and any Subsequent Shelf Registration) to a Form S-3 Shelf as soon as practicable after the Company is eligible to use Form S-3.

2.1.2 Subsequent Shelf Registration. If any Shelf ceases to be effective under the Securities Act for any reason at any time while Registrable Securities are still outstanding, the Company shall, subject to Section 4.4, use its reasonable best efforts to as promptly as is reasonably practicable cause such Shelf to again become effective under the Securities Act (including obtaining the prompt withdrawal of any order suspending the effectiveness of such Shelf), and shall use its reasonable best efforts to as promptly as is reasonably practicable amend such Shelf in a manner reasonably expected to result in the withdrawal of any order suspending the effectiveness of such Shelf or file an additional registration statement as a Shelf Registration (a “SubsequentShelf Registration”) registering the resale of all Registrable Securities (determined as of two Business Days prior to such filing), and pursuant to any method or combination of methods legally available to, and requested by, any Holder. If a Subsequent Shelf Registration is filed, the Company shall use its reasonable best efforts to (a) cause such Subsequent Shelf Registration to become effective under the Securities Act as promptly as is reasonably practicable after the filing thereof (it being agreed that the Subsequent Shelf Registration shall be an Automatic Shelf Registration Statement if the Company is a Well-Known Seasoned Issuer) and (b) keep such Subsequent Shelf Registration continuously effective, available for use and in compliance with the provisions of the Securities Act until such time as there are no longer any Registrable Securities. Any such Subsequent Shelf Registration shall be on Form S-3 to the extent that the Company is eligible to use such form. Otherwise, such Subsequent Shelf Registration shall be on another appropriate form. In the event that any Holder holds Registrable Securities that are not registered for resale on a delayed or continuous basis, the Company, upon request of a Holder shall promptly use its reasonable best efforts to cause the resale of such Registrable Securities to be covered by either, at the Company’s option, the Shelf or a Subsequent Shelf Registration and cause the same to become effective as soon as practicable after such filing and such Shelf or Subsequent Shelf Registration shall be subject to the terms hereof.

2.1.3 Requests for Underwritten Shelf Takedowns. At any time and from time to time after the Shelf has been declared effective by the Commission, a Holder or a group of Holders (in such case, each, a “Demanding Holder”) may request to sell all or any portion of its Registrable Securities in an Underwritten Offering that is registered pursuant to the Shelf (each, an “UnderwrittenShelf Takedown”); provided that the Company shall only be obligated to effect an Underwritten Shelf Takedown if such offering shall include Registrable Securities proposed to be sold by the Demanding Holder(s) with a total offering price reasonably expected to exceed, in the aggregate, $50,000,000 (the “Minimum TakedownThreshold”). All requests for Underwritten Shelf Takedowns shall be made by giving written notice to the Company, which shall specify the approximate number of Registrable Securities proposed to be sold in the Underwritten Shelf Takedown and the expected price range (net of underwriting discounts and commissions) of such Underwritten Shelf Takedown. The Demanding Holder(s) that requested such Underwritten Shelf Takedown shall have the right to select the Underwriters for such offering (which shall consist of one or more reputable nationally recognized investment banks), subject to the initial Demanding Holder’s prior approval (which shall not be unreasonably withheld, conditioned or delayed), and to agree to the pricing and other terms of such offering. The Company is not obligated to effect more than (A) for the Management Holders, acting individually or together, three Underwritten Shelf Takedowns pursuant to this subsection 2.1.3 in any 12-month period and (B) for Sponsor, one Underwritten Shelf Takedown pursuant to this subsection 2.1.3 in any 12-month period; provided that, the Company shall not be obligated to effect any Underwritten Shelf Takedowns for Sponsor during the 12-month period beginning on the Closing Date. Notwithstanding anything to the contrary in this Agreement, the Company may effect any Underwritten Offering pursuant to any then effective Registration Statement, including a Form S-3, that is then available for such offering.

2.1.4 Reduction of Underwritten Shelf Takedown. If the managing Underwriter or Underwriters in an Underwritten Shelf Takedown, in good faith, advise the Company, the Demanding Holders and the Holders requesting piggyback rights pursuant to this Agreement with respect to such Underwritten Shelf Takedown (the “Requesting Holders”) (if any) in writing that the dollar amount or number of Registrable Securities that the Demanding Holders and the Requesting Holders (if any) desire to sell, taken together with all other equity securities that the Company desires to sell and all other equity securities, if any, that have been requested to be sold in such Underwritten Offering pursuant to separate written contractual piggyback registration rights held by any other shareholders, exceeds the maximum dollar amount or maximum number of equity securities that can be sold in the Underwritten Offering without adversely affecting the proposed offering price, the timing, the distribution method, or the probability of success of such offering (such maximum dollar amount or maximum number of such securities, as applicable, the “Maximum Number of Securities”), then the Company shall include in such Underwritten Offering, as follows: At all times (a) first, the Registrable Securities of the Demanding Holders and the Requesting Holders (if any) (pro rata based on the respective number of Registrable Securities that each Demanding Holder and Requesting Holder (if any) has requested be included in such Underwritten Shelf Takedown) that can be sold without exceeding the Maximum Number of Securities; (b) second, to the extent that the Maximum Number of Securities has not been reached under the foregoing clause (a), the equity securities that the Company desires to sell that can be sold without exceeding the Maximum Number of Securities; and (c) third, to the extent that the Maximum Number of Securities has not been reached under the foregoing clauses (a) and (b) such other equity securities of other persons or entities that the Company is obligated to include in such Underwritten Shelf Offering pursuant to separate written contractual arrangements with such persons and that can be sold without exceeding the Maximum Number of Securities.

2.1.5 Withdrawal. Prior to the filing of the applicable “red herring” prospectus or prospectus supplement used for marketing such Underwritten Shelf Takedown, any Demanding Holder initiating an Underwritten Shelf Takedown shall have the right to withdraw from such Underwritten Shelf Takedown for any or no reason whatsoever upon written notification (a “WithdrawalNotice”) to the Company and the Underwriter or Underwriters (if any) of their intention to withdraw from such Shelf Takedown; provided that any Demanding Holder (to the extent they are not withdrawing) may elect to have the Company continue an Underwritten Shelf Takedown if the Minimum Takedown Threshold would still be satisfied by the Registrable Securities proposed to be sold in the Underwritten Shelf Takedown by such Demanding Holders, as applicable or if such Underwritten Shelf Takedown would be made with respect to all of the Registrable Securities of such Holder. If withdrawn, a demand for an Underwritten Shelf Takedown shall constitute a demand for an Underwritten Shelf Takedown for purposes of subsection 2.1.3, unless either (a) such withdrawal occurs during a period the Company has deferred taking action pursuant to Section 4.4 hereof or (b) the withdrawing Demanding Holder reimburses the Company for all Registration Expenses with respect to such Underwritten Shelf Takedown; provided that, if a Holder elects to continue an Underwritten Shelf Takedown pursuant to the proviso in the immediately preceding sentence, such Underwritten Shelf Takedown shall count as an Underwritten Shelf Takedown demanded by such Holder, as applicable, for purposes of subsection 2.1.3. Following the receipt of any Withdrawal Notice, the Company shall promptly forward such Withdrawal Notice to any other Holders that had elected to participate in such Underwritten Shelf Takedown. Notwithstanding anything to the contrary in this Agreement, the Company shall be responsible for the Registration Expenses incurred in connection with an Underwritten Shelf Takedown prior to its withdrawal under this subsection 2.1.5, other than if a Demanding Holder elects to pay such Registration Expenses pursuant to the second sentence of this subsection 2.1.5.

2.2 Piggyback Registration.

2.2.1 Piggyback Rights. If the Company (for its own account or for the account of persons or entities other than the Holders of Registrable Securities) or any Holder proposes to conduct a registered offering of, or if the Company proposes to file a Registration Statement under the Securities Act with respect to the Registration of equity securities of the Company, or securities or other obligations exercisable or exchangeable for, or convertible into equity securities of the Company, for its own account or for the account of shareholders of the Company (or by the Company and by the shareholders of the Company including, without limitation, an Underwritten Shelf Takedown pursuant to Section 2.1 hereof), other than a Registration Statement (or any registered offering with respect thereto) (a) filed in connection with any employee stock option or other benefit plan, (b) pursuant to a Registration Statement on Form S-4 (or similar form that relates to a transaction subject to Rule 145 under the Securities Act or any successor rule thereto), (c) for an exchange offer or offering of securities solely to the Company’s existing shareholders, (d) for an offering of debt that is convertible into equity securities of the Company or (e) for a dividend reinvestment plan, then the Company shall give written notice of such proposed offering to all of the Holders of Registrable Securities as soon as practicable but not less than ten days before the anticipated filing date of such Registration Statement or, in the case of an Underwritten Offering pursuant to a Shelf Registration, the launch date of such offering, which notice shall (i) describe the amount and type of securities to be included in such offering, the intended method(s) of distribution, and the name of the proposed managing Underwriter or Underwriters, if any and if known, in such offering, and (ii) offer to all of the Holders of Registrable Securities the opportunity to include in such registered offering such number of Registrable Securities as such Holders may request in writing within five days after receipt of such written notice (such registered offering, a “PiggybackRegistration”). The Company shall, in good faith, cause such Registrable Securities to be included in such Piggyback Registration and, if applicable, shall use its reasonable best efforts to cause the managing Underwriter or Underwriters of such Piggyback Registration to permit the Registrable Securities requested by the Holders pursuant to this subsection 2.2.1 to be included therein on the same terms and conditions as any similar securities of the Company included in such registered offering and to permit the sale or other disposition of such Registrable Securities in accordance with the intended method(s) of distribution thereof. The inclusion of any Holder’s Registrable Securities in a Piggyback Registration shall be subject to such Holder’s agreement to abide by the terms of Section 4.3 below.

2.2.2 Reduction of Piggyback Registration. If the managing Underwriter or Underwriters in an Underwritten Offering that is to be a Piggyback Registration, in good faith, advises the Company and the Holders of Registrable Securities participating in the Piggyback Registration in writing that the dollar amount or number of the equity securities that the Company desires to sell, taken together with (a) the Registrable Securities, if any, as to which Registration has been requested pursuant to Section 2.2 hereof and (b) the equity securities, if any, as to which Registration or a registered offering has been requested pursuant to separate written contractual registration rights of other shareholders of the Company, exceeds the Maximum Number of Securities, then:

(i) If the Registration or registered offering is undertaken for the Company’s account, the Company shall include in any such Registration or registered offering (A) first, the equity securities that the Company desires to sell that can be sold without exceeding the Maximum Number of Securities; (B) second, to the extent that the Maximum Number of Securities has not been reached under the foregoing clause (A), the Registrable Securities of Holders exercising their rights to register their Registrable Securities pursuant to subsection 2.2.1 hereof, pro rata based on the respective number of Registrable Securities that each Holder has requested be included in such Registration, that can be sold without exceeding the Maximum Number of Securities; and (C) third, to the extent that the Maximum Number of Securities has not been reached under the foregoing clauses (A) and (B), the equity securities, if any, as to which Registration or a registered offering has been requested pursuant to written contractual piggyback registration rights of other shareholders of the Company, that can be sold without exceeding the Maximum Number of Securities;

(ii) If the Registration or registered offering is pursuant to a request by persons or entities other than the Holders of Registrable Securities, then the Company shall include in any such Registration or registered offering (A) first, the equity securities of such requesting persons or entities that can be sold without exceeding the Maximum Number of Securities; (B) second, to the extent that the Maximum Number of Securities has not been reached under the foregoing clause (A), the Registrable Securities of Holders exercising their rights to register their Registrable Securities pursuant to subsection 2.2.1, pro rata based on the respective number of Registrable Securities that each Holder has requested be included in such Underwritten Offering, that can be sold without exceeding the Maximum Number of Securities; (C) third, to the extent that the Maximum Number of Securities has not been reached under the foregoing clauses (A) and (B), the equity securities that the Company desires to sell that can be sold without exceeding the Maximum Number of Securities; and (D) fourth, to the extent that the Maximum Number of Securities has not been reached under the foregoing clauses (A), (B) and (C), the equity securities for the account of other persons or entities that the Company is obligated to register pursuant to separate written contractual piggyback arrangements with such persons or entities that can be sold without exceeding the Maximum Number of Securities.

(iii) If the Registration or registered offering is pursuant to a request by Holder(s) of Registrable Securities pursuant to Section 2.1 hereof, then the Company shall include in any such Registration or registered offering securities pursuant to subsection 2.1.4.

2.2.3 Piggyback Registration Withdrawal. Any Holder of Registrable Securities (other than a Demanding Holder, whose right to withdraw from an Underwritten Shelf Takedown, and related obligations, shall be governed by subsection 2.1.5) shall have the right to withdraw from a Piggyback Registration for any or no reason whatsoever upon written notification to the Company and the Underwriter or Underwriters (if any) of his, her or its intention to withdraw from such Piggyback Registration prior to the effectiveness of the Registration Statement filed with the Commission with respect to such Piggyback Registration or, in the case of a Piggyback Registration pursuant to a Shelf Registration, the filing of the applicable “red herring” prospectus or prospectus supplement with respect to such Piggyback Registration used for marketing such transaction. The Company (whether on its own good faith determination or as the result of a request for withdrawal by persons pursuant to separate written contractual obligations) may withdraw a Registration Statement filed with the Commission in connection with a Piggyback Registration (which, in no circumstance, shall include the Shelf) at any time prior to the effectiveness of such Registration Statement. Notwithstanding anything to the contrary in this Agreement (other than subsection 2.1.5), the Company shall be responsible for the Registration Expenses incurred in connection with the Piggyback Registration prior to its withdrawal under this subsection 2.2.3.

2.2.4 Unlimited Piggyback Registration Rights; For purposes of clarity, subject to subsection 2.1.5, any Piggyback Registration effected pursuant to Section 2.2 hereof shall not be counted as a demand for an Underwritten Shelf Takedown under subsection 2.1.3 hereof.

2.3 Restrictions on Transfer. In connection with any Underwritten Offering of equity securities of the Company, each Holder participating in such Underwritten Offering agrees that it shall not Transfer any Company Ordinary Shares (other than those included in such offering pursuant to this Agreement), without the prior written consent of the Company, during the seven days prior (to the extent notice of such Underwritten Offering has been provided) to, and the 30-day period beginning on, the date of pricing of such offering, except in the event the Underwriter managing the offering otherwise agrees to a shorter period by written consent. Each Holder agrees to execute a customary lock-up agreement in favor of the Underwriters to such effect (in each case on substantially the same terms and conditions as all such Holders). Notwithstanding the foregoing, with respect to an Underwritten Offering, a Holder shall not be subject to this Section 2.3 with respect to an Underwritten Offering unless each shareholder of the Company that (together with their Affiliates) holds at least 10% of the issued and outstanding Company Ordinary Shares (on a fully-exchanged basis after giving effect to the exchange of all Common Units for Company Ordinary Shares) and each of the Company’s directors and executive officers have agreed to a lock-up on terms at least as restrictive with respect to such Underwritten Offering as requested of the Holders. A Holder’s obligations under the second sentence of this Section 2.3 shall only apply for so long as such Holder (together with its Affiliates) holds at least 10% of the issued and outstanding Company Ordinary Shares (on a fully-exchanged basis after giving effect to the exchange of all Common Units for Company Ordinary Shares).

Article III

LOCK-UP

3.1 Lock-Up.

3.1.2 Each of the Management Holders, Terra OpCo Quotaholders and Sponsor (the “Locked-Up Holders”), severally, and not jointly, agrees with the Company not to effect any Transfer, or make a public announcement of any intention to effect such Transfer, of any Lock-Up Shares Beneficially Owned or otherwise held by such Locked-Up Holder during the Lock-Up Period (such restrictions, the “Lock-Up”); provided that the Lock-Up shall not apply to Transfers permitted pursuant to Section 3.2; provided, further, that any waiver of the Lock-Up shall require the approval of a majority of the independent directors of the Board; provided, further, that any such waiver must apply to an equal proportionate share of the Lock-Up Shares held by each Locked-Up Holder. “Lock-UpShares” means the equity securities of the Company held by the Management Holders and Terra OpCo Quotaholders and the equity securities of the Company held by the Sponsor that were issued in exchange for GSR III Class B Ordinary Shares, directly or indirectly, as of the Closing Date.

3.1.3 During the Lock-Up Period, any purported Transfer of Lock-Up Shares other than in accordance with this Agreement shall be null and void, and the Company shall refuse to recognize any such Transfer for any purpose.

3.1.4 The Locked-Up Holders acknowledge and agree that, notwithstanding anything to the contrary contained in this Agreement, the equity securities of the Company Beneficially Owned by such Locked-Up Holder shall remain subject to any restrictions on Transfer under applicable securities Laws of any Governmental Authority, including all applicable holding periods under the Securities Act and other rules of the Commission.

3.2 Permitted Transfers.

3.2.1 . Notwithstanding anything to the contrary contained in this Agreement, during the Lock-Up Period applicable to any Lock-Up Shares of a Locked-Up Holder, such Locked-Up Holder may Transfer, without the consent of the Company, any of such Lock-Up Shares to (a) any of such Locked-Up Holder’s Permitted Transferees, upon written notice to the Company or (b)(i) a charitable organization, upon written notice to the Company, (ii) in the case of an individual, by virtue of Laws of descent and distribution upon death of the individual, (iii) in the case of an individual, pursuant to a qualified domestic relations order or (iv) pursuant to any liquidation, merger, stock exchange or other similar transaction which results in all of the Company’s shareholders having the right to exchange their Company Ordinary Shares for cash, securities or other property subsequent to the Business Combination; provided that in connection with any Transfer of such Lock-Up Shares pursuant to clause (b)(ii) or clause (b)(iii), (A) the restrictions and obligations contained in Section 3.1 and this Section 3.2 will continue to apply to such Lock-Up Shares after any Transfer of such Lock-Up Shares and (B) the Transferee of such Lock-Up Shares shall have no rights under this Agreement, unless, for the avoidance of doubt, such Transferee is a Permitted Transferee in accordance with this Agreement. Any Transferee of Lock-Up Shares that is a Permitted Transferee of the Transferor shall be required, at the time of and as a condition to such Transfer, to become a party to this Agreement, by executing and delivering a joinder to this Agreement, whereupon such Transferee will be treated as a Holder (with the same rights and obligations as the Transferor) for all purposes of this Agreement. Notwithstanding anything to the contrary, and for the avoidance of doubt, the Sponsor shall be permitted to forfeit any portion of its Lock-Up Shares pursuant to the Sponsor Support Agreement.

3.3 Other Lock-Up Restrictions. Each of the Company and the Sponsor hereby acknowledge and agree that this Article III supersedes Section 4 of the Sponsor Support Agreement in all respects, and, upon execution of this Agreement by each of the Company and the Sponsor, the Sponsor Support Agreement shall be deemed amended to remove Section 4 of the Sponsor Support Agreement.

Article IV

COMPANY PROCEDURES

4.1 General Procedures. In connection with effecting any Shelf Registration, Shelf Takedown and/or other disposition of Registrable Securities pursuant to a registration statement contemplated herein (to the extent applicable), the Company shall use its reasonable best efforts to effect such Registration to permit the sale of such Registrable Securities in accordance with the intended plan of distribution thereof, and pursuant thereto the Company shall, as expeditiously as possible:

4.1.1 prepare and file with the Commission as soon as practicable a Registration Statement with respect to such Registrable Securities and use its reasonable best efforts to cause such Registration Statement to become effective and remain effective until all Registrable Securities have ceased to be Registrable Securities;

4.1.2 prepare and file with the Commission such amendments and post-effective amendments to the Registration Statement, and such supplements to the Prospectus, as may be reasonably requested by any Holder that holds at least 5% of the Registrable Securities registered on such Registration Statement or any Underwriter of Registrable Securities or as may be required by the rules, regulations or instructions applicable to the registration form used by the Company or by the Securities Act or rules and regulations thereunder to keep the Registration Statement effective until all Registrable Securities covered by such Registration Statement are sold in accordance with the intended plan of distribution set forth in such Registration Statement or supplement to the Prospectus;

4.1.3 prior to filing a Registration Statement or Prospectus, or any amendment or supplement thereto, furnish without charge to the Underwriters, if any, and the Holders of Registrable Securities included in such Registration, and such Holders’ legal counsel, copies of such Registration Statement as proposed to be filed, each amendment and supplement to such Registration Statement (in each case including all exhibits thereto and documents incorporated by reference therein), the Prospectus included in such Registration Statement (including each preliminary Prospectus), and such other documents as the Underwriters and the Holders of Registrable Securities included in such Registration or the legal counsel for any such Holders may request to facilitate the disposition of the Registrable Securities owned by such Holders;

4.1.4 prior to any public offering of Registrable Securities, use its reasonable best efforts to (a) register or qualify the Registrable Securities covered by the Registration Statement under such securities or “blue sky” laws of such jurisdictions in the United States as the Holders of Registrable Securities included in such Registration Statement (in light of their intended plan of distribution) may request (or provide evidence satisfactory to such Holders that the Registrable Securities are exempt from such registration or qualification) and (b) take such action necessary to cause such Registrable Securities covered by the Registration Statement to be registered with or approved by such other Governmental Authorities as may be necessary by virtue of the business and operations of the Company and do any and all other acts and things that may be necessary or advisable to enable the Holders of Registrable Securities included in such Registration Statement to consummate the disposition of such Registrable Securities in such jurisdictions; provided, however, that the Company shall not be required to qualify generally to do business in any jurisdiction where it would not otherwise be required to qualify or take any action to which it would be subject to general service of process or taxation in any such jurisdiction where it is not then otherwise so subject;

4.1.5 cause all such Registrable Securities to be listed on each securities exchange or automated quotation system on which similar securities issued by the Company are then listed;

4.1.6 provide a transfer agent or warrant agent, as applicable, and registrar for all such Registrable Securities no later than the effective date of such Registration Statement;

4.1.7 advise each seller of such Registrable Securities, promptly after it shall receive notice or obtain knowledge thereof, of the issuance of any stop order by the Commission suspending the effectiveness of such Registration Statement or the initiation or threatening of any proceeding for such purpose and promptly use its reasonable best efforts to prevent the issuance of any stop order or to obtain its withdrawal if such stop order should be issued;

4.1.8 at least five days prior to the filing of any Registration Statement or Prospectus or any amendment or supplement to such Registration Statement or Prospectus or any document that is to be incorporated by reference into such Registration Statement or Prospectus (or such shorter period of time as may be necessary in order to comply with the Securities Act, the Exchange Act, and the rules and regulations promulgated under the Securities Act or Exchange Act, as applicable), furnish, without charge, a copy thereof to each seller of such Registrable Securities or its counsel (excluding any exhibits thereto and any filing made under the Exchange Act that is to be incorporated by reference therein);

4.1.9 notify the Holders at any time when a Prospectus relating to such Registration Statement is required to be delivered under the Securities Act, of the happening of any event as a result of which the Prospectus included in such Registration Statement, as then in effect, includes a Misstatement, as applicable, and then to correct such Misstatement as set forth in Section 4.4 hereof;

4.1.10 permit representatives of the Holders, the Underwriters or other financial institutions facilitating each transaction, if any, and any attorney, consultant or accountant retained by such Holders or Underwriter to participate, at each such person’s own expense, in the preparation of the Registration Statement, and cause the Company’s officers, directors and employees to supply all information reasonably requested by any such representative, Underwriter, financial institution, attorney, consultant or accountant in connection with the Registration; provided, however, that such representatives, Underwriters or financial institutions agree to confidentiality arrangements reasonably satisfactory to the Company, prior to the release or disclosure of any such information;

4.1.11 obtain a “cold comfort” letter from the Company’s independent registered public accountants in the event of an Underwritten Offering or other disposition pursuant to a registration statement contemplated herein that is facilitated by a financial institution which the participating Holders may rely on, in customary form and covering such matters of the type customarily covered by “cold comfort” letters as the managing Underwriter may reasonably request, and reasonably satisfactory to a majority-in-interest of the participating Holders;

4.1.12 on the date the Registrable Securities are delivered for sale pursuant to such Registration, obtain an opinion, dated such date, of counsel representing the Company for the purposes of such Registration, addressed to the Holders, the placement agent or sales agent, if any, and the Underwriters or financial institution, if any, covering such legal matters with respect to the Registration in respect of which such opinion is being given as the Holders, placement agent, sales agent, Underwriter or financial institution may reasonably request and as are customarily included in such opinions and negative assurance letters, and reasonably satisfactory to a majority in interest of the participating Holders;

4.1.13 in the event of any Underwritten Offering or other disposition pursuant to a registration statement contemplated herein that is facilitated by a financial institution or similar agent, enter into and perform its obligations under an underwriting agreement, in usual and customary form, with the managing Underwriter of such offering or such applicable financial institution;

4.1.14 make available to its security holders, as soon as reasonably practicable, an earnings statement covering the period of at least 12 months beginning with the first day of the Company’s first full calendar quarter after the effective date of the Registration Statement which satisfies the provisions of Section 11(a) of the Securities Act and Rule 158 thereunder (or any successor rule promulgated thereafter by the Commission);

4.1.15 with respect to an Underwritten Offering pursuant to subsection 2.1.3, use its reasonable best efforts to make available senior executives of the Company to participate in customary “road show” presentations that may be reasonably requested by the Underwriter in such Underwritten Offering; and

4.1.16 otherwise, in good faith, cooperate reasonably with, and take such customary actions as may reasonably be requested by the Holders, in connection with such Registration.

4.2 Registration Expenses. The Registration Expenses of all Registrations shall be borne by the Company. It is acknowledged by the Holders that the Holders selling any Registrable Securities in an offering shall bear all incremental selling expenses relating to the sale of Registrable Securities, such as Underwriters’ commissions and discounts, brokerage fees, Underwriter marketing costs and, other than as set forth in the definition of “Registration Expenses,” all reasonable fees and expenses of any legal counsel representing the Holders, in each case, as mutually agreed amongst such Holders.

4.3 Requirements for Participation in Underwritten Offerings. Notwithstanding anything in this Agreement to the contrary, if any Holder does not provide the Company with its requested Holder Information, the Company may exclude such Holder’s Registrable Securities from the applicable Registration Statement or Prospectus if the Company determines, based on the advice of counsel, that such information is necessary to effect the registration and such Holder continues thereafter to withhold such information. No Holder may participate in any Underwritten Offering for equity securities of the Company pursuant to a Registration initiated by the Company hereunder unless such Holder (a) agrees to sell such Holder’s securities on the basis provided in any underwriting and other arrangements approved by the Company and (b) completes and executes all customary questionnaires, powers of attorney, indemnities, lock-up agreements, underwriting agreements and other customary documents as may be reasonably required under the terms of such underwriting arrangements. Subject to the minimum thresholds set forth in subsections 2.1.3 and 4.1.15 of this Agreement, the exclusion of a Holder’s Registrable Securities as a result of this Section 4.3 shall not affect the registration of the other Registrable Securities to be included in such Registration.

4.4 Suspension of Sales; Adverse Disclosure; Restrictions on Registration Rights.

4.4.1 Upon receipt of written notice from the Company that a Registration Statement or Prospectus contains a Misstatement, as applicable, each Holder shall forthwith discontinue disposition of Registrable Securities until it has received copies of a supplemented or amended Prospectus correcting such Misstatement (it being understood that the Company hereby covenants to prepare and file such supplement or amendment as soon as practicable after the time of such notice), or until it is advised in writing by the Company that the use of the Prospectus may be resumed.

4.4.2 If the filing, initial effectiveness or continued use of a Registration Statement in respect of any Registration at any time would require the Company to make an Adverse Disclosure, and the majority of the Board concludes as a result that it is essential to defer such filing, initial effectiveness or continued use at such time (a “Suspension Event”), the Company may, upon giving prompt written notice of such action to the Holders (a “Suspension Notice”), delay the filing or initial effectiveness of, or suspend use of, such Registration Statement for the shortest period of time, but in no event more than 45 days for a single Suspension Event, determined in good faith by the Company to be necessary for such purpose (a “Suspension Period”); provided that the Company shall not declare more than two Suspension Events in any 12-month period; provided further, that no Suspension Event shall be declared within the 30 days following the conclusion of a prior Suspension Period; provided further, that the total Suspension Period in any consecutive 12-month period shall not exceed an aggregate of 90 days. In the event the Company exercises its rights under the preceding sentence, the Holders agree to suspend, immediately upon their receipt of the notice referred to above, their use of the Prospectus relating to any Registration in connection with any sale or offer to sell Registrable Securities. The Company shall immediately notify the Holders of the expiration of any period during which it exercised its rights under this Section 4.4 (an “End of Suspension Notice”).

4.4.3 (a) During the period starting with the date 60 days prior to the Company’s good faith estimate of the date of the filing of, and ending on a date 120 days after the effective date of, a Company-initiated Registration and provided that the Company continues to actively employ, in good faith, all reasonable efforts to maintain the effectiveness of the applicable Shelf Registration Statement, or (b) if, pursuant to subsection 2.1.3, a Demanding Holder has requested an Underwritten Shelf Takedown and the Company and such Demanding Holder are unable to obtain the commitment of Underwriters to firmly underwrite such offering, the Company may, upon giving prompt written notice of such action to the Holders, delay any other registered offering pursuant to subsection 2.1.3.

4.5 Reporting Obligations. As long as any Holder shall own Registrable Securities, the Company, at all times while it shall be a reporting company under the Exchange Act, covenants to file timely (or obtain extensions in respect thereof and file within the applicable grace period) all reports required to be filed by the Company after the date hereof pursuant to Sections 13(a) or 15(d) of the Exchange Act and to promptly furnish the Holders with true and complete copies of all such filings; provided that any documents publicly filed or furnished with the Commission pursuant to the Electronic Data Gathering, Analysis and Retrieval System shall be deemed to have been furnished or delivered to the Holders pursuant to this Section 4.5.

4.6 Other Obligations. In connection with a sale or transfer of Registrable Securities exempt from Section 5 of the Securities Act or through any broker-dealer transactions described in the plan of distribution set forth within the Prospectus and pursuant to the Registration Statement of which such Prospectus forms a part, the Company shall, subject to the receipt of any customary documentation reasonably required from the applicable Holders and/or their broker(s) in connection therewith, (a) promptly instruct its transfer agent to remove any restrictive legends applicable to the Registrable Securities being sold or transferred and (b) cause its legal counsel to deliver the necessary legal opinions, if any, to the transfer agent in connection with the instruction under subclause (a). In addition, the Company shall cooperate reasonably with, and take such customary actions as may reasonably be requested by the Holders, in connection with the aforementioned sales or transfers; provided, however, that the Company shall have no obligation to participate in any “road shows” or assist with the preparation of any offering memoranda or related documentation with respect to any sale or transfer of Registrable Securities in any transaction that does not constitute an Underwritten Offering.

Article V

INDEMNIFICATION AND CONTRIBUTION

5.1 Indemnification.

5.1.1 The Company agrees to indemnify, to the extent permitted by law, each Holder, its officers and directors and each person who controls such Holder (within the meaning of the Securities Act) against all losses, claims, damages, liabilities and expenses (including reasonable attorneys’ fees) caused by any (a) Misstatement contained in any Registration Statement, Prospectus or preliminary Prospectus or any amendment thereof or supplement thereto, as applicable, or (b) any violation or alleged violation by the Company of the Securities Act or any other applicable federal or state securities laws or any rule or regulation promulgated thereunder application and relating to action or inaction required of the Company in connection with any such registration, qualification or compliance, except, in each case, insofar as the same are caused by or contained in any information or affidavit furnished in writing to the Company by or on behalf of such Holder expressly for use therein.

5.1.2 In connection with any Registration Statement in which a Holder is participating, such Holder shall furnish to the Company in writing such information and affidavits as the Company reasonably requests for use in connection with any such Registration Statement or Prospectus (the “Holder Information”) and, to the extent permitted by law, shall indemnify the Company, its directors and officers and agents and each person who controls the Company (within the meaning of the Securities Act) against any losses, claims, damages, liabilities and expenses (including without limitation reasonable and documented, out-of-pocket attorneys’ fees) resulting from any Misstatement contained in the Registration Statement, Prospectus or preliminary Prospectus or any amendment thereof or supplement thereto, as applicable, but only to the extent that such Misstatement is contained in any information or affidavit so furnished in writing by such Holder expressly for use therein; provided, however, that the obligation to indemnify shall be several, not joint and several, among such Holders, and the liability of each such Holder shall be in proportion to and limited to the net proceeds received by such Holder from the sale of Registrable Securities pursuant to such Registration Statement.

5.1.3 Any person entitled to indemnification herein shall (a) give prompt written notice to the indemnifying party of any claim with respect to which it seeks indemnification (provided that the failure to give prompt notice shall not impair any person’s right to indemnification hereunder to the extent such failure has not materially prejudiced the indemnifying party) and (b) unless in such indemnified party’s reasonable judgment a conflict of interest between such indemnified and indemnifying parties may exist with respect to such claim, permit such indemnifying party to assume the defense of such claim with counsel reasonably satisfactory to the indemnified party. If such defense is assumed, the indemnifying party shall not be subject to any liability for any settlement made by the indemnified party without its consent (but such consent shall not be unreasonably withheld). An indemnifying party who is not entitled to, or elects not to, assume the defense of a claim shall not be obligated to pay the fees and expenses of more than one counsel for all parties indemnified by such indemnifying party with respect to such claim, unless in the reasonable judgment of any indemnified party a conflict of interest may exist between such indemnified party and any other of such indemnified parties with respect to such claim. No indemnifying party shall, without the consent of the indemnified party, consent to the entry of any judgment or enter into any settlement which cannot be settled in all respects by the payment of money (and such money is so paid by the indemnifying party pursuant to the terms of such settlement) or which settlement does not include as an unconditional term thereof the giving by the claimant or plaintiff to such indemnified party of a release from all liability in respect to such claim or litigation.

5.1.4 The indemnification provided for under this Agreement shall remain in full force and effect regardless of any investigation made by or on behalf of the indemnified party or any officer, director or controlling person of such indemnified party and shall survive the transfer of securities. The Company and each Holder participating in an offering also agrees to make such provisions as are reasonably requested by any indemnified party for contribution to such party in the event the Company’s or such Holder’s indemnification is unavailable for any reason.

5.1.5 If the indemnification provided under this Section 5.1 from the indemnifying party is unavailable or insufficient to hold harmless an indemnified party in respect of any losses, claims, damages, liabilities and expenses referred to herein, then the indemnifying party, in lieu of indemnifying the indemnified party, shall contribute to the amount paid or payable by the indemnified party as a result of such losses, claims, damages, liabilities and expenses in such proportion as is appropriate to reflect the relative fault of the indemnifying party and the indemnified party, as well as any other relevant equitable considerations. The relative fault of the indemnifying party and indemnified party shall be determined by reference to, among other things, whether any action in question, including any untrue or alleged untrue statement of a material fact or omission or alleged omission to state a material fact, was made by, or relates to information supplied by, such indemnifying party or indemnified party, and the indemnifying party’s and indemnified party’s relative intent, knowledge, access to information and opportunity to correct or prevent such action; provided, however, that the liability of any Holder under this subsection 5.1.5 shall be limited to the amount of the net proceeds received by such Holder in such offering giving rise to such liability. The amount paid or payable by a party as a result of the losses or other liabilities referred to above shall be deemed to include, subject to the limitations set forth in subsections 5.1.1, 5.1.2 and 5.1.3 above, any legal or other fees, charges or expenses reasonably incurred by such party in connection with any investigation or proceeding. The parties hereto agree that it would not be just and equitable if contribution pursuant to this subsection 5.1.5 were determined by pro rata allocation or by any other method of allocation, which does not take account of the equitable considerations referred to in this subsection 5.1.5. No person guilty of fraudulent misrepresentation (within the meaning of Section 11(f) of the Securities Act) shall be entitled to contribution pursuant to this subsection 5.1.5 from any person who was not guilty of such fraudulent misrepresentation.

Article VI

MISCELLANEOUS

6.1 Notices. All notices or other communications required or permitted to be given hereunder shall be in writing and shall be delivered by hand or electronic mail or postage prepaid mail (registered or certified) or nationally recognized overnight courier service and shall be deemed given when so delivered by hand or electronic mail, or if mailed, three days after mailing (one Business Day in the case of overnight courier service), as follows:

(a)	If to the Company, to:

Terra Innovatum

Via Matteo Trenta 117

Lucca, Italy

Attention: Alessandro Petruzzi, CEO

Email: a.petruzzi@terrainnovatum.com

with a copy to:

Loeb & Loeb LLP

345 Park Avenue

New York, NY 10154

Attention: Mitchell S. Nussbaum ;Tahra Wright ;Rima Moawad

Email: mnussbaum@loeb.com/twright@loeb.com/rmoawad@loeb.com

(b)	If to GSR III, to:

GSR III Acquisition Corp.

5900 Balcones Drive, Suite 100

Austin, TX 78731

Attention: Co-Chief Executive Officers

Email: gus@gsrspac.com; lew@gsrspac.com

with copies (which shall not constitute notice) to:

Latham & Watkins LLP

10250 Constellation Blvd., Suite 1100

Los Angeles, CA 90067

Attention: Steven Stokdyk; Brian Duff

Email: Steven.Stokdyk@lw.com; Brian.Duff@lw.com

If to any other Holder, at such Holder’s address or facsimile number as set forth in the Company’s books and records.

Any party may change its address for notice at any time and from time to time by written notice to the other parties hereto, and such change of address shall become effective 10 days after delivery of such notice as provided in this Section 6.1.

6.2 Assignment; No Third Party Beneficiaries.

6.2.1 This Agreement and the rights, duties and obligations of the Company hereunder may not be assigned or delegated by the Company in whole or in part.

6.2.2 Prior to the expiration of the Lock-Up Period with respect to any Lock-Up Shares of a Locked-Up Holder, such Holder may not assign or delegate such Locked-Up Holder’s rights, duties or obligations under this Agreement in connection with a Transfer of such Locked-Up Holder’s Registrable Securities, in whole or in part, except in connection with a Transfer pursuant to Section 3.2.

6.2.3 After the expiration of the Lock-Up Period with respect to Lock-Up Shares held by a Locked-Up Holder, and, at any time with respect to Registrable Securities held by any other Holder, each such Holder may assign or delegate its rights, duties or obligations under this Agreement in connection with a Transfer of such Holder’s Registrable Securities, in whole or in part, to (a) any of such Holder’s Permitted Transferees, provided, that each such Permitted Transferee holds, after giving effect to such assignment or delegation, at least 2% of the then-outstanding Company Ordinary Shares, (b) an Affiliate of such Holder, (c) direct and/or indirect equity holders of any Holder pursuant to a distribution as described in Section 6.14 of this Agreement or (d) with the prior written consent of the Company, any other entity or person.

6.2.4 This Agreement and the provisions hereof shall be binding upon and shall inure to the benefit of each of the parties and its successors and the permitted assigns of the Holders.

6.2.5 Other than as expressly set forth herein, this Agreement is for the sole benefit of the parties hereto and their respective successors and permitted assigns and nothing in this Agreement expressed or implied shall give or be construed to give to any person or entity, other than the parties hereto and such successors and permitted assigns, any legal or equitable rights under this Agreement.

6.2.6 No assignment by any party hereto of such party’s rights, duties and obligations hereunder shall be binding upon or obligate the Company unless and until the Company shall have received (a) written notice of such assignment as provided in Section 6.1 hereof and (b) the written agreement of the assignee, in a form reasonably satisfactory to the Company, to be bound by the terms and provisions of this Agreement (which may be accomplished by an addendum or certificate of joinder to this Agreement). Any transfer or assignment made other than as provided in this Section 6.2 shall be null and void.

6.3 Execution of Agreement. This Agreement may be executed in one or more counterparts, all of which shall be considered one and the same agreement, and shall become effective when one or more such counterparts have been signed by each of the parties and delivered to the other party. Facsimile or electronic mail transmission of counterpart signatures to this Agreement shall be acceptable and binding.

6.4 Governing Law; Venue.

6.4.1 This Agreement and all disputes, claims or controversies relating to, arising out of, or in connection with this Agreement shall be governed by and construed in accordance with the internal laws of the State of Delaware applicable to contracts executed in and to be performed in the State of Delaware, without giving effect to any choice of law or conflict of laws, rules or provisions (whether of the State of Delaware or any other jurisdiction) that would cause the application of the laws of any jurisdiction other than the State of Delaware.

6.4.2 Any proceeding or Action based upon, arising out of or related to this Agreement must be brought in the Court of Chancery of the State of Delaware (or, to the extent such Court does not have subject matter jurisdiction, the Superior Court of the State of Delaware), or, if it has or can acquire jurisdiction, in the United States District Court for the District of Delaware, and each of the parties irrevocably submits to the exclusive jurisdiction of each such court in any such proceeding or Action, waives any objection it may now or hereafter have to personal jurisdiction, venue or to convenience of forum, agrees that all claims in respect of the proceeding or Action shall be heard and determined only in any such court, and agrees not to bring any proceeding or Action arising out of or relating to this Agreement in any other court. Nothing herein contained shall be deemed to affect the right of any party to serve process in any manner permitted by Law or to commence Legal Proceedings or otherwise proceed against any other party in any other jurisdiction, in each case, to enforce judgments obtained in any Action, suit or proceeding brought pursuant to this subsection 6.4.2.

6.5 Waiver of Jury Trial. Each party acknowledges and agrees that any controversy which may arise under this Agreement is likely to involve complicated and difficult issues, and therefore each such party hereby irrevocably, unconditionally and voluntarily waives any right such party may have to a trial by jury in respect of any Action, suit or proceeding directly or indirectly arising out of or relating to this Agreement.

6.6 Amendments and Waivers. Only upon the written consent of the Company and the Holders of at least a majority in interest of the total Registrable Securities at the time in question as determined in good faith by the Company, compliance with any of the provisions, covenants and conditions set forth in this Agreement may be waived, or any of such provisions, covenants or conditions may be amended or modified; provided, however, that notwithstanding the foregoing, any amendment hereto or waiver hereof that adversely affects one Holder, solely in its capacity as a holder of the shares of capital stock of the Company, in a manner that is materially different from the other Holders (in such capacity) shall require the consent of the Holder so affected. No provision of this Agreement may be waived unless such waiver is in writing and signed by the party or parties against whom such waiver is to be effective. No course of dealing between any Holder or the Company and any other party hereto or any failure or delay on the part of a Holder or the Company in exercising any rights or remedies under this Agreement shall operate as a waiver of any rights or remedies of any Holder or the Company. No single or partial exercise of any rights or remedies under this Agreement by a party shall operate as a waiver or preclude the exercise of any other rights or remedies hereunder or thereunder by such party. The rights and remedies of the parties hereunder are cumulative and are not exclusive of any rights or remedies that they would otherwise have hereunder.

6.7 Other Registration Rights. Other than the registration rights set forth in the Original Agreement, the subscribers who have registration rights pursuant to the transactions contemplated by that certain PIPE Subscription Agreements, dated September 23, 2025 and September 30, 2025, by and among, among others, GSR III and the subscribers set forth therein, the Company represents and warrants that no person, other than a Holder of Registrable Securities hereunder, has any right to require the Company to register any securities of the Company for sale or to include such securities of the Company in any Registration Statement filed by the Company for the sale of securities for its own account or for the account of any other person. The Company shall not hereafter enter into any agreement with respect to its securities which is inconsistent with or violates the rights granted to any Holder of Registrable Securities in this Agreement, including any agreement that would allow such current or future holder to require the Company to include securities in any registration statement filed by the Company for such holders on a basis other than pari passu with, or expressly subordinate to, the registration rights of the Holders hereunder provided. Further, the Company represents and warrants that this Agreement supersedes any other registration rights agreement or agreement with similar terms and conditions and in the event of a conflict between any such agreement or agreements and this Agreement, the terms of this Agreement shall prevail. Notwithstanding any other rights and remedies the Holders may have in respect of the Company pursuant to this Agreement, if the Company enters into any other registration rights or similar agreement with respect to any of its securities that contains provisions that violate this Section 6.7, the terms and conditions of such agreement shall immediately be deemed to have been amended without further action by the Company or any Holder, so that such Holders shall each be entitled to the benefit of any such more favorable or less restrictive terms or conditions, as the case may be.

6.8 Rule 144. With a view to making available to the Holders the benefits of Rule 144 promulgated under the Securities Act, the Company covenants that it will (a) make available information necessary to comply with Rule 144, if available with respect to resales of the Registrable Securities under the Securities Act, at all times, and (b) cooperate with any Holder and take such further action as the Holders may reasonably request, all to the extent required from time to time to enable such Holders to sell Registrable Securities without registration under the Securities Act within the limitation of the exemptions provided by Rule 144 promulgated under the Securities Act (if available with respect to resales of the Registrable Securities), as such rule may be amended from time to time. Upon the reasonable request of any Holder, the Company will deliver to it a written statement as to whether they have complied with such information requirements, and, if not, the specific reasons for non-compliance. This Section 6.8 shall survive the termination of the Agreement so long as any Holder continues to hold Registrable Securities.

6.9 Term. This Agreement shall terminate with respect to any Holder on the date that such Holder no longer holds any Registrable Securities, except as otherwise provided herein. The provisions of Section 4.5 and Article V shall survive any termination.

6.10 Holder Information. Each Holder agrees, if requested in writing, to represent to the Company the total number of Registrable Securities held by such Holder for the Company to make determinations hereunder, including, without limitation, for purposes of Section 6.8 hereof.

6.11 Severability. It is the desire and intent of the parties that the provisions of this Agreement be enforced to the fullest extent permissible under the laws and public policies applied in each jurisdiction in which enforcement is sought. Accordingly, if any particular provision of this Agreement shall be adjudicated by a court of competent jurisdiction to be invalid, prohibited or unenforceable for any reason, such provision, as to such jurisdiction, shall be ineffective, without invalidating the remaining provisions of this Agreement or affecting the validity or enforceability of this Agreement or affecting the validity or enforceability of such provision in any other jurisdiction. Notwithstanding the foregoing, if such provision could be more narrowly drawn so as not to be invalid, prohibited or unenforceable in such jurisdiction, it shall, as to such jurisdiction, be so narrowly drawn, without invalidating the remaining provisions of this Agreement or affecting the validity or enforceability of such provision in any other jurisdiction.

6.12 Specific Performance. The parties agree that irreparable damage would occur in the event that any of the provisions of this Agreement were not performed in accordance with their specific terms or were otherwise breached. It is accordingly agreed that the Company shall be entitled to an injunction or injunctions to prevent breaches of this Agreement by a Holder and to enforce specifically the terms and provisions hereof.

6.13 Entire Agreement; Restatement. This Agreement constitutes the full and entire agreement and understanding between the parties with respect to the subject matter hereof and supersedes all prior agreements and understandings relating to such subject matter. Upon the Closing Date, the Original Agreement and all of the respective rights and obligations of the parties thereunder are terminated in their entirety and shall no longer be of any force or effect. Upon any amendment or restatement, this Agreement shall no longer be of any force or effect.

6.14 Distributions. In the event that any Holder distributes, or has distributed, any of its Registrable Securities to its direct and/or indirect equity holders, such distributees shall be treated as the applicable Holder hereunder; provided that only the holders of a majority-in-interest of the Registrable Securities held by all such distributees, as determined in good faith by the Company, shall be entitled to take any action under this Agreement that such Holder is entitled to take, provided, further, that such distributees, taken as a whole, shall not be entitled to rights in excess of those conferred to the applicable Holder, as if it remained a single entity party to this Agreement.

6.15 Adjustments. If, and as often as, there are any changes in the Registrable Securities by way of stock split, stock dividend, combination or reclassification, or through merger, consolidation, reorganization, recapitalization or sale, or by any other means, appropriate adjustment shall be made in the provisions of this Agreement, as may be required, so that the rights, privileges, duties and obligations hereunder shall continue with respect to the Registrable Securities as so changed.

6.16 Further Assurances. From time to time, at another party’s request and without further consideration (but at the requesting party’s reasonable cost and expense), each party shall execute and deliver such additional documents and take all such further action as may be reasonably necessary to consummate the transactions contemplated by this Agreement.

6.17 Opt-Out Notices. Any Holder may deliver written notice (an “Opt-Out Notice”) to the Company requesting that such Holder not receive notice from the Company of the proposed filing or withdrawal of any Shelf Registration Statement or Piggyback Registration, or any event that would lead to a Suspension Event as contemplated by Section 4.4; provided, however, that such Holder may later revoke any such Opt-Out Notice in writing. Following receipt of an Opt-Out Notice from a Holder (unless subsequently revoked), the Company shall not deliver any notice to such Holder pursuant to Sections 2.1, 2.2 or 4.4, as applicable, and such Holder shall no longer be entitled to the rights associated with any such notice. Each time prior to a Holder’s intended use of an effective Shelf Registration Statement, such Holder will notify the Company in writing at least two Business Days in advance of such intended use. If a Suspension Notice was previously delivered (or would have been delivered but for the provisions of this Section 6.17) and the Suspension Event remains in effect, the Company will so notify such Holder, within one Business Day of such Holder’s notification to the Company, by delivering to such Holder a copy of such previous notice of such Suspension Event, and thereafter will provide such Holder with the related End of Suspension Notice immediately upon its availability.

[SIGNATURE PAGES FOLLOW]

IN WITNESS WHEREOF, the parties hereto have duly executed this Agreement as of the date first above written.

Terra Innovatum Global N.V.
By:	/s/ Alessandro Petruzzi
	Name:	Alessandro Petruzzi
	Title:	Chief Executive Officer